{
  "cells": [
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "Wf5KrEb6vrkR"
      },
      "source": [
        "# Welcome to Colab!"
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "C1XfGyQXQK1n"
      },
      "source": [
        "## Access popular AI models via Google-Colab-AI Without an API Key\n",
        "All users have access to most popular LLMs via the `google-colab-ai` Python library, and paid users have access to a wider selection of models. For more details, refer to the [getting started with google colab ai](https://colab.research.google.com/github/googlecolab/colabtools/blob/main/notebooks/Getting_started_with_google_colab_ai.ipynb).\n",
        "\n"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "JQesyTg7QSU-"
      },
      "outputs": [],
      "source": [
        "from google.colab import ai\n",
        "response = ai.generate_text(\"What is the capital of France?\")\n",
        "print(response)"
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "-sdyeRMXPvU_"
      },
      "source": [
        "## Explore the Gemini API\n",
        "The Gemini API gives you access to Gemini models created by Google DeepMind. Gemini models are built from the ground up to be multimodal, so you can reason seamlessly across text, images, code, and audio.\n",
        "\n",
        "**How to get started?**\n",
        "*  Go to [Google AI Studio](https://aistudio.google.com/) and log in with your Google account.\n",
        "*  [Create an API key](https://aistudio.google.com/app/apikey).\n",
        "* Use a quickstart for [Python](https://colab.research.google.com/github/google-gemini/cookbook/blob/main/quickstarts/Get_started.ipynb), or call the REST API using [curl](https://colab.research.google.com/github/google-gemini/cookbook/blob/main/quickstarts/rest/Prompting_REST.ipynb).\n",
        "\n",
        "**Discover Gemini's advanced capabilities**\n",
        "*  Play with Gemini [multimodal outputs](https://colab.research.google.com/github/google-gemini/cookbook/blob/main/quickstarts/Image-out.ipynb), mixing text and images in an iterative way.\n",
        "*  Discover the [multimodal Live API](https://colab.research.google.com/github/google-gemini/cookbook/blob/main/quickstarts/Get_started_LiveAPI.ipynb ) (demo [here](https://aistudio.google.com/live)).\n",
        "*  Learn how to [analyze images and detect items in your pictures](https://colab.research.google.com/github/google-gemini/cookbook/blob/main/quickstarts/Spatial_understanding.ipynb\") using Gemini (bonus, there's a [3D version](https://colab.research.google.com/github/google-gemini/cookbook/blob/main/examples/Spatial_understanding_3d.ipynb) as well!).\n",
        "*  Unlock the power of [Gemini thinking model](https://colab.research.google.com/github/google-gemini/cookbook/blob/main/quickstarts/Get_started_thinking.ipynb), capable of solving complex task with its inner thoughts.\n",
        "      \n",
        "**Explore complex use cases**\n",
        "*  Use [Gemini grounding capabilities](https://colab.research.google.com/github/google-gemini/cookbook/blob/main/examples/Search_grounding_for_research_report.ipynb) to create a report on a company based on what the model can find on internet.\n",
        "*  Extract [invoices and form data from PDF](https://colab.research.google.com/github/google-gemini/cookbook/blob/main/examples/Pdf_structured_outputs_on_invoices_and_forms.ipynb) in a structured way.\n",
        "*  Create [illustrations based on a whole book](https://colab.research.google.com/github/google-gemini/cookbook/blob/main/examples/Book_illustration.ipynb) using Gemini large context window and Imagen.\n",
        "\n",
        "To learn more, check out the [Gemini cookbook](https://github.com/google-gemini/cookbook) or visit the [Gemini API documentation](https://ai.google.dev/docs/).\n"
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "Nma_JWh-W-IF"
      },
      "source": [
        "Colab now has AI features powered by [Gemini](https://gemini.google.com). The video below provides information on how to use these features, whether you're new to Python, or a seasoned veteran.\n",
        "\n",
        "<center>\n",
        "  <a href=\"https://www.youtube.com/watch?v=V7RXyqFUR98\" target=\"_blank\">\n",
        "  <img alt='Thumbnail for a video showing 3 AI-powered Google Colab features' src=\"data:image/png;base64,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\" height=\"188\" width=\"336\">\n",
        "  </a>\n",
        "</center>"
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "5fCEDCU_qrC0"
      },
      "source": [
        "<div class=\"markdown-google-sans\">\n",
        "  <h2>What is Colab?</h2>\n",
        "</div>\n",
        "\n",
        "Colab, or \"Colaboratory\", allows you to write and execute Python in your browser, with\n",
        "- Zero configuration required\n",
        "- Access to GPUs free of charge\n",
        "- Easy sharing\n",
        "\n",
        "Whether you're a **student**, a **data scientist** or an **AI researcher**, Colab can make your work easier. Watch [Introduction to Colab](https://www.youtube.com/watch?v=inN8seMm7UI) or [Colab Features You May Have Missed](https://www.youtube.com/watch?v=rNgswRZ2C1Y) to learn more, or just get started below!"
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "GJBs_flRovLc"
      },
      "source": [
        "<div class=\"markdown-google-sans\">\n",
        "\n",
        "## **Getting started**\n",
        "</div>\n",
        "\n",
        "The document you are reading is not a static web page, but an interactive environment called a **Colab notebook** that lets you write and execute code.\n",
        "\n",
        "For example, here is a **code cell** with a short Python script that computes a value, stores it in a variable, and prints the result:"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "gJr_9dXGpJ05",
        "outputId": "beb4aaca-6eac-4b30-f2ff-ea4308968122"
      },
      "outputs": [
        {
          "data": {
            "text/plain": [
              "86400"
            ]
          },
          "execution_count": null,
          "metadata": {},
          "output_type": "execute_result"
        }
      ],
      "source": [
        "seconds_in_a_day = 24 * 60 * 60\n",
        "seconds_in_a_day"
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "2fhs6GZ4qFMx"
      },
      "source": [
        "To execute the code in the above cell, select it with a click and then either press the play button to the left of the code, or use the keyboard shortcut \"Command/Ctrl+Enter\". To edit the code, just click the cell and start editing.\n",
        "\n",
        "Variables that you define in one cell can later be used in other cells:"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "-gE-Ez1qtyIA",
        "outputId": "e8f0c2b1-3c1e-4476-f8c2-d8f31cdb5e75"
      },
      "outputs": [
        {
          "data": {
            "text/plain": [
              "604800"
            ]
          },
          "execution_count": null,
          "metadata": {},
          "output_type": "execute_result"
        }
      ],
      "source": [
        "seconds_in_a_week = 7 * seconds_in_a_day\n",
        "seconds_in_a_week"
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "lSrWNr3MuFUS"
      },
      "source": [
        "Colab notebooks allow you to combine **executable code** and **rich text** in a single document, along with **images**, **HTML**, **LaTeX** and more. When you create your own Colab notebooks, they are stored in your Google Drive account. You can easily share your Colab notebooks with co-workers or friends, allowing them to comment on your notebooks or even edit them. To learn more, see [Overview of Colab](/notebooks/basic_features_overview.ipynb). To create a new Colab notebook you can use the File menu above, or use the following link: [create a new Colab notebook](http://colab.research.google.com#create=true).\n",
        "\n",
        "Colab notebooks are Jupyter notebooks that are hosted by Colab. To learn more about the Jupyter project, see [jupyter.org](https://www.jupyter.org)."
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "UdRyKR44dcNI"
      },
      "source": [
        "<div class=\"markdown-google-sans\">\n",
        "\n",
        "## Data science\n",
        "</div>\n",
        "\n",
        "With Colab you can harness the full power of popular Python libraries to analyze and visualize data. The code cell below uses **numpy** to generate some random data, and uses **matplotlib** to visualize it. To edit the code, just click the cell and start editing."
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "4_kCnsPUqS6o"
      },
      "source": [
        "You can import your own data into Colab notebooks from your Google Drive account, including from spreadsheets, as well as from Github and many other sources. To learn more about importing data, and how Colab can be used for data science, see the links below under [Working with Data](#working-with-data)."
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "height": 249
        },
        "id": "C4HZx7Gndbrh",
        "outputId": "65838ba2-0ea9-41b7-e3f9-a725be449d3b"
      },
      "outputs": [
        {
          "data": {
            "text/markdown": [
              "![Sample Visualization](data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAASAAAADYCAYAAABLNT5AAAAAOXRFWHRTb2Z0d2FyZQBNYXRwbG90bGliIHZlcnNpb24zLjYuMSwgaHR0cHM6Ly9tYXRwbG90bGliLm9yZy/av/WaAAAACXBIWXMAAAsTAAALEwEAmpwYAABA6UlEQVR4nO29eZQUVZ73/Y2MyKX2AqoKWUUFpChAVpXRplUG9YyKLbjxSg+uHNt2jtO+zul+n/bpZdpRWkdb7WYe27d1pO1umFHHdm1EwQVBxGKHgqIQCmqj1twzI2N9/oi4kRGZkVWZtUVVcT/ncKiKzIq8ERnxvb/t/oJRVVUFhUKhOIDL6QFQKJRzFypAFArFMagAUSgUx6ACRKFQHIMKEIVCcQwqQBQKxTGoAFEoFMegAkShUByDChCFQnEMKkAUCsUxqABRKBTHoAI0BPi3f/s3VFVVYc6cOZg7dy6+/vrrAf28q666CtXV1Vm997XXXsOqVass2zo6OlBeXo5EIoG/+7u/69exvfbaa3j44YcBAC+99BL++Mc/5ryPzz77DDt37jR+7+1+KAMP5/QAznW++uorvP/++9i7dy+8Xi86OjogCILTwzJYsWIFHnvsMcRiMeTn5wMA3nzzTSxfvhxer9dyo/c3Dz74YK/+7rPPPkNhYaEhjr3dD2XgoRaQw7S0tKCsrAxerxcAUFZWhvHjxwMA/vVf/xWLFi3CrFmzsHbtWpDGBVdddRV+9KMfYcmSJaisrMQ333yDFStWYNq0aXj88ccBAPX19ZgxYwbWrFmDOXPm4NZbb0UsFkv7/C1btmDx4sWYP38+brvtNkQiEcvrxcXFWLJkCd577z1j26ZNmwyrqLCw0DiOJUuWYO7cuZg1axa2b99ueR3QhOvuu+8GALz33nu47LLLMG/ePPz93/89Wltb08b2i1/8Av/+7/+O5uZmzJ071/jHsixOnz5tu4/6+nq89NJL+M1vfoO5c+di+/btxn4AYP/+/bj88ssxZ84c3HLLLfD7/cY5/fGPf4xLL70U06dPN8ZPGVioADnMtddei4aGBkyfPh0PPfQQPv/8c+O1hx9+GN988w0OHz6MeDyO999/33jN4/Hgiy++wIMPPoibb74Z69evx+HDh/Haa6+hs7MTAFBbW4u1a9fi4MGDKC4uxn/8x39YPrujowNPPPEEPvnkE+zduxcLFy7Ec889lzbGVatWYdOmTQCA5uZmHD9+HFdffbXlPX/5y19w3XXXYf/+/Thw4ADmzp3b7XFfeeWV2LVrF/bt24c777wTTz/9dMb3jh8/Hvv378f+/fvxwAMPYOXKlTj//PNt9zFlyhQ8+OCD+NGPfoT9+/fjO9/5jmVf//iP/4hf//rXOHjwIGbPno1f/vKXxmuSJGH37t14/vnnLdspAwd1wRymsLAQe/bswfbt2/Hpp5/ijjvuwLp163D33Xfj008/xdNPP41YLIauri5UVVXhpptuAgAsX74cADB79mxUVVVh3LhxAIALL7wQDQ0NKC0txaRJk3DFFVcAAFavXo0XX3wRjz32mPHZu3btQk1NjfEeQRCwePHitDHeeOONeOihhxAKhfDf//3fuPXWW8GyrOU9ixYtwr333gtRFPG9732vRwFqbGzEHXfcgZaWFgiCgAsuuKDHc7Vjxw784Q9/MKyTXPcRDAYRCATw3e9+FwCwZs0a3HbbbcbrK1asAAAsWLAA9fX1PY6H0neoBTQEYFkWV111FX75y1/id7/7Hd566y3wPI+HHnoIb775Jg4dOoQHHngAPM8bf0NcNpfLZfxMfpckCQDAMIzlc1J/V1UVy5YtM6yLmpoavPLKK2njy8vLw/XXX4+3337b4n6ZWbJkCb744gtMmDAB3//+942gr/kzzeP/p3/6Jzz88MM4dOgQfv/731tes6OlpQX33Xcf/uu//stw63LdR0+Q88iyrHEOKQMLFSCHqa2tRV1dnfH7/v37cf755xs3U1lZGSKRCN58882c933mzBl89dVXAICNGzfiyiuvtLx++eWXY8eOHThx4gQAIBaL4fjx47b7WrVqFZ577jm0trbi8ssvT3v99OnTqKiowAMPPID77rsPe/fuBQCMHTsWR48ehaIoePvtt433B4NBTJgwAQCwYcOGbo9DFEXcfvvt+PWvf43p06f3uI+ioiKEw+G0/ZSUlGDUqFGGBfX6668b1hDFGagAOUwkEsGaNWswc+ZMzJkzBzU1NfjFL36B0tJSPPDAA5g9eza+973vYdGiRTnvu7KyEhs2bMCcOXPQ1dWFH/zgB5bXy8vLjTT7nDlzcPnll+PYsWO2+7r22mvR3NyMO+64I82SArTM09y5czFv3jy89dZbeOSRRwAA69atw4033ohrrrnGcBMBLcB822234Tvf+Q7Kysq6PY6dO3fim2++wc9//nMjEN3c3JxxHzfddBPefvttIwhtZsOGDfiXf/kXzJkzB/v378fPfvaz7k8iZUBhaE/okUl9fT1uvPFGHD582OmhUCgZoRYQhUJxDGoBUSgUx6AWEIVCcQwqQBQKxTGoAFEoFMcYcpXQZWVlmDJlitPDoFDOOerr69HR0TGonznkBGjKlClZt4qgUCj9x8KFCwf9M6kLRqFQHIMKEIVCcQwqQBQKxTGoAFEoFMegAkTpNaqqYtuxVigKLaan9A4qQJRec7AxiHtfq8auU51OD4UyTKECROk1IV7U/o/T5l2U3kEFiNJr4oIMAOBF2eGRUIYrVIAovSauCw/5PyZIuPl3X+JQY9DJYVGGEVSAKL2GWD7EEmoO8DjQGMT+xoCDo6IMJ6gAUXoNEZ54ihBFEzQmRMkOKkCUXsNLivZ/iitGBYiSLTkJUENDA66++mpUVlaiqqoKL7zwAgCgq6sLy5Ytw7Rp07Bs2TLjaZMff/wxFixYgNmzZ2PBggXYtm1b/x8BxTEMC0hIxoAAIEIFiJIlOQkQx3F49tlncfToUezatQvr169HTU0N1q1bh6VLl6Kurg5Lly7FunXrAGitNd577z0cOnQIGzZswPe///0BOQiKMxDLh5es2TBqAVGyJScBGjduHObPnw9Ae/ZSZWUlmpqa8M4772DNmjUAtKdN/vWvfwUAzJs3z3jOeVVVFXieRyKR6MfhU5wkGfvRXLGYEQOiaXlKdvQ6BlRfX499+/bhsssuQ2trq/HMp3HjxqGtrS3t/W+99RbmzZtneYonZXiTWgdEBIm6YJRs6VVDskgkgpUrV+L5559HcXFxj+8/cuQIfvzjH2PLli22r7/88st4+eWXAQDt7e29GRLFAUgQOi0LJlABomRHzhaQKIpYuXIl7rrrLqxYsQKA9vjdlpYWANozvCsqKoz3NzY24pZbbsEf//hHXHTRRbb7XLt2Laqrq1FdXY3y8vLeHIeFRn8Mz318HJKs9HlflMykBqHJ/2F9iQaF0hM5CZCqqrjvvvtQWVmJRx991Ni+fPly49ncGzZswM033wwACAQCuOGGG/DUU0/hiiuu6Mdhd89HR1rx4tY6fHK0ddA+81yEuF4xUdL/JzEgKkCU7MhJgHbs2IHXX38d27ZtM57R/eGHH+InP/kJPv74Y0ybNg0ff/wxfvKTnwAAfve73+HEiRP41a9+ZbzfLj7U3/ijAgDgtZ31A/5Z5zIk7R43/qdBaEpu5BQDuvLKK5HpQapbt25N2/b444/j8ccf793I+kBXTBOgXSe7UNcaxrSxRYM+hnOBuG75pMeAqABRsmNEVkIHYgJ8ngRYl4I/fnXa6eGMWGIZsmCCpNL4GyUrRqQAdUUF5PkiGDumCW/ubaBp4QEiKTzWOiAg3Q274cXteKO6YfAGRxkWjEgB6owk4OYETBh7BnFBwfbjvU/tX/ebz/H6LmpF2UEEKCFa14QBQMSUiudFGUeaQzjSHBrcAVKGPMNWgLprguWPCXC7BZQWd8HDSdh6rHeBb0lWUNsawcn2SG+HOaLhdeERZc3lMtf/mJdjBONi2jYKBRimAvTTtw/h+ue/sH1NVVUEYiI8nAAXo2J06VlsO3a2V43TieuWkGg8IxVFUZGQVLAu7RzxkoJYQgTDpK8HMwTIgQLFk+0RVP7vzTjeGh7wz/JHBXxLJ6ucGJYCNK7Eh/rOmG3BWyQhQVIAt1vLhJWPakNXVMKhpty79IV5XYBEKkCpEFEm5zkuyIiJMrxuba2fOQZEBCjiQHq++rQfcVHGsbMDL0C/3XYC/8/Lu9K2t4Z4bNx9JmMGOReCMRHiCArwD0sBmjleW/5hd1EFYtrF7uG0G6NsVBsAFdt64YaRpusJiaaVUyEuMDnPvCgjLsjweDQBMgf+g/p3EnGgQvrbNs0i6YwM/CLojkgCreFEWnjgzT2N+P/+5xBOd8b6tH9VVXHNs5/hzyMoJjksBahqfAkA4IiNVdOlFyGSmdnjFlBaFMAnR8/m/DmGBTTCXLDNh1vwx6/q+7QPknIn55kXZfAWCyjdBXNiiUad7np1DIIAkWM+G+Qt28nvB/rYqpYXFXRGBZwNJY9l1cu78H8++7ZP+3WSYSlAFUVe5Hlk1LSkZ1X8ehEimZkBoGzUWRxpDqMtzKe9vztGqgD95456/P6Lvl208RQLKC7KiIsKPESAhHQBijiwRON4my5AYaGHd/YdYvW1pAgQ+f1gH5v1k3MqmK7HY2dDhsgOR4alADEMg9KiMA7bWEBEgMjMDAClRVqHxhNtuQUIyYwtjDAXrL4zgkCsbzckqXom5znMS5AVwGvnghlB6ME9j7woo8mv3fyd0YG3gMK6wJ4NxS3bzwY11+tAg79P+yfn3BwDEiRlWE+Qw1KAAGB0UQx1bRHLbAAAXVHtInCbLCCfV7sgUk3jniAWUH8+92rntx245z93Q3bocca8KKM1JCCaUNLOXa77AZLnuZO4vpwABqqtCxYb5CD0t+0RaGdZzdn67Q0kxpVmAYW03w83B/tUIU4sILMAibIyrGOUw1aARhVFIcpqmlUTiGk3gJtLmvtej3YBnA3lKkB6ELofBWj3qS58Wts+KDOyHQ1dyUBoIN57K8hwwXQLiCwAZlkZbk62zYJJyuAG9Mm1UVQQGpwYkG6hmCc6UVbQFRGR54uCF1Wc6EOanpxTMnGoqgpBVo16rOHIsBWg0cVRAMCRZqsb1hUV4HFLYJjkNo6V4XFLvbeA+vGmIWY0CZYPNvWmTAzJGPYGctETC4gcD+uSwbGyrQsGDO5K+RNtETCMilHFneiMCP2SBu8OcmxmC6g9nIAKoGK0lgQ52ND7OBC5dgQ5WQAK9O/1OdgMWwEqyufBsemBaH9MMGZlMz5PPM007onQAAShieXQFXFGgE53Ro2f/X0QwTQLKEYsIAksK1lcMHO8KVM19P6GQNpk0ldOtEVQkBeHz8MjIakDGoNSlKQl0hxIijyxukeXdMDNyX3KhKUGoYkrFh/GHSiHrQC5GKAwP5SWivdHRbBcurntcccsF0Y2GC5YPwoQWbDZ6ZAFZK5F8ffFAhLsY0CsSwbLipabPRAXwEA7h8SqTOXn7x7Gkx8e7fV47KhtDSHfFzRqk/qrFmjPaT92n+qybDNn/VqCySB0qz7p+TxxFBV09UmAUoPQRIhoDMghigu7UH3aj//1PwcN96ozysNjI0BeL2+5MLKB3Cx9CdamQi6ivtwMvCj32p2o74waqfK+ZMJS64DMMSCXS7QUHQbjIrxe7fvJtBwjGBfQ0Y+BYlFWcLozhoL8sHG8/RUHeuajY/h/39hn2UZcTq8njq6oZFwzxALyeXmUFAZwrCXUa8EwLCDZagEN50r9YS1AUycfx4Sxp7DpmzO44cUvkJBkbSEqZ++CmS+MbAgZafjs/+YvX5/pdiY3XLBeWkBtYR4Ln/gE7x1s6dXf13dEUFKopYP7YgEZAsSJANSUGJBkqfkJxSXk6ZnITK1RYgnJaCTXH5zujEJWgMK8iFEc2dFPbm8wJqChyzqhEdeyME8LMreGkokPl0uBmxNQWBCCpFgTAbkQSwlCE8ucxoAcws2JmHnRIcy5+Bt0RkV8c8qPQEyy1AARfPoMnEs6Nsxr+xEkNWuL49PaNrx7oCnj66SNaW9dsLf2NCGSkHKuaQK0GbMpwKOoIATWpfTJAiJpeE1wFJMASboAJUsYRFk1SiEyxYBigoxATOq3QPHRFq04r3AALCBS7/P1yaQbRta5FeRrn0ssn9YgjzyPAIaBIcJNgd5ZesR9JxaUYQHROiBnGVPaDtal4INDLRBl1VIFTfB5cq8FIkFoFcmMQ0/EBdlY+2QHuQF7YwGpqor/+ua0/ve530zNgTgUFcj3ReFxixnHcLQlhKf+drTbmpW4KIN1KWAYgGMVIwjtYmVLEJpkwPK82qxvJ0CqqiImKBBl1dLUzI73DzZjzau7ezzWPaf94FgZhfmhpAD1UzU0EZtdJzuNbeS4CnQLiCQ8zoZ4eDzasfv0c9Ac6D4UIEgK/vW9GsOKIpDJS9QFR6Au2NCAY2WUFnfig4PNAGCfBdMtoFwyYRFeAvRStmz99pggIS5mLg5LWkC5C8g39X7Ud2oXb28EjKTg831RuDkhowv25p5G/P7zk/jtthMZ98ULMlhWu/BZl2wINHHBYvrTUokA+QwXLP28JCQFpC6zp+P66ttOfH683ZLat+Ob+k4UF/rhcqlwuVR43FK/1V6RdPvOb5ON7iKGAOkWkO6eNQdi8Lq1n72eBBioPQrQwcYAXt1xCluPWhdQkxhQIiUInYuFPtQYEQIEAGWlrYbFYhcD8uZoAcmKNisTMcvWzCUCk+kGIbGT3rgDm3afgZuVUVwQQGcv4hln9BR8ni8KjuMNqyUVsrbot9vqsOd0l+174qIMzqUdi8uVFBVWt4BEWYUgKUkB0s9/xCYLZraKMo0p9fVGf+Y4SkyQcLQljNKi5Ni97kS/uGAJSRNbjzuBM6Y4EDkGn5eHm5XREuShqirawgkjAO9iVOT5BDT1IEC1+vlPtXKJdSimpOFzsdCHGiNHgEYlZwu7GBDHSuD0CyMbyIxGzPdsBYg8KSKTG9bbLFg0IeGDQ80YW9YAnzeOjkjucYT6zhhYlwKvJwE3J6Irar+P2tYQyke3wOeN45FN+2xdsbioGMLj0puSMVDhYhRwrGSMmZwHj1sA61Jss2Dm4sSeAuNEeBv9mW/iAw1BKCosAsRxfL8IEBHQ8lFaYSGJAxEB4lgJPi+Ps0EeIV4CL6rweZLn2euJoqUHATqut5lJjROSIHTCJvaTKRD91p5GbBjCj6caMQJUkBdBvk/7ou1iQFoQkE9bKJgJUgNEBCjbTBgRmEAPFlAoLue0HqwlGEdCUjGqpBMed6JXGaPTnTEU5MXAMJqVaFcJHeZFtIYElBb5MWXCcTT6edslLLwopwkQx2kxIVYXoEhCMiwgjhPh5mTbLJhZlHoqjuzURbM7ASJWW2lxcvGnx833y3owIpaj9Ha/JA5EXEuWlbSas2DciOEQ61v7Odat9QYk+1yluqPkwY9iSiU0kDkO9M6BZvzP3sbsDs4BRowAMQwwplSblewsIG17LGsLiNQAeQ0LyDrDvLO/CZ/aNDkjT4iwu7lVVQUvquA4ASp6djfMJN1LER63gGBMyrnNbHuEh9utXfwet4BgPD3rRLJrhXlheN3aubKLy2gCpI2JCBGr/08soJggGwLk5gRwKRXSBPO2nmJAxCroLpW957QfRfkRy3pAj1volzQ8yYBxnIjiok7sO5O0gBioYF0yvN44GrtixhjNFlCeN46zoUTG705VVRw7qxXXprrZ5DwZQWjTpJgp5uiPJlCcl9Pj/waVESNAADBlwglcPOUIPG5768PnjWeshm4L85abkQgQqaJNnWGe+7gWP3/3UNoNzBsCZHfTaq+RjFAugeQQuZFZER53AoqaOc6Uia5owoiPuTkBipoUNkKdLkAF+REj/mVXMhATJEOAiPCwbNIKAKwWkJsTtQppWwvI7IJlPieKoiIY0/4+kwWkKCqqT3ehuKjTst3rSSDCy1lZsntOd6Etw8Jl4oJxrASfJ462cLL9CLEAR5d0ojMq4pFNWrEiiQEB2jUoyio6MgTE2yMJBOPETbeOgTzymlg+5lXxmRakBmICSqgADQ75vhimTMjcaMvn4dEeFtJcH39UwJW//hR/O5zsmpjqgqXGgDojWhCy1tQMSlZU4+KwEwcSoCb1ILkEkolQcJxoWHi51hL5Y6IhKmQfqUJZ1xoG61K0TJn+Hrt1a3FBTgpPmgWUbEwfjIvwcNriYJdLtHXBYlkGoUO8aGTLGrqsdVBNgTj+/y9O4vlPjiPMyxhVZA2ek+8xm0zYva99g998ctz2tYgR6xHh9SQQiEnaE0ESEty68E6oaMC8GbshKloRotdjFSAAaM5QC3T8rHZced5omkgl23FoJyEbCygQF1GS7+7+gB1k6ErjAOD18FBULQM1tthnbD8b4iFICupaI8BsbVt3LhgvyogktC//b4fOYsZ5Wo/quKlth50LRl7P8/XeAuJY0Yhx5fL3kqwgwssYy1k7RnZFBZw/psB4X11rBAX5ETBM8qa1E4WYKBmC42JJLIiMMRmEDsVFuDndUmIlo7rcDLmpXS4Z/mhmq85ot8sJaAy4oKoqZEXFqztO4bmPa8GL2o3pYhSMLumw/K0hQBEB40ryMn6GJCsIxiUczLBmyxAgToLXzUPVxxUVJMPyA4CKMWdRWrwVfMIH1pUUijxDgOKYO6k0bf9kQhtd0onWjgKoqgpGb+1AsmCKqk12ZgGys4BkRUWEl1GSN3QFaERZQD3hM335ZohYmIOtaRaQ6Qs23/h/O9xs/BxPWYCZCnmduGB2s7G2himatj1sxIAkY0y5CBAJirsNC0j7PVUoa1tDKPBpHQY4VoKLUQxLK5KQ8MqXpyArKuKCbAgPmxKMTnXBOF3sOFaybUwfM85LvNtjIq8VFwYQTSgIxSX8+eszePLDYygqasF35n+Cay77EFdf9jfk+azfMZlI2nvIhJHzfLw1Yvv0ibDJBSPueVs4gTAvgWWtx+ZxCygutHZr6KkY8fjZMHweEYX5YUgKEDZZh+YiTUFSjEJEwN4CCvMiVACl1AUbGuTrlseZlAAmcUPMfj9xeexcMOI6jS5px/HWKE51aIJh7pwYjNu4GvoF5LNxwUK8iP/918NY9G8f47vPfJbWmiLEi3AxWuqbuFE5CVBKr2wSC/KntMpoCSaM5QQMA3g9kuGCbTlyFr96vwa7TnYiISkZXTBt3ypqz4YRiAtgWe0ccimr5I3PFUgNTSxjaYD5eEsKAwCABn8MnxxtRWF+FPNm7EZ+XgxuTjJcQDMkDtNTHRgRGFFWcbI9fSIgFhDLShZRiyQkwwLsDo6V4ObkjLVAx1pDyM8Lwk0mGf3cq6oKXlCM57AJspLigmk/P/72ITy7pRZAcnKhFtAQIc8XBZB+YRHroMWUog/z2uzPceQLT17UxDefdJ62LGKzHjuyumA2FpCYzBJ53ZJFQD6pacXru06D4bR91XdYRVJzZWTdNSIClH1di9Gq1p2sywGsdTdGBiw/GddycwnDAmoxPd2BF2WT5ZMqQBLGlTfh9V31ONMVM7JRLCvbtmWNJiQwjKotGO4mBkTEslgXoG/bI/j6VCdGl5y1NKCzw+vhs6pCNruINS3aJPDbbXV494Bm6Ub4ZLaLWEAd4QQivGi4nt3BMHpvKpsYkKKoON4atiwfIeeeFxWoSFqwgqRYLDTStfOrkx348oTmfpLreijHgM4pAWJdCgp8vGGxEAwXLGgWIO2GJzeV2QXr0DMfxYUBFBeEsEP/wpMmsmobNyEumFYrkrAIUH1nDAxUzJm+BwDS1gGFeMm4kbXV1XJaEDqSkDL2r04+LSRpjTBQLUJZZyNAHMcbriKxHvadCYAX1aTwsNb/AeCiSbUQZAXtYQEcl4wNxUUlLQUdTchwszLcbqHbBamdKRbQ2/uaIEgqykrbbd9vJtsq5JApeVDTHEIgJuD5T47jf/ZotTSRhGRMBFYLKDsBArRixEabbGxTII64oOgCpCcadJeRJDDINSBmsIAiCQlt+kRKvtsRYwE1NDTg6quvRmVlJaqqqvDCCy8AALq6urBs2TJMmzYNy5Ytg9+fLAB76qmnMHXqVFx88cX46KOP+nf0vcDnC+PbdutjTEi8xh+VjFklzEtwcxJcrvSqU3IjeNwJeDxx4++JwHg9PAKxdOuECBTrki03NqC1j8j3JeD1JOBiFCO9SwjzIlg2KRYeTkhzwW588QvM+9UWPLJpX9qjiEmBH7GANEtKsgjlqY6IfqMmbw6PO2Gkg0mMbPcpLcXNpsWAkgJUkBfF+PIz2mdyKcHplGromKC5TR5O6HZBqj8qgGNleD083JyMz4+3w8VoxZnZ4PVEs7CAkgHxI80hfFzTClkB2vRzEOYlwyom/a/bwwlEBdkShO4OnzeOJhsBIuc3zxtPc7NjKQ3gUmNAZOKJCsmJiWRiR0wanuM4PPvsszh69Ch27dqF9evXo6amBuvWrcPSpUtRV1eHpUuXYt26dQCAmpoabNq0CUeOHMHmzZvx0EMPQZbtL67BoiAvgpMdUcssG9DdExVaD18gecOTm8oc5OuMJMC6FH3hpWgErMlF4PPEEbCJAREXjGVluN0Jy3KK+s4ofN6wZqJ7xbSq3WBcBGcKcrpTLChZUXGmKw4XG8T7Bxux/lPrQlJ/yhNjAc0NM7tgnREBXo8IF6Na3tOlv4fUUJH4VloMKOUGvGjScbAu2Qi6s0Z2TL9pE8nfNauw+9hWZ1SAxy3qVe0xqPpyC7uYjx1aFXJ6XMcMccFKi7pwpDlglGaQZmmplo62xkxALCFnbQH5vHH4o+nWKrHE3W7BsFSJmEQNC0j7XZRTg9AKVFVLDvCi9lQSMumUjhQXbNy4cZg/fz4AoKioCJWVlWhqasI777yDNWvWAADWrFmDv/71rwCAd955B3feeSe8Xi8uuOACTJ06Fbt399xKYSApyIsgLiiG0ADWjBVxfUK8pAtQesuDzogAn97jxdz7hgiMz8sjwqcvtSC9e1mXNtubg9D1HRE9RqW1j20LWS2gYDzpygCAm+Mt68lCca1GZtJ59SgqCBhuIsEf09Zimd0klk1Ylj50RgW4U7pJujkBEV6GKCtoCcZRmJ/M6mSKARHyfHF8Z8EnmKjHyoiARhIivrf+Szy9+RgA7eZysaJtYNxyDKbxeb2auzimNL0aPRN53jjOBtOrkA83BQ3rlbhgo0s6EIzL+Ky2DQwUdEVFqKqqB5uT43O742jyxyAp6QLc3TiA9EyY8Uw7TgTLKuBY2cYCSrYJFiQFDOnWIGrPByOa1B5OGDGgYt8IsYDM1NfXY9++fbjsssvQ2tqKcePGAdBEqq1NuyiampowadIk428mTpyIpqbMzboGg/w87Sb/1hSIDsSS1oUhQHFBT0OrYBjV4oK1RxJw68sUzMsLYoYLFtf3Yc2KxFJiQMG4pFf3igjGZWNsHjeP1pQ1a2E+1QISLC5cl3HxCvCkWFeAdvN6UyrE3ZxgCWR3RRPgOOvfEaukLZyAPyqhfFQrXIx2LrqLARE0l1I1zhWgLRZtCvBGe5BIQgLrShZYZrSAIglwugCRmzgXAfJ545AUayeCP2w/iRt/+yX+pD9vPay3YBlVrLl1iqrV9EiKZoWmfg8edwL1etlEthYQmWhSnxUfTLFSvaaeTSR4T86RKGtBaDenbedF2VJl3hFJIBDTikA5duiGens1skgkgpUrV+L5559HcXFxxvfZBRMZm3TFyy+/jIULF2LhwoVob+85oNgXCnzazGkORPtjCSPw2qpbHiFeNCwO1mXt79MR4eHWb1SO01Y8S7JisYCA9AWpcVMXQY9HW07RHkngdJc2lnz9wvR60hdOhk1BaEB3jfRZGUjGeDxuAW63gI6Um9gfE4yb17qP5LaOSCJtIS/JxhxtDkHVx1ik17akxoBSLaBUiIXwcU0rAKBdP8YoL1pcsEyPC+qMJoz3VIxuwXljmlBcmP2TNIgrSALR6z89gSc+0NrnkgxfiBfh5hQUF2jH6PMkjEfqdEQEXYBMLpiHNzKM2QpQgT7RpCVD4gJcjGqcJ7ebzxiEFnQLiGVlMNAmSHPsrCOSQDAuGjG/oUrOAiSKIlauXIm77roLK1asAACMHTsWLS1aj+KWlhZUVFQA0CyehoYG428bGxsxfvz4tH2uXbsW1dXVqK6uRnl5ea8OJFt83jhYl4KTpgfEBWICCvK0ACwJBEYSknFBsS5rxqEjkjBuTDIbRhOy8aQI0vsmNRWvLV/Q1guV6DfOntN+S6MwQLMagnHZ1HBK0RexmgRID9iSupoukwB53NrsZ54AuqI2AqTfPMQl8ceEtIW85IYnjz/yeuMoLvDr5yU1BtS9AJHz+UVdu34e9XMtSOBcctozxlLxx0QjNjKmtBOXzNjTY/rdjM9oiRpHQ1cMz3xUi/PKGpHvSyYEQnFN6DlOwuiSDoyvqDeWUnTo9T4slxQach1ox5+dALk5AR5OMiwny/GZnmnnNrUQSQ1Ci7K27MflUsCyil6dn/z89oiAQEwAx9qfy6FCTgKkqiruu+8+VFZW4tFHHzW2L1++HBs2bAAAbNiwATfffLOxfdOmTUgkEjh16hTq6upw6aWX9uPwc4dhtBnopGn2CcS1PtI+r4DWEA9RVhBLKIa4aBZQ8mmUXdHkmipy0YUToqnQ0N4CigmyETAtLgiAY2V8fbITpzuIBaQJEVmFTqp2SZDbPMMayySi1riJ2609F01WtJuJ0BlNt2687oThWkiygnA8WeSY+jk1zcQi4FFSZBUgIozuHi52IlAxQzQ1kYwmtGUMbk4rDbCLASUkGTFBydjpIBvMlfDf1GtrxS6YeAIed9yIx4VMLtaiWTsx7fxaS0/pSEqw2WsSoGwtIIYB8nyRNAsoGEvGwQCrmx1NtYBkbYJyMYpxfZpdsPZwwtbqHWrkFJ3asWMHXn/9dcyePRtz584FADz55JP4yU9+gttvvx2vvPIKJk+ejDfeeAMAUFVVhdtvvx0zZ84Ex3FYv349WJbt94PIlTxTKp4XZQiSqsdOYmgN8th3JgAVMMroGZMABeMiZCW5Sp5cdJGEhLgow+VSjAs2tSlZTJCNm9DlUlFS1Imd3xbjkkmjkOdNGK+RGbc1xGNCaZ5pGYY1BgRogeNJo/MNN8DDJTMoHdGEUYQWiAkoLkkRINNSAllVocI6o2ufqf3NEb0oz+flkeeLISHUGEJUmB/BgplfYXSpdf1VKubYSVFBEOFoCYJxEXFBQTEr2ZYGEMgaMbt2u9ni5rQanmY9/uTmZBTlh+DmkjGz1HIH7TP18xRKIC4o1onAk7sFBGgCdDKlHMQfS1aNa58roKlTNLJb2jGQNLzmdjGMds0lJNlSZd4RSehPiBnaLlhOAnTllVdmLBLbunWr7faf/vSn+OlPf5r7yAaQgrwITjfHIcpKMvXJifB64mgJxfFlXTsYqBhdorkKLkY2YkCkp0zSBdMFiNfSqpxLMb70VBfMXD0MAKOLO1F3pgKKCvi8SZeQCFCbKR4FwOqCGevBkgtGSZbLnM6+qFxL0YfiMsaMSb2xdEsrnIDLMPvtXDAVDV1xcKxWdsAwwIUTrWn+slE9x+7MN+55ZU0IR0vQHk4gLiazcx63YLsglVgCfREgQAteNwXiqO+IoLiw01h0S/YfjAsWoSSfyUA11uiZXyfWaurx9URBXhSnGhMQJAUeTnNE/KZ2KYBWNErcbNIILWkBaUFol0uzgHgxaQExUNAR1mJARcUjyAUbKeTnac+MauiKGSl4Nydowd8Qjy/q2lFSFDBWcbtcspGGJ0FBYnqTorRwQkJcd7HIRZTugiV76ADAKH3F9rftUeT7zAKkV9iGSUZOt4As2RdSKZsUG6/HuoDWcCviom7d2FtA7RHeVFxpfY9W8auv1fIkcoq5pOJyKWAYFQV5Mct6LiBpPbBcwnbBqGEB9dGl8HiiONoSxIm2qNGy1RzQD8bFNKtBWxMnGrG6TBZQLgKU74tCUa3rEv1xawzO49G/24iAmCAZtWeA1pRMMCwgbYIkApTni6E1zBvxrKHMOSlAJBN2sj1qXNhEgCIJBQcbgxhdkkzvMoxsuGCpN2oyCC0hprcpZRjAw0lp2ZyYIFsWLJYUBoxWDSQFr+1be3oCqYZOWkCmCz8lYGuukUk2EtOtJFOK3ozXZAH5MwiQeZvH030RX09oNzKP0SWthkiSNW/k5i0u8GPfGX9aPyVyLH2JAQFaJqzRr7XRGFVMBChhxMy0Suf0m9aSbufMMaDkeHJxwfL1x/fUm+JAwVhKptPkSpP4IalLE2QFgiyDYRQwLskSA8rzxVDfoQmc3QMahhLnpgDpKfcT7REEiQXkFo3WmYqqPWuM4HLJRtNvkpWwc8HiQrJNqdstpt1EMUGyZIpcLhWler0JyYABSFZDh1KC0KaLk2UluFnZKGbrNNXwGC5YhKS17cWFZbWLuj2cMIlUuoVB9mtuLdpbLp31JaZPqTHOH7EAyCrv8eVNEGUVmw9bn/zanUDmAglEM4xqxLDIPtsjCUQTcpoLBmgFh6QLo7nthsulGBZirhYQkEzFJyQZcVGxumCm7zGqL1dhmOQTMRKS5oK5GFmrA9JjQPm+qFGtTi2gIYibk+DzCPi2LWKKAQlG7IVjZZQWJdezuVyKsdpYiwGpxkxsDkKb+yRzrJAWA9LMaGuqelSx5obl+6xFaR533KgFsnPBtExKsu9wpyl+4HIp8HCSYa11maw8M5pFImgCFMl8g5O/8/aDAOX5tFhSelxFzw4WBlCYF01rpK5ZemqfZ3QiQMUFIeMziRg2+GO61ZAuJFpm0VpQmXwtoQmBK/se3R63CK9bwin9+IOmWKR5v4A26cX1tWaGBSQpECTZaNFCChFdjGIUaWr7oxbQkCQ/L4S6tnCyURcnGjfYqOJ2y8VEfGxAiwF53ZJR3Wuk4XlJj/GQ1HQiLZtjJ0ATx57B1MnHUFRgLajzuOOmZSFaejrVxPd5I0YRo7ndqvb3giFA/gwWkHbcccMCcnOy7U1EbgSft/uFnLlAeg2d7rLGgBgGGFvWgK9P+S1LFVpDCfg8Up9iUECygrrE1DM66Q4SF8veBSOkCpDbHYM7y/VolrH4woYFlLwOk9+RzxuHxy1h35kAorp1TarQBX0tmCZ8SQHiOMUSlxpxhYgjhYK8ME60hZPZI5eMPG8cHCdi7Bir+e9iFGPhYGdEsFyM2iNutCKwmKktZ+oyB0Dr6ZIqIl5PAhdNOp52Y3k9PFoNC0iE2y2nvSfPF0NTQMvmRXjZcvFyHI+uiLVWyG429Hh4tIa1ToSZ3BuyvT9cMOt+eTR2EbcmeV7Gl2vWD+nBAwCHmwMoyAv0+TML8rRnxZPqZm0c2vERMbBzwSz1PikWUp43ZizNyQVzKp5Y4ubvgGGA0qJ2bD/Rplk3LjHFAtLrgBgFvCQbNUrmzBy1gIYoBXkRRBJaH2hSfcqyMq5a9BHGVzRY3msuRNTWgVktATcrIaJbQMTC8Xl4nA0lLA/1i6ek4bvD60mgK6IXCPLJhudm8rwx8KJqNBKzWkDJ2hZ/TNQrZm3WarkTmgUUFYzlJakQwTU/36o/4DjeWNFttiry82IoLfLj3f3aukFBUnC8NYKiHJZdZMLjFnH1pR9hjKlmiRwfESC7uIk122V9ffqUo5hX+XXOY8n3RdEaEsCLsmUhqpnRpe1oDiRwoi0MVq+VYhjVWAvGuBQjRKC1NZEsEySNAQ1RyNqvPaf9llmCLJUw43Ill0W0h+NpFcWsviLeXOdTWBCGIKlG6lZRtGeC9bRcgUAanndGBX1dWvpMRvr2kAbqZgEyrwfTFqLauy9k2cfZYNw2AA0ApcVdKCn0oyA/Yvt6bzFbFamW4ZjSVhxtCSMYE1HXFoYoqyguCPTr5xNcLtWyNMLOAvJ0U+/jcQtpMbxsIGvCTnfGTDEg6/c8Ri/VCMYl09IXxWIBaUkSxWgL6/VQARryFOhp0GBctFSf2uEyWUAdEcEyGwIAywpaHZCpoK4oX5uta/WnXJK/z8UCArRixGBctLSAIJCL/kCj9lnWDEpyPZhWEWt/jOTGOtURy5jiLikM4vJLtmfddydbrFaFdd+jSzqhAthd34XDTdrx5bLwNOexuAU06VmuVBcLSKbbtUxU/3wmycYebw2bLCDrd1CQF0Gex5rwcDGqZS0YmSCjCQmsS9K/R9WSth+qnLMC5PXwRuCwJz+ZfMExQUJMUNKyQaxLQpgXtRiPLjDao21UHDurLecgq5mz7pqni8uxsyEE4/Yl9eQJC3YWkHk9WGuYT2uzQSBCJymq7SOtBxLLQk6X9byUFPnBuhR8fbITh5tCcLOypVShv3G7eeOZY7YumD7W3gSbM1GYp10jWvN+UV8Jb90/wwClek1asv+SNiGKsppcCyYqiCS0rgIuRoXPI8Hjzr4swCnOWQFimOQM1JOZ6mIUSEpyaYTZdQAAlhMRiAn6jJQ0kwvzYsZzvs3tWLOhKD+EfF8c7x1otrQGMcOxMnweEcdayHGY1hHpP9d3RnG4KWhUHqdiPpa+FvnlCvls1iaFzboUlBT68dXJDhxqCqCwINBvlocd5nNn74LpY7WxjnqLy6WgMC+K2taw1rtH7/aYClkSRCYvl0vVm9InLSBJIQtpk09z4Xqw7IcC56wAAVoqHujZAiLVyqSPjCfFAuJYyViiYZ7BCvIDqGkOAEi2a802BsQwwHllDfjyRAc6I6LtTQFoqXhJn7rNj6Qm1tC7B5ohK0DZqFbbvzcfS+pC1IEmWcxpf05GlXTgaEsYR5pDxpMwBnosdmIIaDe91601TutPCvKCONoSRKCbhaMkDmQsDWIUw6LWYkDkceDJLGxJUQeKC7ts9ja0OKcFiMSBepr5iVXT6CftMqw3KsdKCPHpFk5hfghNgYSeoievZz+DjitvgqJqvV/siuMAwOfVMzcp/j65od7Z3wQ3J1kKK82Yj2XQXTBPDwJU3Gkcf3HBwMV/ANNyk27cFrc7kbZSvq8UFoTQ6OfRFIiDzRCny/PFsWDmVxhfoTX5Z5hk7x/GtD7MXOYx86KDqJp6sF/HOhCc0wJUmJelC6bf2A16zYrXkypApiUSJgEq0rvq1Z4NGwLkytIFA7RMXXGBNkY7FwxIZsLS+/hov3dEBIwuactYpavN7H1vddEbDKsjQ1ystMhvFN4NlgWUydIEgMnj6jBx7Ol+/VySjT3SHMqYKAC0bgPEwnW5kuu+zBYQkNtykKHAOS1AxYVBsC7J8hwsO8gX3OjXnt2V6qqYv3TzzVSUnxSgXF0wwtgyrSbJneHGIG1G3SljMotJ2ag2dAcR1MGPAZGlI/bHxrIySoq0xm3EWh0okmKY+RxMOu8MxpU3Z3y9N5BrRFbUrFPmDJNsz+EyWUBA7teX0wzddvmDgM/LY+nlH/YY3HQxxAWLw+tJDxSa07bmi8HnjcPNyjh2NmQ8HC7XVPb48kY0t01OW6pBIKn41M53ZD2YIHEo66FxO8fFARQOugVExpj6THUzF06sRYwvGNAANGDubjC45yDPFwPHypBkNicBilgsoOQ1NdwsoHNagABkdWGzhgUUt12Qaf7SzRcDwwCFBUEcbQlh9oSStNezweflceX8bRlfJxaQXfzG4xbg88aMFrGZ8HoSYBi1W/djoPB6Yt0mAbRGZwP7oALA5IINcuEew2huWCBcmnUMzsWoSRfMNbxdsHNegLKBiEZrmMeYkvTlCJYYUIqFU1QQwIHGAKZWFGmv5xCEzgafNw6GUWwzWFPPP5LVjD6mpB2yzA64lWHHnIurc+qjM1AkLaDBH0tBXhCBcGnW67ZcLhkhgSzeTXHB+vn6GmioAGUBmWFUFWlV0EBKDCjFwrlgwgm0d03Axt1aBqO/fXSXS8X8yq9t41ipi2ozMWFsAyaMbej5jQNAYT8v7+gtbregC/ngL94s1BMN2a5cZ/RKaGD4W0DndBA6W8xfcGoKHrAWp6UKjM/LY17lV0YaPdtCxFwoG9Xeo5tF6R4Xown55HGnBv2zSwq1Eols252Y3XjSkIwwFKzJXKAWUBaYv+CeYkB2AlNUEMK8yl3wh0Y74uZQsiObxvoDwahiP66Y92mP2VgC6UWl/aw9F4xAs2AjELsCPzOZ6oDMjCruMnoQUyipZCs+QPcWEHXBRiBmUekxCzbMZiDK8INJsYBcLuqCjWgsMSCbILTLpYJ1KVBhNY8plIHAfD2ag9AM1AGJMQ4kVICywDzD2AWhAa0tq6LQAA9l4CHLUwCShte7SnLpzfSGOlSAsoB84dqTR+1NXI6VIDPOP3aaMvJJt4D0ByEMQ/efClAWkC/c5838ZFBtOQF1vygDj9kCcjGa1eNyKY5UsvcVKkBZQL7gTE3bAcDlEqBS/aEMAqkWEABwLsXy2O/hAhWgLGEZxdKYPJWK0WchSu5BHBHlXIVJsYAA4opRC2jE4vXGUKi3TrBjyoSTgzgayrmM2QJiSAaMkYddDRCQYx3Qvffei4qKCsyaNcvYduDAASxevBizZ8/GTTfdhFBIu0lFUcSaNWswe/ZsVFZW4qmnnurfkQ8yl83ZjosmHXd6GBSKYfUwUI2yj8L8oNEAbziRkwDdfffd2Lx5s2Xb/fffj3Xr1uHQoUO45ZZb8MwzzwAA3njjDSQSCRw6dAh79uzB73//e9TX1/fbwAcb7REnNMhDcR5iAbGm63H+zN2Ydv4xp4bUa3ISoCVLlmD06NGWbbW1tViyZAkAYNmyZXjrrbcAAAzDIBqNQpIkxONxeDweFBcX99OwKZRzF8YU9xnu9HkpxqxZs/Duu+8C0KyehgatrcOtt96KgoICjBs3DpMnT8Zjjz2WJl4UCiV3iPCMBIu8zwL06quvYv369ViwYAHC4TA8Hg8AYPfu3WBZFs3NzTh16hSeffZZnDxpH6h9+eWXsXDhQixcuBDt7c6sSKZQhgtG5ouhFhBmzJiBLVu2YM+ePVi1ahUuuugiAMBf/vIXXH/99XC73aioqMAVV1yB6upq232sXbsW1dXVqK6uRnl5eV+HRKGMaJIWEBUgtLVpDc8VRcETTzyBBx98EAAwefJkbNu2DaqqIhqNYteuXZgxY0ZfP45COedxmVLvw52cBGjVqlVYvHgxamtrMXHiRLzyyivYuHEjpk+fjhkzZmD8+PG45557AAA//OEPEYlEMGvWLCxatAj33HMP5syZMyAHQaGcS7hGUBA6p0LEjRs32m5/5JFH0rYVFhbijTfe6N2oKBRKRs5ZC4hCoTgPScMzNAhNoVAGGyMITQWIQqEMNskYEHXBKBTKIJOMAdFCRAqFMsgw1AKiUChOkYwBUQuIQqEMMgxUACq1gCgUyuBDWgTTGBCFQnGEfF8U+XlRp4fRZ2hLVgplGHLFvM+cHkK/QC0gCoXiGFSAKBSKY1ABolAojkEFiEKhOAYVIAqF4hhUgCgUimNQAaJQKI5BBYhCoTgGFSAKheIYVIAoFIpjUAGiUCiOQQWIQqE4BhUgCoXiGFSAKBSKY1ABolAojkEFiEKhOAYVIAqF4hhUgCgUimNQAaJQKI5BBYhCoThGTgJ07733oqKiArNmzTK2HThwAIsXL8bs2bNx0003IRQKGa8dPHgQixcvRlVVFWbPng2e5/tv5BQKZdiTkwDdfffd2Lx5s2Xb/fffj3Xr1uHQoUO45ZZb8MwzzwAAJEnC6tWr8dJLL+HIkSP47LPP4Ha7+2/kFApl2JOTAC1ZsgSjR4+2bKutrcWSJUsAAMuWLcNbb70FANiyZQvmzJmDSy65BAAwZswYsCzbH2OmUCgjhD7HgGbNmoV3330XAPDGG2+goaEBAHD8+HEwDIPrrrsO8+fPx9NPP93Xj6JQKCOMPgvQq6++ivXr12PBggUIh8PweDwANBfsyy+/xJ///Gd8+eWXePvtt7F161bbfbz88stYuHAhFi5ciPb29r4OiUKhDBP6LEAzZszAli1bsGfPHqxatQoXXXQRAGDixIn47ne/i7KyMuTn5+Mf/uEfsHfvXtt9rF27FtXV1aiurkZ5eXlfh0ShUIYJfRagtrY2AICiKHjiiSfw4IMPAgCuu+46HDx4ELFYDJIk4fPPP8fMmTP7+nEUCmUEkZMArVq1CosXL0ZtbS0mTpyIV155BRs3bsT06dMxY8YMjB8/Hvfccw8AYNSoUXj00UexaNEizJ07F/Pnz8cNN9wwIAdBoVCGJ1wub964caPt9kceecR2++rVq7F69ercR0WhUM4JaCU0hUJxDCpAFArFMagAUSgUx6ACRKFQHIMKEIVCcQwqQBQKxTGoAFEoFMegAkShUByDChCFQnEMKkAUCsUxqABRKBTHoAJEoVAcgwoQhUJxDCpAFArFMXJqxzGUuHTCpQgLYaeHQaEMeVhm6D4MYtgK0E0X3+T0ECgUSh+hLhiFQnEMKkAUCsUxqABRKBTHoAJEoVAcgwoQhUJxDCpAFArFMRhVVVWnB2GmrKwMU6ZM6fF97e3tQ/4pqnSM/QMdY//Q0xjr6+vR0dExiCMaggKULQsXLkR1dbXTw+gWOsb+gY6xfxiKY6QuGIVCcQwqQBQKxTGGrQCtXbvW6SH0CB1j/0DH2D8MxTEO2xgQhUIZ/gxbC4hCoQx/hqUAbd68GRdffDGmTp2KdevWOT0cAEBDQwOuvvpqVFZWoqqqCi+88AIAoKurC8uWLcO0adOwbNky+P1+R8cpyzLmzZuHG2+8cUiOLxAI4NZbb8WMGTNQWVmJr776asiN8Te/+Q2qqqowa9YsrFq1CjzPD4kx3nvvvaioqMCsWbOMbd2N66mnnsLUqVNx8cUX46OPPhr08QLDUIBkWcYPf/hD/O1vf0NNTQ02btyImpoap4cFjuPw7LPP4ujRo9i1axfWr1+PmpoarFu3DkuXLkVdXR2WLl3quGC+8MILqKysNH4fauN75JFHcP311+PYsWM4cOAAKisrh9QYm5qa8OKLL6K6uhqHDx+GLMvYtGnTkBjj3Xffjc2bN1u2ZRpXTU0NNm3ahCNHjmDz5s146KGHIMvyoI8Z6jBj586d6rXXXmv8/uSTT6pPPvmkgyOyZ/ny5eqWLVvU6dOnq83Nzaqqqmpzc7M6ffp0x8bU0NCgXnPNNerWrVvVG264QVVVdUiNLxgMqlOmTFEVRbFsH0pjbGxsVCdOnKh2dnaqoiiqN9xwg/rRRx8NmTGeOnVKraqqMn7PNK7U++baa69Vd+7cObiDVVV12FlATU1NmDRpkvH7xIkT0dTU5OCI0qmvr8e+fftw2WWXobW1FePGjQMAjBs3Dm1tbY6N65//+Z/x9NNPw+VKfu1DaXwnT55EeXk57rnnHsybNw/3338/otHokBrjhAkT8Nhjj2Hy5MkYN24cSkpKcO211w6pMZrJNK6hch8NOwFSbZJ2DMM4MBJ7IpEIVq5cieeffx7FxcVOD8fg/fffR0VFBRYsWOD0UDIiSRL27t2LH/zgB9i3bx8KCgocdwlT8fv9eOedd3Dq1Ck0NzcjGo3iT3/6k9PDypmhch8NOwGaOHEiGhoajN8bGxsxfvx4B0eURBRFrFy5EnfddRdWrFgBABg7dixaWloAAC0tLaioqHBkbDt27MC7776LKVOm4M4778S2bduwevXqITM+QPtuJ06ciMsuuwwAcOutt2Lv3r1DaoyffPIJLrjgApSXl8PtdmPFihXYuXPnkBqjmUzjGir30bAToEWLFqGurg6nTp2CIAjYtGkTli9f7vSwoKoq7rvvPlRWVuLRRx81ti9fvhwbNmwAAGzYsAE333yzI+N76qmn0NjYiPr6emzatAnXXHMN/vSnPw2Z8QHAeeedh0mTJqG2thYAsHXrVsycOXNIjXHy5MnYtWsXYrEYVFXF1q1bUVlZOaTGaCbTuJYvX45NmzYhkUjg1KlTqKurw6WXXjr4Axz0qFM/8MEHH6jTpk1TL7zwQvWJJ55wejiqqqrq9u3bVQDq7Nmz1UsuuUS95JJL1A8++EDt6OhQr7nmGnXq1KnqNddco3Z2djo9VPXTTz81gtBDbXz79u1TFyxYoM6ePVu9+eab1a6uriE3xp/97GfqxRdfrFZVVamrV69WeZ4fEmO888471fPOO0/lOE6dMGGC+oc//KHbcT3xxBPqhRdeqE6fPl398MMPB328qqqqtBKaQqE4xrBzwSgUysiBChCFQnEMKkAUCsUxqABRKBTHoAJEoVAcgwoQhUJxDCpAFArFMagAUSgUx6ACRKFQHIMKEIVCcQwqQBQKxTH+L3gJ+WGYe+nRAAAAAElFTkSuQmCC)"
            ],
            "text/plain": [
              "<IPython.core.display.Markdown object>"
            ]
          },
          "metadata": {},
          "output_type": "display_data"
        }
      ],
      "source": [
        "import numpy as np\n",
        "import IPython.display as display\n",
        "from matplotlib import pyplot as plt\n",
        "import io\n",
        "import base64\n",
        "\n",
        "ys = 200 + np.random.randn(100)\n",
        "x = [x for x in range(len(ys))]\n",
        "\n",
        "fig = plt.figure(figsize=(4, 3), facecolor='w')\n",
        "plt.plot(x, ys, '-')\n",
        "plt.fill_between(x, ys, 195, where=(ys > 195), facecolor='g', alpha=0.6)\n",
        "plt.title(\"Sample Visualization\", fontsize=10)\n",
        "\n",
        "data = io.BytesIO()\n",
        "plt.savefig(data)\n",
        "image = F\"data:image/png;base64,{base64.b64encode(data.getvalue()).decode()}\"\n",
        "alt = \"Sample Visualization\"\n",
        "display.display(display.Markdown(F\"\"\"![{alt}]({image})\"\"\"))\n",
        "plt.close(fig)"
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "VYV91hbKwP2J"
      },
      "source": [
        "Colab notebooks execute code on Google's cloud servers, meaning you can leverage the power of Google hardware, including [GPUs and TPUs](#using-accelerated-hardware), regardless of the power of your machine. All you need is a browser.\n",
        "\n",
        "For example, if you find yourself waiting for **pandas** code to finish running and want to go faster, you can switch to a GPU Runtime and use libraries like [RAPIDS cuDF](https://rapids.ai/cudf-pandas) that provide zero-code-change acceleration."
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "vwnNlNIEwoZ8"
      },
      "source": [
        "To learn more about accelerating pandas on Colab, see the [10 minute guide](https://colab.research.google.com/github/rapidsai-community/showcase/blob/main/getting_started_tutorials/cudf_pandas_colab_demo.ipynb) or\n",
        " [US stock market data analysis demo](https://colab.research.google.com/github/rapidsai-community/showcase/blob/main/getting_started_tutorials/cudf_pandas_stocks_demo.ipynb)."
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "OwuxHmxllTwN"
      },
      "source": [
        "<div class=\"markdown-google-sans\">\n",
        "\n",
        "## Machine learning\n",
        "</div>\n",
        "\n",
        "With Colab you can import an image dataset, train an image classifier on it, and evaluate the model, all in just [a few lines of code](https://colab.research.google.com/github/tensorflow/docs/blob/master/site/en/tutorials/quickstart/beginner.ipynb)."
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "ufxBm1yRnruN"
      },
      "source": [
        "Colab is used extensively in the machine learning community with applications including:\n",
        "- Getting started with TensorFlow\n",
        "- Developing and training neural networks\n",
        "- Experimenting with TPUs\n",
        "- Disseminating AI research\n",
        "- Creating tutorials\n",
        "\n",
        "To see sample Colab notebooks that demonstrate machine learning applications, see the [machine learning examples](#machine-learning-examples) below."
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "-Rh3-Vt9Nev9"
      },
      "source": [
        "<div class=\"markdown-google-sans\">\n",
        "\n",
        "## More Resources\n",
        "\n",
        "### Working with Notebooks in Colab\n",
        "\n",
        "</div>\n",
        "\n",
        "- [Overview of Colab](/notebooks/basic_features_overview.ipynb)\n",
        "- [Guide to Markdown](/notebooks/markdown_guide.ipynb)\n",
        "- [Importing libraries and installing dependencies](/notebooks/snippets/importing_libraries.ipynb)\n",
        "- [Saving and loading notebooks in GitHub](https://colab.research.google.com/github/googlecolab/colabtools/blob/main/notebooks/colab-github-demo.ipynb)\n",
        "- [Interactive forms](/notebooks/forms.ipynb)\n",
        "- [Interactive widgets](/notebooks/widgets.ipynb)\n",
        "\n",
        "<div class=\"markdown-google-sans\">\n",
        "\n",
        "<a name=\"working-with-data\"></a>\n",
        "### Working with Data\n",
        "</div>\n",
        "\n",
        "- [Loading data: Drive, Sheets, and Google Cloud Storage](/notebooks/io.ipynb)\n",
        "- [Charts: visualizing data](/notebooks/charts.ipynb)\n",
        "- [Getting started with BigQuery](/notebooks/bigquery.ipynb)\n",
        "\n",
        "<div class=\"markdown-google-sans\">\n",
        "\n",
        "### Machine Learning\n",
        "\n",
        "<div>\n",
        "\n",
        "These are a few of the notebooks related to Machine Learning, including Google's online Machine Learning course. See the [full course website](https://developers.google.com/machine-learning/crash-course/) for more.\n",
        "- [Intro to Pandas DataFrame](https://colab.research.google.com/github/google/eng-edu/blob/main/ml/cc/exercises/pandas_dataframe_ultraquick_tutorial.ipynb)\n",
        "- [Intro to RAPIDS cuDF to accelerate pandas](https://nvda.ws/rapids-cudf)\n",
        "- [Getting Started with cuML's accelerator mode](https://colab.research.google.com/github/rapidsai-community/showcase/blob/main/getting_started_tutorials/cuml_sklearn_colab_demo.ipynb)\n",
        "- [Linear regression with tf.keras using synthetic data](https://colab.research.google.com/github/google/eng-edu/blob/main/ml/cc/exercises/linear_regression_with_synthetic_data.ipynb)\n",
        "\n",
        "<div class=\"markdown-google-sans\">\n",
        "\n",
        "<a name=\"using-accelerated-hardware\"></a>\n",
        "### Using Accelerated Hardware\n",
        "</div>\n",
        "\n",
        "- [TensorFlow with GPUs](/notebooks/gpu.ipynb)\n",
        "- [TPUs in Colab](/notebooks/tpu.ipynb)"
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "P-H6Lw1vyNNd"
      },
      "source": [
        "<div class=\"markdown-google-sans\">\n",
        "\n",
        "<a name=\"machine-learning-examples\"></a>\n",
        "\n",
        "### Featured examples\n",
        "\n",
        "</div>\n",
        "\n",
        "- [Retraining an Image Classifier](https://tensorflow.org/hub/tutorials/tf2_image_retraining): Build a Keras model on top of a pre-trained image classifier to distinguish flowers.\n",
        "- [Text Classification](https://tensorflow.org/hub/tutorials/tf2_text_classification): Classify IMDB movie reviews as either *positive* or *negative*.\n",
        "- [Style Transfer](https://tensorflow.org/hub/tutorials/tf2_arbitrary_image_stylization): Use deep learning to transfer style between images.\n",
        "- [Multilingual Universal Sentence Encoder Q&A](https://tensorflow.org/hub/tutorials/retrieval_with_tf_hub_universal_encoder_qa): Use a machine learning model to answer questions from the SQuAD dataset.\n",
        "- [Video Interpolation](https://tensorflow.org/hub/tutorials/tweening_conv3d): Predict what happened in a video between the first and the last frame.\n"
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "# Install and import all required packages\n",
        "!pip install pandas numpy matplotlib seaborn scikit-learn xgboost imbalanced-learn\n",
        "\n",
        "# Importing core libraries\n",
        "import pandas as pd\n",
        "import numpy as np\n",
        "import matplotlib.pyplot as plt\n",
        "import seaborn as sns\n",
        "\n",
        "# Importing machine learning tools\n",
        "from sklearn.model_selection import train_test_split, cross_val_score, GridSearchCV\n",
        "from sklearn.preprocessing import StandardScaler, LabelEncoder\n",
        "from sklearn.ensemble import RandomForestClassifier, GradientBoostingClassifier\n",
        "from sklearn.linear_model import LogisticRegression\n",
        "from sklearn.svm import SVC\n",
        "from xgboost import XGBClassifier\n",
        "\n",
        "# Importing evaluation metrics\n",
        "from sklearn.metrics import (\n",
        "    classification_report, confusion_matrix, roc_auc_score,\n",
        "    roc_curve, accuracy_score, precision_score, recall_score, f1_score\n",
        ")\n",
        "\n",
        "# Feature selection and handling imbalanced data\n",
        "from sklearn.feature_selection import SelectKBest, f_classif\n",
        "from imblearn.over_sampling import SMOTE\n",
        "\n",
        "# Suppress warnings for cleaner output\n",
        "import warnings\n",
        "warnings.filterwarnings('ignore')\n",
        "\n",
        "print(\"All libraries loaded successfully!\")\n"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "zcTGg5zbstHl",
        "outputId": "3f44d31d-92aa-4a2d-ad65-4e8ae589475b"
      },
      "execution_count": 3,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "Requirement already satisfied: pandas in /usr/local/lib/python3.12/dist-packages (2.2.2)\n",
            "Requirement already satisfied: numpy in /usr/local/lib/python3.12/dist-packages (2.0.2)\n",
            "Requirement already satisfied: matplotlib in /usr/local/lib/python3.12/dist-packages (3.10.0)\n",
            "Requirement already satisfied: seaborn in /usr/local/lib/python3.12/dist-packages (0.13.2)\n",
            "Requirement already satisfied: scikit-learn in /usr/local/lib/python3.12/dist-packages (1.6.1)\n",
            "Requirement already satisfied: xgboost in /usr/local/lib/python3.12/dist-packages (3.1.1)\n",
            "Requirement already satisfied: imbalanced-learn in /usr/local/lib/python3.12/dist-packages (0.14.0)\n",
            "Requirement already satisfied: python-dateutil>=2.8.2 in /usr/local/lib/python3.12/dist-packages (from pandas) (2.9.0.post0)\n",
            "Requirement already satisfied: pytz>=2020.1 in /usr/local/lib/python3.12/dist-packages (from pandas) (2025.2)\n",
            "Requirement already satisfied: tzdata>=2022.7 in /usr/local/lib/python3.12/dist-packages (from pandas) (2025.2)\n",
            "Requirement already satisfied: contourpy>=1.0.1 in /usr/local/lib/python3.12/dist-packages (from matplotlib) (1.3.3)\n",
            "Requirement already satisfied: cycler>=0.10 in /usr/local/lib/python3.12/dist-packages (from matplotlib) (0.12.1)\n",
            "Requirement already satisfied: fonttools>=4.22.0 in /usr/local/lib/python3.12/dist-packages (from matplotlib) (4.60.1)\n",
            "Requirement already satisfied: kiwisolver>=1.3.1 in /usr/local/lib/python3.12/dist-packages (from matplotlib) (1.4.9)\n",
            "Requirement already satisfied: packaging>=20.0 in /usr/local/lib/python3.12/dist-packages (from matplotlib) (25.0)\n",
            "Requirement already satisfied: pillow>=8 in /usr/local/lib/python3.12/dist-packages (from matplotlib) (11.3.0)\n",
            "Requirement already satisfied: pyparsing>=2.3.1 in /usr/local/lib/python3.12/dist-packages (from matplotlib) (3.2.5)\n",
            "Requirement already satisfied: scipy>=1.6.0 in /usr/local/lib/python3.12/dist-packages (from scikit-learn) (1.16.3)\n",
            "Requirement already satisfied: joblib>=1.2.0 in /usr/local/lib/python3.12/dist-packages (from scikit-learn) (1.5.2)\n",
            "Requirement already satisfied: threadpoolctl>=3.1.0 in /usr/local/lib/python3.12/dist-packages (from scikit-learn) (3.6.0)\n",
            "Requirement already satisfied: nvidia-nccl-cu12 in /usr/local/lib/python3.12/dist-packages (from xgboost) (2.27.3)\n",
            "Requirement already satisfied: six>=1.5 in /usr/local/lib/python3.12/dist-packages (from python-dateutil>=2.8.2->pandas) (1.17.0)\n",
            "All libraries loaded successfully!\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "# Install and import all required packages\n",
        "!pip install pandas numpy matplotlib seaborn scikit-learn xgboost imbalanced-learn gdown --quiet\n",
        "\n",
        "import pandas as pd\n",
        "import numpy as np\n",
        "import matplotlib.pyplot as plt\n",
        "import seaborn as sns\n",
        "from sklearn.model_selection import train_test_split, cross_val_score, GridSearchCV\n",
        "from sklearn.preprocessing import StandardScaler, LabelEncoder\n",
        "from sklearn.ensemble import RandomForestClassifier, GradientBoostingClassifier\n",
        "from sklearn.linear_model import LogisticRegression\n",
        "from sklearn.svm import SVC\n",
        "from xgboost import XGBClassifier\n",
        "from sklearn.metrics import (\n",
        "    classification_report, confusion_matrix, roc_auc_score,\n",
        "    roc_curve, accuracy_score, precision_score, recall_score, f1_score\n",
        ")\n",
        "from sklearn.feature_selection import SelectKBest, f_classif\n",
        "from imblearn.over_sampling import SMOTE\n",
        "import warnings\n",
        "warnings.filterwarnings('ignore')\n",
        "\n",
        "print(\"All libraries loaded successfully!\")\n",
        "\n",
        "\n",
        "# Step 2: Load dataset for RISK prediction\n",
        "import gdown\n",
        "\n",
        "# Direct download link from Google Drive\n",
        "file_url = \"https://drive.google.com/uc?id=19mKGPNFb35kG__3Eihazyv5O69ZUxDcF\"\n",
        "output_path = \"/content/NACC_dataset.csv\"\n",
        "\n",
        "\n",
        "# Download the file\n",
        "gdown.download(file_url, output_path, quiet=False)\n",
        "\n",
        "try:\n",
        "    # Load the downloaded CSV\n",
        "    df = pd.read_csv(output_path)\n",
        "    print(\"Dataset loaded successfully!\")\n",
        "    print(f\" Dataset shape: {df.shape}\")\n",
        "\n",
        "    # Check longitudinal structure for risk prediction\n",
        "    print(\"\\nInspecting dataset for multiple visits per patient...\")\n",
        "\n",
        "    if 'NACCID' in df.columns and 'VISITYR' in df.columns:\n",
        "        visits_per_patient = df['NACCID'].value_counts()\n",
        "        print(f\"Patients with multiple visits: {(visits_per_patient > 1).sum()}\")\n",
        "        print(f\"Average visits per patient: {visits_per_patient.mean():.2f}\")\n",
        "\n",
        "        df_sorted = df.sort_values(['NACCID', 'VISITYR'])\n",
        "        dementia_status = df_sorted.groupby('NACCID')['DEMENTED'].max()\n",
        "\n",
        "        print(\"Using simplified approach for risk prediction\")\n",
        "        print(\"Target: Predict future dementia risk in currently non-demented patients\")\n",
        "    else:\n",
        "        print(\"Longitudinal data not found. Using baseline risk prediction only.\")\n",
        "\n",
        "except Exception as e:\n",
        "    print(f\"Failed to load dataset: {e}\")\n",
        "    print(\"Generating sample dataset for RISK prediction demonstration...\")\n",
        "\n",
        "    # Simulate dataset\n",
        "    np.random.seed(42)\n",
        "    n_samples = 1000\n",
        "    sample_data = {\n",
        "        'NACCID': range(n_samples),\n",
        "        'SEX': np.random.choice([1, 2], n_samples),\n",
        "        'EDUC': np.random.randint(8, 20, n_samples),\n",
        "        'MARISTAT': np.random.choice([1, 2, 3, 4], n_samples),\n",
        "        'NACCAGE': np.random.randint(60, 90, n_samples),\n",
        "        'RACE': np.random.choice([1, 2, 3, 4, 5], n_samples),\n",
        "        'HISPANIC': np.random.choice([0, 1], n_samples),\n",
        "        'TOBAC30': np.random.choice([0, 1], n_samples),\n",
        "        'ALCFREQ': np.random.choice([0, 1, 2, 3], n_samples),\n",
        "        'HEIGHT': np.random.randint(150, 185, n_samples),\n",
        "        'WEIGHT': np.random.randint(50, 100, n_samples),\n",
        "        'RESIDENC': np.random.choice([1, 2, 3], n_samples),\n",
        "        'NACCLIVS': np.random.choice([1, 2, 3], n_samples),\n",
        "        'INDEPEND': np.random.choice([1, 2, 3], n_samples),\n",
        "        'BILLS': np.random.choice([0, 1], n_samples),\n",
        "        'SHOPPING': np.random.choice([0, 1], n_samples),\n",
        "        'DEMENTIA_RISK': np.random.choice([0, 1], n_samples, p=[0.7, 0.3])\n",
        "    }\n",
        "    df = pd.DataFrame(sample_data)\n",
        "    print(\"Sample RISK prediction dataset is ready!\")\n"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "MYCak2OVs3aj",
        "outputId": "529bf141-540d-45ee-b565-34a501cfc6a3"
      },
      "execution_count": 4,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "All libraries loaded successfully!\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "Downloading...\n",
            "From (original): https://drive.google.com/uc?id=19mKGPNFb35kG__3Eihazyv5O69ZUxDcF\n",
            "From (redirected): https://drive.google.com/uc?id=19mKGPNFb35kG__3Eihazyv5O69ZUxDcF&confirm=t&uuid=f740468f-dc18-4595-ab50-fc52b6c3db58\n",
            "To: /content/NACC_dataset.csv\n",
            "100%|| 509M/509M [00:05<00:00, 90.7MB/s]\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "Dataset loaded successfully!\n",
            " Dataset shape: (195196, 1024)\n",
            "\n",
            "Inspecting dataset for multiple visits per patient...\n",
            "Patients with multiple visits: 35671\n",
            "Average visits per patient: 3.72\n",
            "Using simplified approach for risk prediction\n",
            "Target: Predict future dementia risk in currently non-demented patients\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "# Define the target for RISK prediction\n",
        "print(\"---SETTING UP RISK PREDICTION TARGET---\")\n",
        "\n",
        "# The goal is to predict who is at risk of developing dementia in the future.\n",
        "# Depending on the dataset, we may have an explicit risk column or need to create one.\n",
        "\n",
        "if 'DEMENTIA_RISK' in df.columns:\n",
        "    # If a risk column exists, use it directly\n",
        "    target_column = 'DEMENTIA_RISK'\n",
        "    print(\"Using existing 'DEMENTIA_RISK' column as target\")\n",
        "\n",
        "elif 'DEMENTED' in df.columns:\n",
        "    # If only current diagnosis is available, use it as a proxy\n",
        "    target_column = 'DEMENTED'\n",
        "    print(\"Using current dementia status as a proxy for risk\")\n",
        "    print(\"Interpretation: 1 = high risk of having or developing dementia\")\n",
        "\n",
        "else:\n",
        "    # If no target exists, create a synthetic risk based on known risk factors\n",
        "    np.random.seed(42)\n",
        "\n",
        "    # Calculate risk contributions\n",
        "    age_risk = (df['NACCAGE'] - 60) / 30 if 'NACCAGE' in df.columns else 0\n",
        "    educ_risk = (20 - df['EDUC']) / 12 if 'EDUC' in df.columns else 0\n",
        "    tobacco_risk = df['TOBAC30'] if 'TOBAC30' in df.columns else 0\n",
        "\n",
        "    # Combine risk factors using a logistic-like approach\n",
        "    combined_risk = age_risk + educ_risk + tobacco_risk\n",
        "    risk_probability = 1 / (1 + np.exp(-combined_risk))\n",
        "\n",
        "    # Convert probabilities into binary risk: top 30% as high risk\n",
        "    df['DEMENTIA_RISK'] = (risk_probability > np.percentile(risk_probability, 70)).astype(int)\n",
        "    target_column = 'DEMENTIA_RISK'\n",
        "\n",
        "    print(\"Synthetic 'DEMENTIA_RISK' target created based on risk factors\")\n",
        "\n",
        "# Show distribution of risk in the dataset\n",
        "print(f\"\\n Dementia Risk Distribution:\")\n",
        "risk_counts = df[target_column].value_counts()\n",
        "print(risk_counts)\n",
        "print(f\"High risk prevalence: {risk_counts[1] / len(df) * 100:.1f}%\")\n",
        "\n",
        "print(\"\\nMODEL GOAL: Predict future dementia risk using available non-medical factors\")\n"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "MPhPzbgSwP1h",
        "outputId": "9a804d08-6b38-499f-a90a-4a04afcfbaab"
      },
      "execution_count": 5,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "---SETTING UP RISK PREDICTION TARGET---\n",
            "Using current dementia status as a proxy for risk\n",
            "Interpretation: 1 = high risk of having or developing dementia\n",
            "\n",
            " Dementia Risk Distribution:\n",
            "DEMENTED\n",
            "0    137606\n",
            "1     57590\n",
            "Name: count, dtype: int64\n",
            "High risk prevalence: 29.5%\n",
            "\n",
            "MODEL GOAL: Predict future dementia risk using available non-medical factors\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "# Select non-medical features for dementia risk prediction\n",
        "print(\"---IDENTIFYING NON-MEDICAL RISK FACTORS---\")\n",
        "\n",
        "# Categories of known dementia risk factors from literature\n",
        "dementia_risk_factors = {\n",
        "    'demographic': ['SEX', 'RACE', 'HISPANIC', 'EDUC', 'MARISTAT', 'NACCAGE'],\n",
        "    'lifestyle': ['TOBAC30', 'TOBAC100', 'SMOKYRS', 'ALCOCCAS', 'ALCFREQ', 'HEIGHT', 'WEIGHT'],\n",
        "    'social': ['RESIDENC', 'NACCLIVS', 'INDEPEND', 'NACCFAM', 'INLIVWTH'],\n",
        "    'functional': ['BILLS', 'TAXES', 'SHOPPING', 'GAMES', 'STOVE', 'MEALPREP', 'TRAVEL']\n",
        "}\n",
        "\n",
        "# Keep only columns that exist in the dataset\n",
        "existing_features = []\n",
        "for category, features in dementia_risk_factors.items():\n",
        "    valid_features = [f for f in features if f in df.columns]\n",
        "    existing_features.extend(valid_features)\n",
        "    print(f\"{category.capitalize()} features included: {valid_features}\")\n",
        "\n",
        "print(f\"\\nTotal non-medical risk factors available: {len(existing_features)}\")\n",
        "\n",
        "# Prepare feature matrix and target vector\n",
        "X = df[existing_features].copy()\n",
        "y = df[target_column]\n",
        "\n",
        "print(f\"Prepared dataset shapes: Features X={X.shape}, Target y={y.shape}\")\n"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "TlD_GHrmxrTP",
        "outputId": "6d0a3ace-41dc-4c7f-9e51-84968aaf4239"
      },
      "execution_count": 6,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "---IDENTIFYING NON-MEDICAL RISK FACTORS---\n",
            "Demographic features included: ['SEX', 'RACE', 'HISPANIC', 'EDUC', 'MARISTAT', 'NACCAGE']\n",
            "Lifestyle features included: ['TOBAC30', 'TOBAC100', 'SMOKYRS', 'ALCOCCAS', 'ALCFREQ', 'HEIGHT', 'WEIGHT']\n",
            "Social features included: ['RESIDENC', 'NACCLIVS', 'INDEPEND', 'NACCFAM', 'INLIVWTH']\n",
            "Functional features included: ['BILLS', 'TAXES', 'SHOPPING', 'GAMES', 'STOVE', 'MEALPREP', 'TRAVEL']\n",
            "\n",
            "Total non-medical risk factors available: 25\n",
            "Prepared dataset shapes: Features X=(195196, 25), Target y=(195196,)\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "# Exploratory Data Analysis (EDA) for Dementia Risk Factors\n",
        "print(\"---EXPLORATORY RISK FACTOR ANALYSIS---\")\n",
        "\n",
        "plt.figure(figsize=(20, 12))\n",
        "\n",
        "# Dementia Risk Distribution\n",
        "plt.subplot(2, 3, 1)\n",
        "risk_labels = ['Low Risk', 'High Risk']\n",
        "risk_sizes = [risk_counts[0], risk_counts[1]]\n",
        "colors = ['lightgreen', 'lightcoral']\n",
        "plt.pie(risk_sizes, labels=risk_labels, autopct='%1.1f%%', colors=colors)\n",
        "plt.title('Dementia Risk Distribution\\n(Prediction Target)')\n",
        "\n",
        "# Age vs Risk\n",
        "if 'NACCAGE' in X.columns:\n",
        "    plt.subplot(2, 3, 2)\n",
        "    plt.hist(X[y == 0]['NACCAGE'], bins=15, alpha=0.7, color='lightgreen', label='Low Risk')\n",
        "    plt.hist(X[y == 1]['NACCAGE'], bins=15, alpha=0.7, color='lightcoral', label='High Risk')\n",
        "    plt.xlabel('Age')\n",
        "    plt.ylabel('Frequency')\n",
        "    plt.title('Age Distribution by Dementia Risk')\n",
        "    plt.legend()\n",
        "\n",
        "# Education vs Risk\n",
        "if 'EDUC' in X.columns:\n",
        "    plt.subplot(2, 3, 3)\n",
        "    educ_by_risk = pd.crosstab(X['EDUC'], y)\n",
        "    educ_by_risk.plot(kind='bar', color=['lightgreen', 'lightcoral'], ax=plt.gca())\n",
        "    plt.title('Education Level vs Dementia Risk')\n",
        "    plt.xlabel('Years of Education')\n",
        "    plt.ylabel('Count')\n",
        "    plt.legend(['Low Risk', 'High Risk'])\n",
        "\n",
        "# Lifestyle Factors: Tobacco Use\n",
        "if 'TOBAC30' in X.columns:\n",
        "    plt.subplot(2, 3, 4)\n",
        "    tobacco_risk = pd.crosstab(X['TOBAC30'], y)\n",
        "    tobacco_risk.plot(kind='bar', color=['lightgreen', 'lightcoral'], ax=plt.gca())\n",
        "    plt.title('Tobacco Use vs Dementia Risk')\n",
        "    plt.xlabel('Tobacco Use (0=No, 1=Yes)')\n",
        "    plt.ylabel('Count')\n",
        "    plt.legend(['Low Risk', 'High Risk'])\n",
        "\n",
        "# Social Factors: Marital Status\n",
        "if 'MARISTAT' in X.columns:\n",
        "    plt.subplot(2, 3, 5)\n",
        "    marital_risk = pd.crosstab(X['MARISTAT'], y)\n",
        "    marital_risk.plot(kind='bar', color=['lightgreen', 'lightcoral'], ax=plt.gca())\n",
        "    plt.title('Marital Status vs Dementia Risk')\n",
        "    plt.xlabel('Marital Status')\n",
        "    plt.ylabel('Count')\\\n",
        "    plt.legend(['Low Risk', 'High Risk'])\n",
        "\n",
        "# Feature Correlation with Risk\n",
        "plt.subplot(2, 3, 6)\n",
        "correlations = []\n",
        "features_to_plot = existing_features[:10]  # Top 10 features\n",
        "for feature in features_to_plot:\n",
        "    if X[feature].dtype in ['int64', 'float64']:\n",
        "        corr = np.corrcoef(X[feature], y)[0, 1]\n",
        "        correlations.append(abs(corr))\n",
        "    else:\n",
        "        correlations.append(0)\n",
        "\n",
        "plt.barh(features_to_plot, correlations, color='skyblue')\n",
        "plt.xlabel('Absolute Correlation with Dementia Risk')\n",
        "plt.title('Top 10 Features Correlation with Risk')\n",
        "\n",
        "plt.tight_layout()\n",
        "plt.show()\n",
        "\n",
        "print(\"EDA for dementia risk factors completed!\")\n"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 966
        },
        "id": "3QTFyJ_Hx-fZ",
        "outputId": "100151d3-5f76-4900-8c28-c837785060fb"
      },
      "execution_count": 7,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "---EXPLORATORY RISK FACTOR ANALYSIS---\n"
          ]
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "<Figure size 2000x1200 with 6 Axes>"
            ],
            "image/png": "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\n"
          },
          "metadata": {}
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "EDA for dementia risk factors completed!\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "# Data preprocessing, feature selection, and preparation for modeling\n",
        "print(\"---DATA PREPARATION FOR RISK PREDICTION---\")\n",
        "\n",
        "# Handle missing values\n",
        "for col in X.columns:\n",
        "    if X[col].dtype in ['int64', 'float64']:\n",
        "        X[col].fillna(X[col].median(), inplace=True)\n",
        "    else:\n",
        "        X[col].fillna(X[col].mode()[0] if len(X[col].mode()) > 0 else 0, inplace=True)\n",
        "\n",
        "# Encode categorical variables\n",
        "from sklearn.preprocessing import LabelEncoder\n",
        "\n",
        "label_encoders = {}\n",
        "categorical_cols = X.select_dtypes(include=['object']).columns\n",
        "for col in categorical_cols:\n",
        "    le = LabelEncoder()\n",
        "    X[col] = le.fit_transform(X[col].astype(str))\n",
        "    label_encoders[col] = le\n",
        "\n",
        "print(\"Missing values handled and categorical variables encoded.\")\n",
        "\n",
        "# Remove constant features\n",
        "constant_features = [col for col in X.columns if X[col].nunique() <= 1]\n",
        "if constant_features:\n",
        "    X = X.drop(columns=constant_features)\n",
        "    print(f\"Dropped constant features: {constant_features}\")\n",
        "\n",
        "# Feature selection using univariate statistical test\n",
        "from sklearn.feature_selection import SelectKBest, f_classif\n",
        "\n",
        "k = min(15, X.shape[1])  # Select top 15 features or less\n",
        "selector = SelectKBest(score_func=f_classif, k=k)\n",
        "X_selected = selector.fit_transform(X, y)\n",
        "selected_features = X.columns[selector.get_support()].tolist()\n",
        "\n",
        "print(f\"Selected top {len(selected_features)} features for modeling:\")\n",
        "for i, feature in enumerate(selected_features, 1):\n",
        "    print(f\"  {i}. {feature}\")\n",
        "\n",
        "X = X[selected_features]\n",
        "\n",
        "# Train-test split\n",
        "from sklearn.model_selection import train_test_split\n",
        "\n",
        "X_train, X_test, y_train, y_test = train_test_split(\n",
        "    X, y, test_size=0.2, random_state=42, stratify=y\n",
        ")\n",
        "\n",
        "# Scale features\n",
        "from sklearn.preprocessing import StandardScaler\n",
        "\n",
        "scaler = StandardScaler()\n",
        "X_train_scaled = scaler.fit_transform(X_train)\n",
        "X_test_scaled = scaler.transform(X_test)\n",
        "\n",
        "# Handle class imbalance using SMOTE\n",
        "from imblearn.over_sampling import SMOTE\n",
        "\n",
        "smote = SMOTE(random_state=42)\n",
        "X_train_balanced, y_train_balanced = smote.fit_resample(X_train_scaled, y_train)\n",
        "\n",
        "print(\"Data preprocessing, feature selection, scaling, and balancing completed!\")\n",
        "print(f\"Final training data: X={X_train_balanced.shape}, y={y_train_balanced.shape}\")\n",
        "print(f\"Test data: X={X_test_scaled.shape}, y={y_test.shape}\")\n"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "RI8DM6v7yN_6",
        "outputId": "30deb799-3680-4557-cbde-01b25e409cf1"
      },
      "execution_count": 8,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "---DATA PREPARATION FOR RISK PREDICTION---\n",
            "Missing values handled and categorical variables encoded.\n",
            "Selected top 15 features for modeling:\n",
            "  1. SEX\n",
            "  2. MARISTAT\n",
            "  3. TOBAC30\n",
            "  4. TOBAC100\n",
            "  5. RESIDENC\n",
            "  6. NACCLIVS\n",
            "  7. INDEPEND\n",
            "  8. INLIVWTH\n",
            "  9. BILLS\n",
            "  10. TAXES\n",
            "  11. SHOPPING\n",
            "  12. GAMES\n",
            "  13. STOVE\n",
            "  14. MEALPREP\n",
            "  15. TRAVEL\n",
            "Data preprocessing, feature selection, scaling, and balancing completed!\n",
            "Final training data: X=(220168, 15), y=(220168,)\n",
            "Test data: X=(39040, 15), y=(39040,)\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "# Train and evaluate multiple models for dementia risk prediction\n",
        "print(\"--- RISK PREDICTION MODEL DEVELOPMENT---\")\n",
        "\n",
        "# Define models to train (excluding SVM for speed)\n",
        "models = {\n",
        "    'Logistic Regression': LogisticRegression(random_state=42, max_iter=1000),\n",
        "    'Random Forest': RandomForestClassifier(random_state=42, n_estimators=100),\n",
        "    'Gradient Boosting': GradientBoostingClassifier(random_state=42, n_estimators=100),\n",
        "    'XGBoost': XGBClassifier(random_state=42, eval_metric='logloss', n_estimators=100)\n",
        "}\n",
        "\n",
        "# Dictionary to store results\n",
        "results = {}\n",
        "\n",
        "for name, model in models.items():\n",
        "    print(f\"\\n--- Training {name} ---\")\n",
        "\n",
        "    # Train the model on the balanced training set\n",
        "    model.fit(X_train_balanced, y_train_balanced)\n",
        "\n",
        "    # Predictions on test set\n",
        "    y_pred = model.predict(X_test_scaled)\n",
        "    y_pred_proba = model.predict_proba(X_test_scaled)[:, 1]\n",
        "\n",
        "    # Evaluation metrics\n",
        "    accuracy = accuracy_score(y_test, y_pred)\n",
        "    precision = precision_score(y_test, y_pred)\n",
        "    recall = recall_score(y_test, y_pred)\n",
        "    f1 = f1_score(y_test, y_pred)\n",
        "    auc_score = roc_auc_score(y_test, y_pred_proba)\n",
        "\n",
        "    # Store results\n",
        "    results[name] = {\n",
        "        'model': model,\n",
        "        'accuracy': accuracy,\n",
        "        'precision': precision,\n",
        "        'recall': recall,\n",
        "        'f1': f1,\n",
        "        'auc': auc_score,\n",
        "        'predictions': y_pred,\n",
        "        'probabilities': y_pred_proba\n",
        "    }\n",
        "\n",
        "    # Print performance\n",
        "    print(f\"Accuracy: {accuracy:.4f}\")\n",
        "    print(f\"Precision: {precision:.4f}\")\n",
        "    print(f\"Recall: {recall:.4f}\")\n",
        "    print(f\"F1-Score: {f1:.4f}\")\n",
        "    print(f\"AUC Score: {auc_score:.4f}\")\n",
        "\n",
        "# Compare models and select the best based on AUC\n",
        "comparison_data = []\n",
        "for name, metrics in results.items():\n",
        "    comparison_data.append({\n",
        "        'Model': name,\n",
        "        'Accuracy': metrics['accuracy'],\n",
        "        'Precision': metrics['precision'],\n",
        "        'Recall': metrics['recall'],\n",
        "        'F1-Score': metrics['f1'],\n",
        "        'AUC Score': metrics['auc']\n",
        "    })\n",
        "\n",
        "comparison_df = pd.DataFrame(comparison_data).sort_values('AUC Score', ascending=False)\n",
        "best_model_name = comparison_df.iloc[0]['Model']\n",
        "best_model = results[best_model_name]['model']\n",
        "\n",
        "print(f\"\\nBEST RISK PREDICTION MODEL: {best_model_name}\")\n",
        "print(f\"Best AUC Score: {comparison_df.iloc[0]['AUC Score']:.4f}\")\n",
        "\n",
        "# Display model comparison\n",
        "print(\"\\nMODEL COMPARISON:\")\n",
        "print(comparison_df.round(4))"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "FXuQqSRqzDjH",
        "outputId": "9c7a6530-4a29-454a-df31-baf6d812870c"
      },
      "execution_count": 9,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "--- RISK PREDICTION MODEL DEVELOPMENT---\n",
            "\n",
            "--- Training Logistic Regression ---\n",
            "Accuracy: 0.8978\n",
            "Precision: 0.8053\n",
            "Recall: 0.8620\n",
            "F1-Score: 0.8327\n",
            "AUC Score: 0.9478\n",
            "\n",
            "--- Training Random Forest ---\n",
            "Accuracy: 0.9209\n",
            "Precision: 0.8666\n",
            "Recall: 0.8652\n",
            "F1-Score: 0.8659\n",
            "AUC Score: 0.9631\n",
            "\n",
            "--- Training Gradient Boosting ---\n",
            "Accuracy: 0.9246\n",
            "Precision: 0.8539\n",
            "Recall: 0.8981\n",
            "F1-Score: 0.8754\n",
            "AUC Score: 0.9722\n",
            "\n",
            "--- Training XGBoost ---\n",
            "Accuracy: 0.9265\n",
            "Precision: 0.8704\n",
            "Recall: 0.8823\n",
            "F1-Score: 0.8763\n",
            "AUC Score: 0.9724\n",
            "\n",
            "BEST RISK PREDICTION MODEL: XGBoost\n",
            "Best AUC Score: 0.9724\n",
            "\n",
            "MODEL COMPARISON:\n",
            "                 Model  Accuracy  Precision  Recall  F1-Score  AUC Score\n",
            "3              XGBoost    0.9265     0.8704  0.8823    0.8763     0.9724\n",
            "2    Gradient Boosting    0.9246     0.8539  0.8981    0.8754     0.9722\n",
            "1        Random Forest    0.9209     0.8666  0.8652    0.8659     0.9631\n",
            "0  Logistic Regression    0.8978     0.8053  0.8620    0.8327     0.9478\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "#Enhanced Evaluation for Dementia Risk Prediction\n",
        "print(\"---RISK PREDICTION EVALUATION---\")\n",
        "\n",
        "#1 Final predictions using the best model\n",
        "y_pred_final = best_model.predict(X_test_scaled)\n",
        "\n",
        "# Check if model supports probabilities\n",
        "if hasattr(best_model, \"predict_proba\"):\n",
        "    y_pred_proba_final = best_model.predict_proba(X_test_scaled)[:, 1]\n",
        "else:\n",
        "    # If not, fallback to class labels\n",
        "    y_pred_proba_final = y_pred_final\n",
        "\n",
        "#2 Calculate evaluation metrics\n",
        "final_accuracy = accuracy_score(y_test, y_pred_final)\n",
        "final_precision = precision_score(y_test, y_pred_final)\n",
        "final_recall = recall_score(y_test, y_pred_final)\n",
        "final_f1 = f1_score(y_test, y_pred_final)\n",
        "final_auc = roc_auc_score(y_test, y_pred_proba_final)\n",
        "\n",
        "#3 Cross-validation (ROC AUC)\n",
        "cv_scores = cross_val_score(best_model, X_train_balanced, y_train_balanced,\n",
        "                            cv=5, scoring='roc_auc')\n",
        "\n",
        "print(f\"RISK PREDICTION PERFORMANCE:\")\n",
        "print(f\"Accuracy: {final_accuracy:.4f}\")\n",
        "print(f\"Precision: {final_precision:.4f}\")\n",
        "print(f\"Recall: {final_recall:.4f}\")\n",
        "print(f\"F1-Score: {final_f1:.4f}\")\n",
        "print(f\"AUC Score: {final_auc:.4f}\")\n",
        "print(f\"CV Mean AUC: {cv_scores.mean():.4f}\")\n",
        "\n",
        "#4 Visualizations\n",
        "plt.figure(figsize=(18, 5))\n",
        "\n",
        "# Confusion Matrix\n",
        "plt.subplot(1, 4, 1)\n",
        "cm = confusion_matrix(y_test, y_pred_final)\n",
        "sns.heatmap(cm, annot=True, fmt='d', cmap='Blues',\n",
        "            xticklabels=['Low Risk', 'High Risk'],\n",
        "            yticklabels=['Low Risk', 'High Risk'])\n",
        "plt.title('Confusion Matrix')\n",
        "plt.xlabel('Predicted Risk')\n",
        "plt.ylabel('Actual Risk')\n",
        "\n",
        "# ROC Curve\n",
        "plt.subplot(1, 4, 2)\n",
        "fpr, tpr, thresholds = roc_curve(y_test, y_pred_proba_final)\n",
        "plt.plot(fpr, tpr, color='darkorange', lw=2, label=f'ROC (AUC = {final_auc:.3f})')\n",
        "plt.plot([0, 1], [0, 1], color='navy', lw=2, linestyle='--', label='Random')\n",
        "plt.xlabel('False Positive Rate')\n",
        "plt.ylabel('True Positive Rate')\n",
        "plt.title('ROC Curve')\n",
        "plt.legend()\n",
        "\n",
        "#Feature Importance\n",
        "plt.subplot(1, 4, 3)\n",
        "if hasattr(best_model, 'feature_importances_'):\n",
        "    importance_df = pd.DataFrame({\n",
        "        'feature': selected_features,\n",
        "        'importance': best_model.feature_importances_\n",
        "    }).sort_values('importance', ascending=True)\n",
        "    plt.barh(importance_df['feature'], importance_df['importance'], color='lightgreen')\n",
        "    plt.title('Feature Importance')\n",
        "    plt.xlabel('Importance Score')\n",
        "\n",
        "#Predicted Risk Score Distribution\n",
        "plt.subplot(1, 4, 4)\n",
        "risk_scores = y_pred_proba_final * 100\n",
        "plt.hist(risk_scores, bins=20, color='lightblue', alpha=0.7, edgecolor='black')\n",
        "plt.axvline(x=30, color='red', linestyle='--', alpha=0.7, label='Low/Medium Threshold')\n",
        "plt.axvline(x=60, color='darkred', linestyle='--', alpha=0.7, label='Medium/High Threshold')\n",
        "plt.xlabel('Predicted Dementia Risk (%)')\n",
        "plt.ylabel('Frequency')\n",
        "plt.title('Risk Score Distribution')\n",
        "plt.legend()\n",
        "\n",
        "plt.tight_layout()\n",
        "plt.show()\n",
        "\n",
        "print(\"Enhanced risk prediction evaluation completed!\")"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 592
        },
        "id": "k8t2zFifpT9E",
        "outputId": "9550c9a2-6425-4a9a-abce-d678851792ee"
      },
      "execution_count": 10,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "---RISK PREDICTION EVALUATION---\n",
            "RISK PREDICTION PERFORMANCE:\n",
            "Accuracy: 0.9265\n",
            "Precision: 0.8704\n",
            "Recall: 0.8823\n",
            "F1-Score: 0.8763\n",
            "AUC Score: 0.9724\n",
            "CV Mean AUC: 0.9833\n"
          ]
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "<Figure size 1800x500 with 5 Axes>"
            ],
            "image/png": "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\n"
          },
          "metadata": {}
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "Enhanced risk prediction evaluation completed!\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "# Risk Stratification and Clinical Interpretation\n",
        "print(\"---RISK STRATIFICATION ---\")\n",
        "\n",
        "# Generate predicted risk probabilities for the ENTIRE dataset\n",
        "X_full_scaled = scaler.transform(X)  # Scale entire dataset\n",
        "risk_probabilities_all = best_model.predict_proba(X_full_scaled)[:, 1] * 100\n",
        "\n",
        "# Function to categorize risk\n",
        "def categorize_risk(probability):\n",
        "    if probability < 30:\n",
        "        return \"Low Risk\", \"\"\n",
        "    elif probability < 60:\n",
        "        return \"Medium Risk\", \"\"\n",
        "    else:\n",
        "        return \"High Risk\", \"\"\n",
        "\n",
        "print(\"COMPLETE RISK STRATIFICATION RESULTS:\")\n",
        "print(\"=\" * 80)\n",
        "\n",
        "print(\"\\nPatient ID | Risk Score | Risk Level       | Actual Status   | Recommendation\")\n",
        "print(\"-\" * 80)\n",
        "\n",
        "# Display ALL patients\n",
        "for i in range(len(risk_probabilities_all)):\n",
        "    risk_score = risk_probabilities_all[i]\n",
        "    risk_level, emoji = categorize_risk(risk_score)\n",
        "    actual_status = \"High Risk\" if y.iloc[i] == 1 else \"Low Risk\"\n",
        "\n",
        "    # Clinical recommendation based on risk level\n",
        "    if risk_level == \"Low Risk\":\n",
        "        recommendation = \"Routine screening\"\n",
        "    elif risk_level == \"Medium Risk\":\n",
        "        recommendation = \"Enhanced monitoring\"\n",
        "    else:\n",
        "        recommendation = \"Comprehensive evaluation needed\"\n",
        "\n",
        "    print(f\"Patient {i+1:03d}  | {risk_score:5.1f}%     | {risk_level:12} {emoji} | {actual_status:14} | {recommendation}\")\n",
        "\n",
        "# Overall risk distribution in the entire population\n",
        "low_count = np.sum(risk_probabilities_all < 30)\n",
        "medium_count = np.sum((risk_probabilities_all >= 30) & (risk_probabilities_all < 60))\n",
        "high_count = np.sum(risk_probabilities_all >= 60)\n",
        "total = len(risk_probabilities_all)\n",
        "\n",
        "print(f\"\\nCOMPLETE POPULATION RISK DISTRIBUTION:\")\n",
        "print(f\"Low Risk (<30%): {low_count} patients ({low_count/total*100:.1f}%)\")\n",
        "print(f\"Medium Risk (30-60%): {medium_count} patients ({medium_count/total*100:.1f}%)\")\n",
        "print(f\"High Risk (60%): {high_count} patients ({high_count/total*100:.1f}%)\")\n",
        "\n",
        "# Clinical impact assessment for entire dataset\n",
        "true_high_risk = np.sum((risk_probabilities_all >= 60) & (y == 1))\n",
        "false_high_risk = np.sum((risk_probabilities_all >= 60) & (y == 0))\n",
        "true_low_risk = np.sum((risk_probabilities_all < 30) & (y == 0))\n",
        "false_low_risk = np.sum((risk_probabilities_all < 30) & (y == 1))\n",
        "\n",
        "print(f\"\\nCOMPREHENSIVE CLINICAL IMPACT:\")\n",
        "print(f\"  - Correctly identified {true_high_risk} high-risk patients\")\n",
        "print(f\"  - {false_high_risk} false positives (low-risk flagged as high-risk)\")\n",
        "print(f\"  - Correctly identified {true_low_risk} low-risk patients\")\n",
        "print(f\"  - {false_low_risk} false negatives (high-risk missed)\")\n",
        "\n",
        "# Additional detailed analysis\n",
        "print(f\"\\nMODEL PERFORMANCE ON FULL DATASET:\")\n",
        "accuracy_full = accuracy_score(y, best_model.predict(X_full_scaled))\n",
        "precision_full = precision_score(y, best_model.predict(X_full_scaled))\n",
        "recall_full = recall_score(y, best_model.predict(X_full_scaled))\n",
        "f1_full = f1_score(y, best_model.predict(X_full_scaled))\n",
        "\n",
        "print(f\"  - Accuracy: {accuracy_full:.4f}\")\n",
        "print(f\"  - Precision: {precision_full:.4f}\")\n",
        "print(f\"  - Recall: {recall_full:.4f}\")\n",
        "print(f\"  - F1-Score: {f1_full:.4f}\")\n",
        "\n",
        "# Risk distribution by actual status\n",
        "print(f\"\\nRISK DISTRIBUTION BY ACTUAL STATUS:\")\n",
        "high_risk_actual_high = np.sum((risk_probabilities_all >= 60) & (y == 1))\n",
        "high_risk_actual_low = np.sum((risk_probabilities_all >= 60) & (y == 0))\n",
        "\n",
        "print(f\" - Actual High-Risk patients correctly flagged: {high_risk_actual_high}/{y.sum()} ({high_risk_actual_high/y.sum()*100:.1f}%)\")\n",
        "print(f\" - Low-Risk patients incorrectly flagged: {high_risk_actual_low}/{len(y)-y.sum()} ({high_risk_actual_low/(len(y)-y.sum())*100:.1f}%)\")\n",
        ""
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "EJWWayPXsZ3P",
        "outputId": "c04646e2-b83e-420e-9a51-74a6bf654f2c"
      },
      "execution_count": 14,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "\u001b[1;30;43mStreaming output truncated to the last 5000 lines.\u001b[0m\n",
            "Patient 190218  |  99.8%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190219  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190220  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190221  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190222  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190223  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190224  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190225  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190226  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190227  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190228  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190229  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190230  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190231  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190232  |  51.1%     | Medium Risk   | High Risk      | Enhanced monitoring\n",
            "Patient 190233  |  47.2%     | Medium Risk   | High Risk      | Enhanced monitoring\n",
            "Patient 190234  |  70.2%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190235  |  81.7%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190236  |  80.8%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190237  |  74.7%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190238  |  85.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190239  |  82.3%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190240  |  86.2%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190241  |  91.1%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190242  |  85.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190243  |  99.2%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190244  |  99.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190245  |  99.6%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190246  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190247  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190248  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190249  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190250  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190251  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190252  |   3.4%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190253  |   2.4%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190254  |   4.2%     | Low Risk      | High Risk      | Routine screening\n",
            "Patient 190255  |   2.4%     | Low Risk      | High Risk      | Routine screening\n",
            "Patient 190256  |   1.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190257  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190258  |   0.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190259  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190260  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190261  |   2.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190262  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190263  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190264  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190265  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190266  |   2.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190267  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190268  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190269  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190270  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190271  |   7.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190272  |   6.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190273  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190274  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190275  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190276  |  12.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190277  |  12.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190278  |  18.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190279  |  32.9%     | Medium Risk   | High Risk      | Enhanced monitoring\n",
            "Patient 190280  |  18.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190281  |  10.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190282  |   2.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190283  |  10.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190284  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190285  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190286  |   4.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190287  | 100.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190288  | 100.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190289  | 100.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190290  |   1.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190291  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190292  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190293  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190294  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190295  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190296  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190297  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190298  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190299  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190300  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190301  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190302  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190303  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190304  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190305  |  25.7%     | Low Risk      | High Risk      | Routine screening\n",
            "Patient 190306  |  58.8%     | Medium Risk   | Low Risk       | Enhanced monitoring\n",
            "Patient 190307  |   8.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190308  |  14.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190309  |  41.8%     | Medium Risk   | Low Risk       | Enhanced monitoring\n",
            "Patient 190310  |  84.5%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190311  |  98.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190312  | 100.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190313  | 100.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190314  |  21.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190315  |  17.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190316  |  13.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190317  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190318  |  17.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190319  |  17.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190320  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190321  |  17.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190322  |  17.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190323  |  17.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190324  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190325  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190326  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190327  |  11.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190328  |  90.6%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190329  |  99.5%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190330  |  99.9%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190331  |  99.7%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190332  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190333  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190334  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190335  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190336  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190337  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190338  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190339  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190340  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190341  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190342  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190343  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190344  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190345  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190346  |   2.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190347  |   2.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190348  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190349  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190350  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190351  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190352  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190353  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190354  |  39.9%     | Medium Risk   | Low Risk       | Enhanced monitoring\n",
            "Patient 190355  |   4.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190356  |  97.1%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190357  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190358  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190359  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190360  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190361  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190362  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190363  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190364  |   9.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190365  |   2.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190366  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190367  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190368  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190369  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190370  | 100.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190371  | 100.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190372  |  99.8%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190373  | 100.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190374  | 100.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190375  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190376  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190377  |  99.5%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190378  |  56.8%     | Medium Risk   | Low Risk       | Enhanced monitoring\n",
            "Patient 190379  |  55.0%     | Medium Risk   | Low Risk       | Enhanced monitoring\n",
            "Patient 190380  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190381  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190382  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190383  |   8.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190384  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190385  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190386  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190387  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190388  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190389  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190390  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190391  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190392  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190393  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190394  |   6.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190395  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190396  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190397  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190398  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190399  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190400  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190401  |  11.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190402  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190403  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190404  |   5.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190405  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190406  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190407  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190408  |   1.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190409  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190410  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190411  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190412  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190413  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190414  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190415  |   9.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190416  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190417  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190418  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190419  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190420  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190421  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190422  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190423  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190424  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190425  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190426  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190427  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190428  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190429  |  17.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190430  |   6.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190431  |  15.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190432  |  75.4%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190433  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190434  |   1.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190435  |  60.5%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190436  |  70.3%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190437  |  41.8%     | Medium Risk   | High Risk      | Enhanced monitoring\n",
            "Patient 190438  |  51.7%     | Medium Risk   | High Risk      | Enhanced monitoring\n",
            "Patient 190439  |  77.8%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190440  |  95.6%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190441  |  99.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190442  |   1.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190443  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190444  |   1.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190445  |   1.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190446  |   1.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190447  |   4.4%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190448  |  54.4%     | Medium Risk   | High Risk      | Enhanced monitoring\n",
            "Patient 190449  |  18.8%     | Low Risk      | High Risk      | Routine screening\n",
            "Patient 190450  |  50.1%     | Medium Risk   | High Risk      | Enhanced monitoring\n",
            "Patient 190451  |  38.5%     | Medium Risk   | High Risk      | Enhanced monitoring\n",
            "Patient 190452  |  48.8%     | Medium Risk   | High Risk      | Enhanced monitoring\n",
            "Patient 190453  |  41.1%     | Medium Risk   | Low Risk       | Enhanced monitoring\n",
            "Patient 190454  |  62.0%     | High Risk     | Low Risk       | Comprehensive evaluation needed\n",
            "Patient 190455  |  10.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190456  |   1.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190457  |  67.3%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190458  |  91.2%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190459  |  98.7%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190460  |  92.4%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190461  |  98.7%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190462  |  99.4%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190463  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190464  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190465  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190466  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190467  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190468  |  53.8%     | Medium Risk   | Low Risk       | Enhanced monitoring\n",
            "Patient 190469  |  66.1%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190470  |  74.5%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190471  |  96.2%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190472  |  91.4%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190473  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190474  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190475  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190476  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190477  |  17.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190478  |   7.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190479  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190480  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190481  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190482  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190483  |  99.9%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190484  |  62.4%     | High Risk     | Low Risk       | Comprehensive evaluation needed\n",
            "Patient 190485  |  27.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190486  |   7.0%     | Low Risk      | High Risk      | Routine screening\n",
            "Patient 190487  |   1.8%     | Low Risk      | High Risk      | Routine screening\n",
            "Patient 190488  |  91.9%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190489  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190490  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190491  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190492  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190493  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190494  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190495  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190496  |   3.4%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190497  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190498  |   1.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190499  |   1.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190500  |   1.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190501  |   1.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190502  |   1.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190503  |   1.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190504  |   1.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190505  |  11.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190506  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190507  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190508  |   1.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190509  |   1.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190510  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190511  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190512  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190513  |  99.2%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190514  |  99.4%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190515  |  99.3%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190516  |  99.4%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190517  | 100.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190518  |  11.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190519  |  18.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190520  |  80.6%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190521  |  61.8%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190522  |  98.6%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190523  |  96.4%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190524  |  99.4%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190525  | 100.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190526  |   4.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190527  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190528  | 100.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190529  | 100.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190530  |  99.1%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190531  |  99.2%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190532  |  99.9%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190533  |  99.9%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190534  |  99.9%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190535  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190536  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190537  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190538  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190539  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190540  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190541  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190542  |  17.7%     | Low Risk      | High Risk      | Routine screening\n",
            "Patient 190543  |  79.1%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190544  |  67.4%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190545  |  98.8%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190546  |  98.8%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190547  |  99.9%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190548  |   1.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190549  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190550  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190551  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190552  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190553  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190554  |   7.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190555  |   7.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190556  |   7.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190557  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190558  |  27.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190559  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190560  |   8.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190561  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190562  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190563  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190564  |  10.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190565  |  10.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190566  | 100.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190567  | 100.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190568  | 100.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190569  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190570  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190571  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190572  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190573  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190574  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190575  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190576  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190577  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190578  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190579  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190580  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190581  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190582  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190583  |   4.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190584  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190585  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190586  |   1.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190587  |   1.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190588  |   1.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190589  |   1.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190590  |   1.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190591  |   1.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190592  |   1.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190593  |   1.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190594  |   1.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190595  |   1.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190596  |   1.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190597  |  37.2%     | Medium Risk   | Low Risk       | Enhanced monitoring\n",
            "Patient 190598  |  37.0%     | Medium Risk   | Low Risk       | Enhanced monitoring\n",
            "Patient 190599  |  32.0%     | Medium Risk   | Low Risk       | Enhanced monitoring\n",
            "Patient 190600  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190601  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190602  |   0.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190603  |   3.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190604  |  22.1%     | Low Risk      | High Risk      | Routine screening\n",
            "Patient 190605  |  17.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190606  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190607  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190608  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190609  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190610  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190611  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190612  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190613  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190614  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190615  |   9.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190616  |  34.8%     | Medium Risk   | High Risk      | Enhanced monitoring\n",
            "Patient 190617  |  94.1%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190618  | 100.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190619  | 100.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190620  | 100.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190621  | 100.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190622  |   1.4%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190623  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190624  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190625  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190626  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190627  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190628  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190629  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190630  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190631  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190632  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190633  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190634  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190635  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190636  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190637  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190638  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190639  |  99.3%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190640  |  99.6%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190641  |  13.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190642  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190643  |  17.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190644  |  20.4%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190645  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190646  |  99.0%     | High Risk     | Low Risk       | Comprehensive evaluation needed\n",
            "Patient 190647  |   1.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190648  |   1.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190649  |  11.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190650  |  17.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190651  |   9.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190652  |  99.8%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190653  |   1.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190654  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190655  |   1.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190656  |  15.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190657  |   1.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190658  |   1.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190659  |   1.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190660  |   1.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190661  |   5.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190662  |  48.8%     | Medium Risk   | Low Risk       | Enhanced monitoring\n",
            "Patient 190663  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190664  |   1.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190665  |   1.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190666  |   1.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190667  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190668  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190669  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190670  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190671  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190672  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190673  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190674  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190675  |  49.9%     | Medium Risk   | High Risk      | Enhanced monitoring\n",
            "Patient 190676  |  23.7%     | Low Risk      | High Risk      | Routine screening\n",
            "Patient 190677  |  78.1%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190678  |  82.4%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190679  |  97.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190680  |  78.3%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190681  |  98.7%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190682  |  99.6%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190683  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190684  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190685  | 100.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190686  |  67.6%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190687  |  72.7%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190688  |  93.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190689  |  16.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190690  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190691  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190692  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190693  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190694  |   0.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190695  |  65.1%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190696  |  72.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190697  |  92.4%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190698  |  96.5%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190699  |  98.3%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190700  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190701  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190702  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190703  |  17.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190704  |  17.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190705  |  17.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190706  |   9.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190707  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190708  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190709  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190710  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190711  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190712  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190713  |   7.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190714  |  86.6%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190715  |  88.7%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190716  |  97.1%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190717  |  99.1%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190718  |  99.6%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190719  |  99.5%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190720  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190721  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190722  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190723  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190724  |   3.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190725  |  12.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190726  |  15.8%     | Low Risk      | High Risk      | Routine screening\n",
            "Patient 190727  |   1.5%     | Low Risk      | High Risk      | Routine screening\n",
            "Patient 190728  |  48.6%     | Medium Risk   | High Risk      | Enhanced monitoring\n",
            "Patient 190729  |  54.0%     | Medium Risk   | High Risk      | Enhanced monitoring\n",
            "Patient 190730  |  93.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190731  |  98.9%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190732  |  99.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190733  |   1.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190734  |   1.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190735  |   1.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190736  |   2.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190737  |   2.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190738  |   2.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190739  |   2.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190740  |   2.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190741  |   2.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190742  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190743  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190744  |  10.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190745  |   2.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190746  |   4.4%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190747  |   0.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190748  |   5.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190749  |   9.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190750  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190751  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190752  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190753  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190754  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190755  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190756  |   2.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190757  |   1.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190758  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190759  |   2.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190760  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190761  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190762  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190763  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190764  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190765  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190766  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190767  |   1.2%     | Low Risk      | High Risk      | Routine screening\n",
            "Patient 190768  |   8.8%     | Low Risk      | High Risk      | Routine screening\n",
            "Patient 190769  |   5.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190770  |   9.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190771  |  49.1%     | Medium Risk   | High Risk      | Enhanced monitoring\n",
            "Patient 190772  |  21.2%     | Low Risk      | High Risk      | Routine screening\n",
            "Patient 190773  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190774  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190775  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190776  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190777  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190778  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190779  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190780  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190781  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190782  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190783  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190784  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190785  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190786  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190787  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190788  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190789  |   2.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190790  |   2.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190791  |   2.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190792  |   2.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190793  |   2.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190794  |   2.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190795  |   2.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190796  |   2.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190797  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190798  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190799  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190800  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190801  |  20.9%     | Low Risk      | High Risk      | Routine screening\n",
            "Patient 190802  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190803  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190804  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190805  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190806  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190807  |   1.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190808  |   1.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190809  |   1.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190810  |   1.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190811  |   1.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190812  |   1.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190813  | 100.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190814  | 100.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190815  | 100.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190816  | 100.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190817  | 100.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190818  | 100.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190819  |   5.4%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190820  |   2.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190821  |  24.0%     | Low Risk      | High Risk      | Routine screening\n",
            "Patient 190822  |  50.6%     | Medium Risk   | Low Risk       | Enhanced monitoring\n",
            "Patient 190823  |  33.8%     | Medium Risk   | Low Risk       | Enhanced monitoring\n",
            "Patient 190824  |  27.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190825  |  25.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190826  |  21.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190827  |   7.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190828  |  17.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190829  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190830  |  15.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190831  |  15.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190832  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190833  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190834  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190835  |   7.4%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190836  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190837  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190838  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190839  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190840  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190841  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190842  |  13.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190843  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190844  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190845  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190846  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190847  |  51.4%     | Medium Risk   | High Risk      | Enhanced monitoring\n",
            "Patient 190848  |  93.3%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190849  |  98.9%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190850  |  99.7%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190851  |  99.2%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190852  |   8.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190853  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190854  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190855  |  23.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190856  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190857  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190858  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190859  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190860  |  32.9%     | Medium Risk   | Low Risk       | Enhanced monitoring\n",
            "Patient 190861  |  99.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190862  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190863  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190864  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190865  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190866  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190867  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190868  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190869  |  21.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190870  |   3.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190871  |  73.9%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190872  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190873  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190874  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190875  |  77.4%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190876  |  90.4%     | High Risk     | Low Risk       | Comprehensive evaluation needed\n",
            "Patient 190877  |  91.6%     | High Risk     | Low Risk       | Comprehensive evaluation needed\n",
            "Patient 190878  |  95.8%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190879  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190880  |   1.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190881  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190882  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190883  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190884  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190885  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190886  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190887  |   8.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190888  |  13.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190889  |   8.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190890  |   6.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190891  |   6.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190892  |   2.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190893  |  21.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190894  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190895  |   5.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190896  |   8.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190897  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190898  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190899  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190900  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190901  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190902  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190903  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190904  |   8.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190905  |   2.1%     | Low Risk      | High Risk      | Routine screening\n",
            "Patient 190906  |  21.1%     | Low Risk      | High Risk      | Routine screening\n",
            "Patient 190907  |  74.1%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190908  |  97.8%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190909  |  68.6%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190910  |  85.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190911  |  96.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190912  |  18.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190913  |  12.4%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190914  |  12.4%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190915  |  12.4%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190916  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190917  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190918  |  41.8%     | Medium Risk   | Low Risk       | Enhanced monitoring\n",
            "Patient 190919  |  94.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190920  |  99.4%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190921  |  99.7%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190922  |   6.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190923  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190924  |   2.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190925  |   2.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190926  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190927  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190928  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190929  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190930  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190931  |   8.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190932  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190933  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190934  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190935  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190936  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190937  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190938  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190939  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190940  |   0.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190941  |   3.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190942  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190943  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190944  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190945  |  17.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190946  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190947  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190948  |   4.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190949  |   7.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190950  |  25.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190951  |  13.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190952  |  93.3%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190953  |  99.9%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190954  |  11.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190955  |  34.0%     | Medium Risk   | Low Risk       | Enhanced monitoring\n",
            "Patient 190956  |   1.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190957  |   2.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190958  |  11.4%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190959  |   5.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190960  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190961  |   0.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190962  |   2.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190963  |   0.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190964  |   5.4%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190965  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190966  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190967  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190968  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190969  |  96.9%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190970  |  35.3%     | Medium Risk   | Low Risk       | Enhanced monitoring\n",
            "Patient 190971  | 100.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190972  | 100.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190973  | 100.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190974  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190975  |   2.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190976  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190977  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190978  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190979  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190980  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190981  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190982  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190983  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190984  |  28.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190985  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190986  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190987  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190988  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190989  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190990  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190991  |  57.9%     | Medium Risk   | High Risk      | Enhanced monitoring\n",
            "Patient 190992  |  93.5%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190993  |  99.6%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190994  |  99.8%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190995  | 100.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 190996  |   1.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190997  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190998  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 190999  |  41.8%     | Medium Risk   | Low Risk       | Enhanced monitoring\n",
            "Patient 191000  |  83.4%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191001  |   9.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191002  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191003  |  46.3%     | Medium Risk   | High Risk      | Enhanced monitoring\n",
            "Patient 191004  |  41.2%     | Medium Risk   | High Risk      | Enhanced monitoring\n",
            "Patient 191005  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191006  |  39.4%     | Medium Risk   | High Risk      | Enhanced monitoring\n",
            "Patient 191007  |   1.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191008  |   2.4%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191009  |   0.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191010  |   0.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191011  |   4.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191012  |  12.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191013  |  11.4%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191014  |  13.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191015  |  34.5%     | Medium Risk   | Low Risk       | Enhanced monitoring\n",
            "Patient 191016  |   1.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191017  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191018  |   1.1%     | Low Risk      | High Risk      | Routine screening\n",
            "Patient 191019  |  82.1%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191020  |  97.2%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191021  |  99.5%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191022  |  27.7%     | Low Risk      | High Risk      | Routine screening\n",
            "Patient 191023  |  99.8%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191024  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191025  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191026  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191027  |  20.7%     | Low Risk      | High Risk      | Routine screening\n",
            "Patient 191028  |  93.3%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191029  |  56.7%     | Medium Risk   | Low Risk       | Enhanced monitoring\n",
            "Patient 191030  | 100.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191031  | 100.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191032  |  16.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191033  |  62.4%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191034  |  51.1%     | Medium Risk   | High Risk      | Enhanced monitoring\n",
            "Patient 191035  |  48.4%     | Medium Risk   | High Risk      | Enhanced monitoring\n",
            "Patient 191036  |  99.6%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191037  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191038  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191039  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191040  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191041  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191042  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191043  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191044  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191045  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191046  |   9.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191047  |   7.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191048  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191049  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191050  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191051  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191052  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191053  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191054  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191055  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191056  |  12.8%     | Low Risk      | High Risk      | Routine screening\n",
            "Patient 191057  |  60.1%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191058  |  74.5%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191059  |  95.9%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191060  |  82.7%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191061  |  99.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191062  |  95.9%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191063  |  94.2%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191064  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191065  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191066  |  60.0%     | High Risk     | Low Risk       | Comprehensive evaluation needed\n",
            "Patient 191067  |  25.3%     | Low Risk      | High Risk      | Routine screening\n",
            "Patient 191068  |   0.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191069  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191070  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191071  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191072  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191073  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191074  |   0.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191075  |   0.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191076  |   0.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191077  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191078  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191079  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191080  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191081  |   3.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191082  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191083  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191084  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191085  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191086  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191087  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191088  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191089  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191090  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191091  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191092  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191093  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191094  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191095  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191096  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191097  |   2.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191098  |   6.4%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191099  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191100  |   1.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191101  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191102  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191103  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191104  |   6.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191105  |   2.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191106  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191107  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191108  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191109  |  33.6%     | Medium Risk   | Low Risk       | Enhanced monitoring\n",
            "Patient 191110  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191111  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191112  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191113  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191114  |  15.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191115  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191116  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191117  |   8.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191118  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191119  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191120  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191121  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191122  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191123  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191124  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191125  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191126  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191127  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191128  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191129  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191130  |  10.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191131  |  99.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191132  |  99.8%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191133  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191134  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191135  |   1.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191136  |   1.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191137  |   1.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191138  |   1.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191139  |   1.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191140  |   1.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191141  |   1.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191142  |   9.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191143  |   9.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191144  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191145  |   1.4%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191146  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191147  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191148  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191149  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191150  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191151  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191152  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191153  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191154  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191155  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191156  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191157  |   2.4%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191158  |   2.4%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191159  |   2.4%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191160  |   2.4%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191161  |   2.4%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191162  |   2.4%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191163  |   2.4%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191164  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191165  |   7.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191166  |  47.3%     | Medium Risk   | Low Risk       | Enhanced monitoring\n",
            "Patient 191167  |  98.2%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191168  |  99.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191169  |  97.2%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191170  | 100.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191171  | 100.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191172  | 100.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191173  |  99.8%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191174  |  99.5%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191175  | 100.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191176  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191177  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191178  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191179  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191180  |  17.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191181  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191182  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191183  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191184  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191185  |   4.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191186  |  13.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191187  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191188  |  11.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191189  |   4.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191190  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191191  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191192  |   7.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191193  |  85.6%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191194  |  99.4%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191195  |  99.5%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191196  |  99.8%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191197  |   2.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191198  |   2.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191199  |  38.7%     | Medium Risk   | Low Risk       | Enhanced monitoring\n",
            "Patient 191200  |  69.3%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191201  |  13.3%     | Low Risk      | High Risk      | Routine screening\n",
            "Patient 191202  |  14.2%     | Low Risk      | High Risk      | Routine screening\n",
            "Patient 191203  |  17.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191204  |   1.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191205  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191206  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191207  |  77.2%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191208  |  90.2%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191209  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191210  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191211  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191212  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191213  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191214  |   0.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191215  |   6.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191216  |   8.2%     | Low Risk      | High Risk      | Routine screening\n",
            "Patient 191217  |  38.3%     | Medium Risk   | High Risk      | Enhanced monitoring\n",
            "Patient 191218  |  99.7%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191219  |  64.9%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191220  |  83.5%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191221  |  99.5%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191222  |  99.9%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191223  |  99.7%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191224  |  99.8%     | High Risk     | Low Risk       | Comprehensive evaluation needed\n",
            "Patient 191225  |  56.9%     | Medium Risk   | Low Risk       | Enhanced monitoring\n",
            "Patient 191226  |   1.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191227  |  15.4%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191228  |  10.4%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191229  |  10.4%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191230  |   2.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191231  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191232  |  94.9%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191233  |  99.6%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191234  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191235  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191236  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191237  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191238  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191239  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191240  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191241  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191242  |  12.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191243  |  99.4%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191244  |  99.9%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191245  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191246  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191247  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191248  |  18.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191249  |  18.4%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191250  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191251  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191252  |  40.9%     | Medium Risk   | Low Risk       | Enhanced monitoring\n",
            "Patient 191253  | 100.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191254  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191255  |   2.4%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191256  |   2.4%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191257  |   2.4%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191258  |   2.4%     | Low Risk      | High Risk      | Routine screening\n",
            "Patient 191259  |  30.5%     | Medium Risk   | Low Risk       | Enhanced monitoring\n",
            "Patient 191260  |   2.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191261  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191262  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191263  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191264  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191265  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191266  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191267  | 100.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191268  | 100.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191269  |   4.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191270  |  11.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191271  |   1.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191272  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191273  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191274  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191275  |   0.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191276  |  88.5%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191277  |  98.4%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191278  |  97.7%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191279  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191280  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191281  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191282  |  88.4%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191283  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191284  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191285  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191286  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191287  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191288  |   7.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191289  |   1.8%     | Low Risk      | High Risk      | Routine screening\n",
            "Patient 191290  |   7.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191291  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191292  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191293  |   7.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191294  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191295  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191296  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191297  |  25.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191298  |   7.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191299  |  18.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191300  |  16.2%     | Low Risk      | High Risk      | Routine screening\n",
            "Patient 191301  |  50.4%     | Medium Risk   | High Risk      | Enhanced monitoring\n",
            "Patient 191302  |  58.5%     | Medium Risk   | High Risk      | Enhanced monitoring\n",
            "Patient 191303  |  97.3%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191304  |  97.4%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191305  |  98.6%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191306  |  99.5%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191307  |  99.9%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191308  |  99.9%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191309  |  99.9%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191310  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191311  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191312  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191313  |  96.2%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191314  |  99.6%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191315  |  99.6%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191316  |  99.8%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191317  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191318  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191319  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191320  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191321  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191322  |   3.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191323  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191324  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191325  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191326  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191327  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191328  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191329  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191330  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191331  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191332  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191333  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191334  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191335  |  87.7%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191336  |  72.4%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191337  |  97.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191338  |  98.7%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191339  |  99.5%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191340  |   2.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191341  |   3.2%     | Low Risk      | High Risk      | Routine screening\n",
            "Patient 191342  |  97.7%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191343  |  96.1%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191344  |   5.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191345  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191346  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191347  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191348  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191349  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191350  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191351  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191352  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191353  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191354  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191355  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191356  |   8.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191357  |   2.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191358  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191359  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191360  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191361  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191362  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191363  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191364  |   0.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191365  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191366  |   0.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191367  |   0.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191368  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191369  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191370  |   3.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191371  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191372  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191373  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191374  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191375  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191376  |  11.4%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191377  |   9.4%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191378  |   6.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191379  |  33.3%     | Medium Risk   | Low Risk       | Enhanced monitoring\n",
            "Patient 191380  |   6.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191381  |   2.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191382  |   2.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191383  |   2.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191384  |   6.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191385  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191386  |  38.7%     | Medium Risk   | Low Risk       | Enhanced monitoring\n",
            "Patient 191387  |  94.2%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191388  |  99.9%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191389  |   1.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191390  |   1.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191391  |   1.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191392  |   1.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191393  |   1.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191394  |   1.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191395  |   1.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191396  |   5.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191397  |   2.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191398  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191399  |   3.5%     | Low Risk      | High Risk      | Routine screening\n",
            "Patient 191400  |   3.5%     | Low Risk      | High Risk      | Routine screening\n",
            "Patient 191401  |  41.5%     | Medium Risk   | High Risk      | Enhanced monitoring\n",
            "Patient 191402  |  51.7%     | Medium Risk   | High Risk      | Enhanced monitoring\n",
            "Patient 191403  |  66.7%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191404  |  86.8%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191405  |  98.8%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191406  |  99.6%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191407  | 100.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191408  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191409  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191410  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191411  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191412  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191413  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191414  | 100.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191415  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191416  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191417  |   1.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191418  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191419  |   4.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191420  |   1.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191421  |   5.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191422  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191423  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191424  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191425  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191426  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191427  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191428  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191429  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191430  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191431  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191432  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191433  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191434  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191435  |   1.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191436  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191437  |   0.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191438  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191439  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191440  |   3.2%     | Low Risk      | High Risk      | Routine screening\n",
            "Patient 191441  |  37.2%     | Medium Risk   | High Risk      | Enhanced monitoring\n",
            "Patient 191442  |  69.5%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191443  |  99.4%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191444  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191445  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191446  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191447  |  74.9%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191448  |  99.6%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191449  |  99.6%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191450  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191451  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191452  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191453  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191454  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191455  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191456  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191457  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191458  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191459  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191460  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191461  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191462  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191463  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191464  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191465  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191466  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191467  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191468  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191469  |   0.4%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191470  |  23.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191471  |  53.9%     | Medium Risk   | High Risk      | Enhanced monitoring\n",
            "Patient 191472  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191473  | 100.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191474  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191475  |   1.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191476  |   1.4%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191477  |   1.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191478  |   2.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191479  |   5.0%     | Low Risk      | High Risk      | Routine screening\n",
            "Patient 191480  |  76.6%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191481  |   0.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191482  |   0.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191483  |   0.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191484  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191485  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191486  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191487  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191488  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191489  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191490  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191491  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191492  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191493  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191494  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191495  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191496  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191497  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191498  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191499  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191500  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191501  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191502  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191503  |   5.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191504  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191505  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191506  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191507  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191508  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191509  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191510  |   4.4%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191511  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191512  |  99.7%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191513  |  99.9%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191514  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191515  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191516  |   3.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191517  |   2.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191518  |   2.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191519  |   2.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191520  |   2.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191521  |   2.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191522  |   2.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191523  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191524  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191525  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191526  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191527  |  99.2%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191528  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191529  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191530  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191531  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191532  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191533  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191534  |   5.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191535  |   0.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191536  |   2.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191537  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191538  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191539  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191540  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191541  |  17.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191542  |  13.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191543  |  12.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191544  |  12.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191545  |  43.0%     | Medium Risk   | High Risk      | Enhanced monitoring\n",
            "Patient 191546  |  11.6%     | Low Risk      | High Risk      | Routine screening\n",
            "Patient 191547  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191548  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191549  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191550  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191551  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191552  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191553  |   1.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191554  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191555  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191556  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191557  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191558  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191559  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191560  |  26.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191561  |  38.0%     | Medium Risk   | Low Risk       | Enhanced monitoring\n",
            "Patient 191562  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191563  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191564  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191565  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191566  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191567  |  99.8%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191568  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191569  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191570  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191571  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191572  |   6.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191573  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191574  |   6.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191575  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191576  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191577  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191578  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191579  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191580  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191581  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191582  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191583  |  90.6%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191584  |  96.8%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191585  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191586  |   1.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191587  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191588  |   1.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191589  |   1.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191590  |   1.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191591  |   1.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191592  |   1.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191593  |   0.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191594  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191595  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191596  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191597  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191598  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191599  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191600  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191601  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191602  |  23.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191603  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191604  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191605  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191606  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191607  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191608  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191609  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191610  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191611  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191612  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191613  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191614  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191615  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191616  |   9.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191617  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191618  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191619  |   2.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191620  |   2.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191621  |  20.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191622  |  19.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191623  |  20.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191624  |  28.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191625  |  56.1%     | Medium Risk   | Low Risk       | Enhanced monitoring\n",
            "Patient 191626  |   5.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191627  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191628  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191629  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191630  |  16.4%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191631  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191632  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191633  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191634  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191635  |   0.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191636  |  95.7%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191637  |  76.6%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191638  |  80.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191639  |  99.4%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191640  |  99.8%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191641  |  99.8%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191642  |  99.8%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191643  |  99.8%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191644  |  99.8%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191645  |  46.2%     | Medium Risk   | High Risk      | Enhanced monitoring\n",
            "Patient 191646  |  84.3%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191647  |  88.4%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191648  |  89.9%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191649  |  91.2%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191650  |  94.6%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191651  | 100.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191652  |  99.6%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191653  |   1.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191654  |   3.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191655  |   1.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191656  |   1.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191657  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191658  |   0.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191659  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191660  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191661  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191662  |   1.4%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191663  |  15.4%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191664  |   4.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191665  |  22.0%     | Low Risk      | High Risk      | Routine screening\n",
            "Patient 191666  |  47.2%     | Medium Risk   | High Risk      | Enhanced monitoring\n",
            "Patient 191667  |  54.4%     | Medium Risk   | High Risk      | Enhanced monitoring\n",
            "Patient 191668  |  78.2%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191669  |  99.5%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191670  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191671  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191672  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191673  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191674  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191675  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191676  |  14.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191677  |  13.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191678  |  14.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191679  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191680  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191681  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191682  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191683  |  36.0%     | Medium Risk   | High Risk      | Enhanced monitoring\n",
            "Patient 191684  |   1.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191685  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191686  |   1.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191687  |   1.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191688  |   1.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191689  |   1.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191690  |   1.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191691  |   1.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191692  |   1.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191693  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191694  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191695  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191696  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191697  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191698  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191699  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191700  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191701  |  99.8%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191702  | 100.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191703  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191704  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191705  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191706  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191707  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191708  |  67.6%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191709  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191710  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191711  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191712  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191713  | 100.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191714  | 100.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191715  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191716  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191717  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191718  |   8.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191719  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191720  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191721  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191722  |   5.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191723  | 100.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191724  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191725  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191726  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191727  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191728  |  67.9%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191729  |  94.8%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191730  |  86.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191731  |  30.8%     | Medium Risk   | High Risk      | Enhanced monitoring\n",
            "Patient 191732  |   9.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191733  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191734  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191735  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191736  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191737  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191738  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191739  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191740  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191741  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191742  |   0.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191743  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191744  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191745  |   5.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191746  |  58.9%     | Medium Risk   | High Risk      | Enhanced monitoring\n",
            "Patient 191747  |  88.9%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191748  |  85.2%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191749  |  99.3%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191750  |  94.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191751  |  92.8%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191752  |  99.1%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191753  |  99.2%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191754  |   2.4%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191755  |   4.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191756  |   0.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191757  |   4.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191758  |   2.4%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191759  |   2.4%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191760  |   2.4%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191761  |   2.4%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191762  |   2.4%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191763  |  17.4%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191764  |  61.8%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191765  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191766  |   8.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191767  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191768  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191769  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191770  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191771  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191772  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191773  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191774  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191775  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191776  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191777  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191778  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191779  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191780  |   4.4%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191781  |  28.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191782  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191783  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191784  |   7.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191785  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191786  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191787  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191788  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191789  |   2.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191790  |   2.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191791  |   2.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191792  |   2.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191793  |   9.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191794  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191795  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191796  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191797  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191798  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191799  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191800  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191801  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191802  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191803  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191804  |  89.6%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191805  |   6.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191806  |  56.3%     | Medium Risk   | Low Risk       | Enhanced monitoring\n",
            "Patient 191807  |  10.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191808  |  45.2%     | Medium Risk   | Low Risk       | Enhanced monitoring\n",
            "Patient 191809  |   1.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191810  |   1.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191811  |  10.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191812  |  10.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191813  |  17.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191814  |  40.6%     | Medium Risk   | Low Risk       | Enhanced monitoring\n",
            "Patient 191815  |  24.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191816  | 100.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191817  | 100.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191818  |  13.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191819  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191820  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191821  |   5.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191822  |  26.2%     | Low Risk      | High Risk      | Routine screening\n",
            "Patient 191823  |  90.1%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191824  |  99.5%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191825  |  99.5%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191826  |  99.5%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191827  |  99.5%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191828  |  99.8%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191829  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191830  |   9.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191831  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191832  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191833  |   3.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191834  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191835  |  12.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191836  |   9.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191837  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191838  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191839  |   9.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191840  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191841  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191842  |  20.4%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191843  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191844  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191845  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191846  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191847  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191848  |   1.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191849  |   1.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191850  |   1.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191851  |   1.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191852  |   1.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191853  |   1.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191854  |   1.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191855  |   1.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191856  |   1.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191857  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191858  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191859  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191860  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191861  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191862  |   4.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191863  |   4.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191864  |   6.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191865  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191866  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191867  |   6.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191868  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191869  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191870  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191871  |   6.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191872  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191873  |  23.8%     | Low Risk      | High Risk      | Routine screening\n",
            "Patient 191874  |  14.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191875  |   5.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191876  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191877  |   4.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191878  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191879  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191880  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191881  |   4.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191882  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191883  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191884  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191885  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191886  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191887  |   8.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191888  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191889  |  40.5%     | Medium Risk   | Low Risk       | Enhanced monitoring\n",
            "Patient 191890  |  96.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191891  |  97.5%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191892  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191893  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191894  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191895  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191896  |   0.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191897  |   0.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191898  |   0.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191899  |   0.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191900  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191901  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191902  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191903  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191904  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191905  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191906  |  16.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191907  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191908  |   1.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191909  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191910  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191911  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191912  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191913  |  11.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191914  |  16.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191915  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191916  |  10.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191917  |  18.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191918  |  18.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191919  |  12.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191920  |  18.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191921  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191922  |  34.5%     | Medium Risk   | High Risk      | Enhanced monitoring\n",
            "Patient 191923  |  46.1%     | Medium Risk   | High Risk      | Enhanced monitoring\n",
            "Patient 191924  |  99.7%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191925  | 100.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191926  | 100.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191927  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191928  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191929  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191930  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191931  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191932  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191933  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191934  |  87.7%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191935  |  99.2%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191936  |  99.9%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191937  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191938  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191939  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191940  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191941  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191942  |  65.4%     | High Risk     | Low Risk       | Comprehensive evaluation needed\n",
            "Patient 191943  |  64.3%     | High Risk     | Low Risk       | Comprehensive evaluation needed\n",
            "Patient 191944  |   1.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191945  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191946  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191947  |  13.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191948  |  13.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191949  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191950  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191951  |   8.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191952  |   8.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191953  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191954  |  68.1%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191955  |   1.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191956  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191957  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191958  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191959  |   9.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191960  |   9.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191961  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191962  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191963  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191964  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191965  |   5.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191966  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191967  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191968  |   1.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191969  |   4.3%     | Low Risk      | High Risk      | Routine screening\n",
            "Patient 191970  |   1.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191971  |   1.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191972  |   1.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191973  |   1.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191974  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191975  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191976  |  17.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191977  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191978  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191979  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191980  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191981  |  13.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191982  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191983  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191984  |   5.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191985  |  57.4%     | Medium Risk   | High Risk      | Enhanced monitoring\n",
            "Patient 191986  |  36.0%     | Medium Risk   | High Risk      | Enhanced monitoring\n",
            "Patient 191987  |  43.1%     | Medium Risk   | High Risk      | Enhanced monitoring\n",
            "Patient 191988  |  98.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191989  |  96.7%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191990  |  99.6%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191991  |  99.6%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 191992  |   1.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191993  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191994  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191995  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191996  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191997  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191998  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 191999  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192000  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192001  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192002  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192003  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192004  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192005  |   8.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192006  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192007  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192008  |  13.0%     | Low Risk      | High Risk      | Routine screening\n",
            "Patient 192009  |  54.6%     | Medium Risk   | High Risk      | Enhanced monitoring\n",
            "Patient 192010  |  58.7%     | Medium Risk   | High Risk      | Enhanced monitoring\n",
            "Patient 192011  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192012  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192013  |  22.0%     | Low Risk      | High Risk      | Routine screening\n",
            "Patient 192014  |   1.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192015  |   1.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192016  |   1.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192017  |  41.1%     | Medium Risk   | Low Risk       | Enhanced monitoring\n",
            "Patient 192018  |   1.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192019  |   1.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192020  |   1.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192021  |   1.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192022  |   1.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192023  |   1.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192024  |   4.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192025  |   1.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192026  |   1.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192027  |   1.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192028  |   1.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192029  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192030  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192031  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192032  |  14.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192033  |  97.9%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192034  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192035  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192036  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192037  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192038  |  69.4%     | High Risk     | Low Risk       | Comprehensive evaluation needed\n",
            "Patient 192039  |   3.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192040  |   6.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192041  |  56.2%     | Medium Risk   | Low Risk       | Enhanced monitoring\n",
            "Patient 192042  |  97.3%     | High Risk     | Low Risk       | Comprehensive evaluation needed\n",
            "Patient 192043  |  95.1%     | High Risk     | Low Risk       | Comprehensive evaluation needed\n",
            "Patient 192044  |  67.7%     | High Risk     | Low Risk       | Comprehensive evaluation needed\n",
            "Patient 192045  |  95.8%     | High Risk     | Low Risk       | Comprehensive evaluation needed\n",
            "Patient 192046  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192047  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192048  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192049  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192050  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192051  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192052  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192053  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192054  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192055  |   0.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192056  |   0.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192057  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192058  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192059  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192060  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192061  |   1.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192062  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192063  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192064  |  98.6%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192065  |  98.2%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192066  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192067  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192068  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192069  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192070  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192071  |   1.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192072  |   0.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192073  |   0.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192074  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192075  |   0.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192076  |   0.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192077  |  48.5%     | Medium Risk   | High Risk      | Enhanced monitoring\n",
            "Patient 192078  |   1.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192079  |   1.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192080  |   1.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192081  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192082  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192083  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192084  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192085  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192086  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192087  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192088  |   1.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192089  |   1.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192090  |  94.4%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192091  |  99.4%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192092  |  99.8%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192093  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192094  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192095  |   1.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192096  |   1.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192097  |   1.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192098  |   1.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192099  |   1.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192100  |   1.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192101  |   1.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192102  |   1.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192103  |   1.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192104  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192105  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192106  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192107  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192108  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192109  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192110  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192111  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192112  |   1.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192113  |   1.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192114  |   1.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192115  |   1.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192116  |   1.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192117  |   1.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192118  |   1.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192119  |   1.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192120  |   1.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192121  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192122  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192123  |   1.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192124  |   1.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192125  |   2.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192126  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192127  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192128  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192129  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192130  | 100.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192131  | 100.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192132  | 100.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192133  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192134  |   1.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192135  |   2.4%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192136  |   2.4%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192137  |   2.4%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192138  |   2.4%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192139  |   2.4%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192140  |   2.4%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192141  |   2.4%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192142  |   2.4%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192143  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192144  |   1.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192145  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192146  |  36.4%     | Medium Risk   | High Risk      | Enhanced monitoring\n",
            "Patient 192147  |  19.8%     | Low Risk      | High Risk      | Routine screening\n",
            "Patient 192148  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192149  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192150  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192151  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192152  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192153  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192154  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192155  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192156  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192157  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192158  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192159  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192160  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192161  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192162  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192163  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192164  |   0.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192165  |   1.4%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192166  |   1.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192167  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192168  |   4.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192169  |   4.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192170  |  17.4%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192171  |   3.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192172  |  78.7%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192173  | 100.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192174  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192175  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192176  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192177  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192178  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192179  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192180  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192181  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192182  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192183  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192184  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192185  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192186  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192187  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192188  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192189  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192190  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192191  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192192  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192193  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192194  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192195  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192196  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192197  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192198  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192199  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192200  |   1.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192201  |   2.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192202  |   2.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192203  |   2.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192204  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192205  |  80.5%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192206  |  97.5%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192207  |  99.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192208  |  98.9%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192209  |  18.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192210  |  35.0%     | Medium Risk   | Low Risk       | Enhanced monitoring\n",
            "Patient 192211  |  48.2%     | Medium Risk   | Low Risk       | Enhanced monitoring\n",
            "Patient 192212  |  99.3%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192213  |  99.8%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192214  |  99.7%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192215  |   6.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192216  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192217  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192218  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192219  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192220  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192221  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192222  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192223  |  33.1%     | Medium Risk   | High Risk      | Enhanced monitoring\n",
            "Patient 192224  |   0.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192225  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192226  |   1.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192227  |   1.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192228  |   1.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192229  |   3.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192230  |   1.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192231  |   9.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192232  |  75.2%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192233  |  50.2%     | Medium Risk   | Low Risk       | Enhanced monitoring\n",
            "Patient 192234  |  96.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192235  |   3.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192236  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192237  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192238  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192239  |   2.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192240  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192241  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192242  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192243  |   6.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192244  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192245  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192246  |   9.7%     | Low Risk      | High Risk      | Routine screening\n",
            "Patient 192247  |  84.3%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192248  |  99.1%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192249  |  99.7%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192250  |  53.2%     | Medium Risk   | Low Risk       | Enhanced monitoring\n",
            "Patient 192251  |   3.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192252  |   6.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192253  |   4.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192254  |   2.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192255  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192256  |  99.3%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192257  |  98.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192258  |  93.5%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192259  |  99.6%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192260  |  99.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192261  |  99.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192262  |  99.9%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192263  |  99.9%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192264  |  99.5%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192265  |  99.8%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192266  | 100.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192267  |   3.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192268  |   1.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192269  |   1.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192270  |   1.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192271  |   1.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192272  |   1.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192273  |   1.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192274  |   4.4%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192275  |   1.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192276  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192277  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192278  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192279  |   1.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192280  |   1.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192281  |   1.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192282  |   1.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192283  |   1.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192284  |   1.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192285  |   4.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192286  |   0.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192287  |   0.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192288  |   7.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192289  |   0.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192290  |  10.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192291  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192292  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192293  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192294  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192295  |   2.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192296  |   2.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192297  |  99.5%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192298  |  99.6%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192299  |   5.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192300  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192301  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192302  | 100.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192303  | 100.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192304  |  18.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192305  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192306  |  99.6%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192307  |  99.6%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192308  |   1.8%     | Low Risk      | High Risk      | Routine screening\n",
            "Patient 192309  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192310  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192311  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192312  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192313  |   4.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192314  |  20.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192315  |  34.5%     | Medium Risk   | High Risk      | Enhanced monitoring\n",
            "Patient 192316  |  83.7%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192317  |  93.9%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192318  |  91.4%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192319  |  99.2%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192320  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192321  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192322  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192323  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192324  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192325  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192326  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192327  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192328  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192329  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192330  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192331  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192332  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192333  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192334  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192335  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192336  |  18.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192337  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192338  |  12.4%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192339  |  47.4%     | Medium Risk   | Low Risk       | Enhanced monitoring\n",
            "Patient 192340  |  16.4%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192341  |  87.9%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192342  |  94.8%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192343  |  95.1%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192344  |  99.7%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192345  |  96.2%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192346  |  99.6%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192347  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192348  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192349  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192350  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192351  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192352  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192353  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192354  |   0.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192355  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192356  |   0.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192357  |   0.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192358  |   2.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192359  |   2.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192360  |   2.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192361  |   2.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192362  |  89.9%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192363  |  90.3%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192364  | 100.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192365  | 100.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192366  | 100.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192367  | 100.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192368  | 100.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192369  |  93.7%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192370  |  94.5%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192371  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192372  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192373  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192374  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192375  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192376  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192377  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192378  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192379  |  13.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192380  |  44.7%     | Medium Risk   | Low Risk       | Enhanced monitoring\n",
            "Patient 192381  |  77.6%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192382  |  14.0%     | Low Risk      | High Risk      | Routine screening\n",
            "Patient 192383  |  41.7%     | Medium Risk   | High Risk      | Enhanced monitoring\n",
            "Patient 192384  |  63.7%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192385  |  90.5%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192386  |  63.4%     | High Risk     | Low Risk       | Comprehensive evaluation needed\n",
            "Patient 192387  |  53.0%     | Medium Risk   | Low Risk       | Enhanced monitoring\n",
            "Patient 192388  |  56.1%     | Medium Risk   | Low Risk       | Enhanced monitoring\n",
            "Patient 192389  |  99.5%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192390  |  99.5%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192391  | 100.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192392  | 100.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192393  |  30.3%     | Medium Risk   | High Risk      | Enhanced monitoring\n",
            "Patient 192394  |  72.4%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192395  |  97.3%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192396  |  99.6%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192397  |  19.8%     | Low Risk      | High Risk      | Routine screening\n",
            "Patient 192398  |  13.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192399  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192400  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192401  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192402  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192403  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192404  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192405  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192406  |   0.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192407  |   0.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192408  |   0.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192409  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192410  |  22.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192411  |   1.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192412  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192413  |   9.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192414  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192415  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192416  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192417  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192418  |   7.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192419  |   2.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192420  |  13.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192421  |   6.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192422  |  21.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192423  |  45.8%     | Medium Risk   | Low Risk       | Enhanced monitoring\n",
            "Patient 192424  |  29.4%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192425  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192426  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192427  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192428  |   5.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192429  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192430  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192431  |   3.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192432  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192433  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192434  | 100.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192435  | 100.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192436  |  99.9%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192437  |   2.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192438  | 100.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192439  | 100.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192440  |  90.8%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192441  |  96.7%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192442  |  99.4%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192443  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192444  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192445  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192446  |  99.4%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192447  |  28.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192448  |  46.5%     | Medium Risk   | Low Risk       | Enhanced monitoring\n",
            "Patient 192449  |  37.9%     | Medium Risk   | Low Risk       | Enhanced monitoring\n",
            "Patient 192450  |  10.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192451  |  42.8%     | Medium Risk   | Low Risk       | Enhanced monitoring\n",
            "Patient 192452  |   3.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192453  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192454  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192455  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192456  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192457  |   1.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192458  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192459  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192460  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192461  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192462  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192463  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192464  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192465  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192466  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192467  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192468  |  97.8%     | High Risk     | Low Risk       | Comprehensive evaluation needed\n",
            "Patient 192469  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192470  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192471  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192472  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192473  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192474  |  31.3%     | Medium Risk   | Low Risk       | Enhanced monitoring\n",
            "Patient 192475  |  18.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192476  |  22.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192477  |  16.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192478  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192479  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192480  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192481  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192482  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192483  |   7.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192484  |   4.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192485  |  42.3%     | Medium Risk   | High Risk      | Enhanced monitoring\n",
            "Patient 192486  |  13.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192487  |   7.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192488  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192489  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192490  |  54.4%     | Medium Risk   | High Risk      | Enhanced monitoring\n",
            "Patient 192491  |  86.3%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192492  |  97.2%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192493  |  13.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192494  |  10.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192495  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192496  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192497  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192498  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192499  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192500  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192501  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192502  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192503  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192504  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192505  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192506  |   1.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192507  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192508  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192509  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192510  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192511  |  17.4%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192512  |   4.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192513  |   1.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192514  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192515  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192516  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192517  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192518  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192519  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192520  |  18.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192521  |  70.1%     | High Risk     | Low Risk       | Comprehensive evaluation needed\n",
            "Patient 192522  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192523  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192524  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192525  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192526  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192527  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192528  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192529  |   6.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192530  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192531  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192532  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192533  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192534  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192535  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192536  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192537  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192538  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192539  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192540  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192541  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192542  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192543  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192544  |   1.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192545  |  11.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192546  |   1.4%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192547  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192548  |  32.1%     | Medium Risk   | Low Risk       | Enhanced monitoring\n",
            "Patient 192549  |  23.9%     | Low Risk      | High Risk      | Routine screening\n",
            "Patient 192550  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192551  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192552  |   1.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192553  |  19.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192554  |  28.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192555  |  11.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192556  |  72.5%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192557  |  74.3%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192558  |   6.4%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192559  |   1.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192560  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192561  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192562  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192563  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192564  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192565  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192566  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192567  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192568  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192569  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192570  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192571  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192572  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192573  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192574  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192575  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192576  |   3.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192577  |   1.2%     | Low Risk      | High Risk      | Routine screening\n",
            "Patient 192578  |  47.1%     | Medium Risk   | High Risk      | Enhanced monitoring\n",
            "Patient 192579  |  43.9%     | Medium Risk   | High Risk      | Enhanced monitoring\n",
            "Patient 192580  |  88.5%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192581  |  97.3%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192582  |  99.1%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192583  |  94.4%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192584  |  94.6%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192585  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192586  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192587  |  78.7%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192588  |  98.6%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192589  |  98.6%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192590  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192591  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192592  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192593  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192594  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192595  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192596  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192597  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192598  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192599  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192600  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192601  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192602  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192603  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192604  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192605  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192606  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192607  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192608  | 100.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192609  |  10.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192610  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192611  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192612  |  11.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192613  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192614  |  90.0%     | High Risk     | Low Risk       | Comprehensive evaluation needed\n",
            "Patient 192615  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192616  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192617  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192618  |   3.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192619  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192620  |  98.5%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192621  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192622  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192623  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192624  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192625  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192626  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192627  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192628  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192629  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192630  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192631  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192632  |   7.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192633  |   1.4%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192634  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192635  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192636  |  98.6%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192637  |  96.2%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192638  |  98.2%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192639  |  99.4%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192640  |  98.2%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192641  |   0.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192642  |  97.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192643  |  98.8%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192644  |  98.3%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192645  |   1.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192646  |   1.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192647  |   1.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192648  |   1.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192649  |   1.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192650  |   1.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192651  |   1.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192652  |   1.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192653  |   1.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192654  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192655  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192656  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192657  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192658  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192659  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192660  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192661  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192662  |   1.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192663  |   1.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192664  |   1.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192665  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192666  |   1.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192667  |   1.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192668  |   1.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192669  |  12.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192670  |  17.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192671  |  12.4%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192672  |   9.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192673  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192674  |  99.8%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192675  |  99.8%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192676  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192677  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192678  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192679  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192680  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192681  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192682  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192683  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192684  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192685  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192686  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192687  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192688  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192689  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192690  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192691  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192692  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192693  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192694  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192695  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192696  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192697  |  95.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192698  |  98.4%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192699  |  99.3%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192700  |  99.8%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192701  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192702  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192703  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192704  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192705  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192706  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192707  |   8.4%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192708  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192709  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192710  |   7.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192711  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192712  |   8.4%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192713  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192714  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192715  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192716  |   2.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192717  |  30.8%     | Medium Risk   | High Risk      | Enhanced monitoring\n",
            "Patient 192718  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192719  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192720  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192721  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192722  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192723  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192724  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192725  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192726  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192727  |   2.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192728  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192729  |   7.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192730  |  65.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192731  |   8.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192732  |   9.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192733  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192734  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192735  |  99.4%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192736  |  99.8%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192737  |  99.8%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192738  |  99.8%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192739  |  99.8%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192740  |  99.8%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192741  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192742  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192743  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192744  |   3.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192745  |   3.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192746  |   0.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192747  |   3.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192748  |   3.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192749  |   3.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192750  |  35.6%     | Medium Risk   | Low Risk       | Enhanced monitoring\n",
            "Patient 192751  |  99.5%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192752  |  86.0%     | High Risk     | Low Risk       | Comprehensive evaluation needed\n",
            "Patient 192753  |  86.2%     | High Risk     | Low Risk       | Comprehensive evaluation needed\n",
            "Patient 192754  |  96.1%     | High Risk     | Low Risk       | Comprehensive evaluation needed\n",
            "Patient 192755  |  84.9%     | High Risk     | Low Risk       | Comprehensive evaluation needed\n",
            "Patient 192756  |  98.9%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192757  |  99.7%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192758  |  99.8%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192759  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192760  |   7.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192761  |  10.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192762  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192763  |  16.8%     | Low Risk      | High Risk      | Routine screening\n",
            "Patient 192764  |  21.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192765  |  93.6%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192766  |  96.9%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192767  |  85.7%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192768  |  80.3%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192769  |  97.7%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192770  |  99.9%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192771  |  72.9%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192772  |  92.5%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192773  |  99.1%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192774  |  99.7%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192775  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192776  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192777  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192778  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192779  |  26.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192780  |  73.2%     | High Risk     | Low Risk       | Comprehensive evaluation needed\n",
            "Patient 192781  |  57.7%     | Medium Risk   | High Risk      | Enhanced monitoring\n",
            "Patient 192782  |  86.9%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192783  |  36.6%     | Medium Risk   | Low Risk       | Enhanced monitoring\n",
            "Patient 192784  |  38.7%     | Medium Risk   | Low Risk       | Enhanced monitoring\n",
            "Patient 192785  |  12.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192786  |  21.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192787  |  79.4%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192788  |  78.2%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192789  |  85.7%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192790  |  90.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192791  |  47.9%     | Medium Risk   | Low Risk       | Enhanced monitoring\n",
            "Patient 192792  |  34.3%     | Medium Risk   | Low Risk       | Enhanced monitoring\n",
            "Patient 192793  | 100.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192794  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192795  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192796  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192797  |  32.9%     | Medium Risk   | Low Risk       | Enhanced monitoring\n",
            "Patient 192798  |   6.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192799  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192800  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192801  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192802  |  28.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192803  |  35.7%     | Medium Risk   | Low Risk       | Enhanced monitoring\n",
            "Patient 192804  |  27.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192805  |  22.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192806  |   2.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192807  |   2.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192808  |   2.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192809  |   2.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192810  |   2.4%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192811  |   2.4%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192812  |   2.4%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192813  |   2.4%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192814  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192815  |   9.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192816  |   9.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192817  |  11.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192818  |  41.4%     | Medium Risk   | Low Risk       | Enhanced monitoring\n",
            "Patient 192819  |  14.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192820  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192821  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192822  |   7.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192823  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192824  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192825  |   1.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192826  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192827  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192828  |   2.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192829  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192830  |   1.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192831  |   1.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192832  |  76.6%     | High Risk     | Low Risk       | Comprehensive evaluation needed\n",
            "Patient 192833  |  19.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192834  |   1.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192835  |  12.3%     | Low Risk      | High Risk      | Routine screening\n",
            "Patient 192836  |  19.9%     | Low Risk      | High Risk      | Routine screening\n",
            "Patient 192837  |  95.4%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192838  |  99.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192839  |   1.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192840  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192841  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192842  |  12.4%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192843  |  10.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192844  |   4.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192845  |   4.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192846  |  65.1%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192847  |  95.1%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192848  |  96.3%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192849  |  99.2%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192850  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192851  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192852  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192853  |  20.6%     | Low Risk      | High Risk      | Routine screening\n",
            "Patient 192854  |  55.7%     | Medium Risk   | High Risk      | Enhanced monitoring\n",
            "Patient 192855  |  43.6%     | Medium Risk   | High Risk      | Enhanced monitoring\n",
            "Patient 192856  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192857  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192858  |   2.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192859  |   2.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192860  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192861  |   2.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192862  |   2.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192863  |   2.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192864  |   8.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192865  |  13.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192866  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192867  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192868  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192869  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192870  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192871  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192872  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192873  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192874  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192875  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192876  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192877  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192878  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192879  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192880  |   3.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192881  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192882  |  25.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192883  |  26.4%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192884  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192885  |   1.4%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192886  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192887  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192888  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192889  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192890  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192891  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192892  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192893  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192894  |   2.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192895  |   2.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192896  |   2.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192897  |   2.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192898  |   2.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192899  |   2.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192900  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192901  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192902  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192903  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192904  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192905  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192906  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192907  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192908  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192909  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192910  |  92.2%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192911  |  98.9%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192912  |  98.8%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192913  |   2.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192914  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192915  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192916  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192917  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192918  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192919  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192920  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192921  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192922  |   4.5%     | Low Risk      | High Risk      | Routine screening\n",
            "Patient 192923  |  65.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192924  |  95.8%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192925  |  86.3%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192926  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192927  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192928  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192929  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192930  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192931  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192932  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192933  |   3.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192934  |   2.4%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192935  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192936  |   3.2%     | Low Risk      | High Risk      | Routine screening\n",
            "Patient 192937  |  29.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192938  |   3.4%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192939  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192940  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192941  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192942  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192943  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192944  |  83.6%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192945  |  94.9%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192946  |  98.2%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192947  |  99.6%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192948  |  96.1%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192949  |  97.8%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192950  |  98.7%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192951  |  99.7%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192952  |  96.9%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192953  |  93.6%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192954  |  98.3%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192955  |  98.8%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192956  |  99.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192957  |  99.2%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192958  |  99.6%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192959  |  14.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192960  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192961  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192962  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192963  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192964  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192965  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192966  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192967  |   1.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192968  |   0.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192969  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192970  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192971  | 100.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192972  |  99.9%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192973  | 100.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192974  | 100.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 192975  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192976  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192977  |   8.4%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192978  |  45.3%     | Medium Risk   | Low Risk       | Enhanced monitoring\n",
            "Patient 192979  |  55.5%     | Medium Risk   | Low Risk       | Enhanced monitoring\n",
            "Patient 192980  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192981  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192982  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192983  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192984  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192985  |   1.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192986  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192987  |  20.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192988  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192989  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192990  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192991  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192992  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192993  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192994  |   1.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192995  |   1.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192996  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192997  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192998  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 192999  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193000  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193001  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193002  |   2.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193003  |   2.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193004  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193005  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193006  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193007  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193008  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193009  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193010  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193011  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193012  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193013  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193014  |  28.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193015  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193016  |  23.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193017  |  23.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193018  |  82.3%     | High Risk     | Low Risk       | Comprehensive evaluation needed\n",
            "Patient 193019  |   1.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193020  |   1.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193021  |   1.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193022  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193023  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193024  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193025  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193026  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193027  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193028  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193029  |  30.0%     | Medium Risk   | High Risk      | Enhanced monitoring\n",
            "Patient 193030  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193031  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193032  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193033  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193034  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193035  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193036  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193037  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193038  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193039  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193040  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193041  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193042  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193043  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193044  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193045  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193046  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193047  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193048  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193049  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193050  |   0.4%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193051  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193052  |   3.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193053  |   8.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193054  |  18.9%     | Low Risk      | High Risk      | Routine screening\n",
            "Patient 193055  |  74.1%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193056  |  90.3%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193057  | 100.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193058  |  99.8%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193059  |   9.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193060  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193061  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193062  |   7.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193063  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193064  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193065  |   6.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193066  |   9.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193067  |   6.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193068  |   5.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193069  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193070  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193071  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193072  |  29.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193073  |  83.3%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193074  |  42.5%     | Medium Risk   | High Risk      | Enhanced monitoring\n",
            "Patient 193075  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193076  |   1.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193077  |   1.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193078  |   1.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193079  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193080  |   2.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193081  |   2.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193082  |   2.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193083  |   2.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193084  |   5.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193085  |   2.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193086  |   8.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193087  |   2.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193088  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193089  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193090  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193091  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193092  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193093  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193094  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193095  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193096  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193097  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193098  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193099  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193100  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193101  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193102  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193103  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193104  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193105  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193106  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193107  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193108  |   0.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193109  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193110  |   0.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193111  |  21.2%     | Low Risk      | High Risk      | Routine screening\n",
            "Patient 193112  |  61.6%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193113  |   6.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193114  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193115  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193116  |   4.4%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193117  |  30.9%     | Medium Risk   | Low Risk       | Enhanced monitoring\n",
            "Patient 193118  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193119  |   4.4%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193120  |   2.4%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193121  |   2.4%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193122  | 100.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193123  | 100.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193124  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193125  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193126  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193127  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193128  |   4.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193129  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193130  |   1.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193131  |   2.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193132  |   1.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193133  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193134  |  18.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193135  |  12.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193136  |  11.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193137  |   0.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193138  |   1.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193139  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193140  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193141  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193142  |  17.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193143  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193144  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193145  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193146  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193147  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193148  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193149  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193150  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193151  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193152  |   6.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193153  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193154  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193155  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193156  |   7.4%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193157  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193158  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193159  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193160  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193161  |   2.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193162  |  16.6%     | Low Risk      | High Risk      | Routine screening\n",
            "Patient 193163  |  99.9%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193164  |  66.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193165  |  85.4%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193166  |  73.4%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193167  |  99.3%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193168  |   2.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193169  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193170  |   2.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193171  |   7.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193172  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193173  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193174  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193175  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193176  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193177  |   6.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193178  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193179  |   9.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193180  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193181  |   1.5%     | Low Risk      | High Risk      | Routine screening\n",
            "Patient 193182  |  20.4%     | Low Risk      | High Risk      | Routine screening\n",
            "Patient 193183  |  92.6%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193184  |   6.4%     | Low Risk      | High Risk      | Routine screening\n",
            "Patient 193185  |  96.9%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193186  |  99.3%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193187  |  99.9%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193188  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193189  |   6.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193190  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193191  |   6.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193192  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193193  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193194  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193195  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193196  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193197  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193198  |   8.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193199  |  23.9%     | Low Risk      | High Risk      | Routine screening\n",
            "Patient 193200  |   8.9%     | Low Risk      | High Risk      | Routine screening\n",
            "Patient 193201  |  18.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193202  |  12.4%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193203  |  18.4%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193204  |  55.3%     | Medium Risk   | High Risk      | Enhanced monitoring\n",
            "Patient 193205  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193206  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193207  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193208  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193209  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193210  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193211  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193212  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193213  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193214  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193215  |  99.6%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193216  |  94.2%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193217  |  99.7%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193218  |  99.5%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193219  |  99.4%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193220  |  99.8%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193221  |  27.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193222  |  63.9%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193223  |  96.2%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193224  |  96.1%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193225  |  93.3%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193226  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193227  |   2.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193228  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193229  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193230  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193231  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193232  |   2.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193233  |  10.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193234  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193235  |  17.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193236  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193237  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193238  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193239  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193240  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193241  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193242  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193243  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193244  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193245  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193246  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193247  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193248  |  18.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193249  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193250  | 100.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193251  | 100.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193252  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193253  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193254  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193255  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193256  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193257  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193258  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193259  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193260  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193261  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193262  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193263  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193264  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193265  |  29.9%     | Low Risk      | High Risk      | Routine screening\n",
            "Patient 193266  |  29.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193267  |  17.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193268  |  31.3%     | Medium Risk   | Low Risk       | Enhanced monitoring\n",
            "Patient 193269  |   9.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193270  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193271  |   6.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193272  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193273  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193274  |   6.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193275  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193276  |   0.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193277  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193278  |   3.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193279  |  96.7%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193280  |  96.7%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193281  |  86.2%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193282  |  90.1%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193283  |  97.2%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193284  |  99.4%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193285  | 100.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193286  | 100.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193287  | 100.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193288  |   1.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193289  |   1.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193290  |   1.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193291  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193292  |   1.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193293  |   1.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193294  |   1.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193295  |  25.1%     | Low Risk      | High Risk      | Routine screening\n",
            "Patient 193296  |  96.1%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193297  |  96.1%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193298  |  99.3%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193299  |  99.6%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193300  |  99.6%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193301  |  99.9%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193302  |  99.1%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193303  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193304  |  99.2%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193305  |  99.4%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193306  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193307  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193308  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193309  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193310  |   8.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193311  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193312  |   0.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193313  |  26.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193314  |  21.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193315  |  40.3%     | Medium Risk   | High Risk      | Enhanced monitoring\n",
            "Patient 193316  |  21.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193317  |   4.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193318  |   4.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193319  |   1.4%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193320  |   5.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193321  |  22.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193322  |  12.4%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193323  |  12.4%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193324  |   7.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193325  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193326  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193327  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193328  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193329  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193330  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193331  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193332  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193333  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193334  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193335  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193336  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193337  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193338  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193339  |  93.8%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193340  |  92.1%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193341  |  99.6%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193342  |  88.4%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193343  |   7.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193344  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193345  |  22.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193346  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193347  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193348  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193349  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193350  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193351  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193352  |   2.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193353  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193354  |   1.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193355  |   2.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193356  |   1.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193357  |   1.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193358  |   3.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193359  |   1.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193360  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193361  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193362  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193363  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193364  |   2.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193365  |   7.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193366  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193367  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193368  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193369  |   0.4%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193370  |   1.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193371  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193372  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193373  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193374  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193375  |   1.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193376  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193377  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193378  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193379  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193380  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193381  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193382  |   1.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193383  |   1.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193384  |   1.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193385  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193386  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193387  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193388  |   1.4%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193389  |  11.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193390  |   4.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193391  |   1.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193392  |   4.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193393  |   4.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193394  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193395  |   1.0%     | Low Risk      | High Risk      | Routine screening\n",
            "Patient 193396  |   9.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193397  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193398  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193399  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193400  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193401  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193402  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193403  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193404  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193405  |   9.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193406  |   1.4%     | Low Risk      | High Risk      | Routine screening\n",
            "Patient 193407  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193408  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193409  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193410  |   8.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193411  |  26.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193412  |  22.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193413  |  51.8%     | Medium Risk   | High Risk      | Enhanced monitoring\n",
            "Patient 193414  |  48.8%     | Medium Risk   | High Risk      | Enhanced monitoring\n",
            "Patient 193415  |  62.7%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193416  |  74.9%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193417  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193418  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193419  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193420  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193421  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193422  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193423  |  11.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193424  |   6.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193425  |  11.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193426  |   8.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193427  |  21.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193428  |   6.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193429  |  89.3%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193430  |  98.7%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193431  |  92.2%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193432  |   5.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193433  |   9.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193434  |   1.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193435  |   1.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193436  |   1.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193437  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193438  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193439  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193440  |  95.1%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193441  |  97.7%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193442  |  97.7%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193443  |  99.7%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193444  |  93.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193445  |   1.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193446  |  25.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193447  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193448  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193449  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193450  |  20.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193451  |  23.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193452  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193453  |  23.5%     | Low Risk      | High Risk      | Routine screening\n",
            "Patient 193454  |  17.4%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193455  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193456  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193457  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193458  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193459  |  94.8%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193460  |   1.2%     | Low Risk      | High Risk      | Routine screening\n",
            "Patient 193461  |   3.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193462  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193463  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193464  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193465  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193466  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193467  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193468  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193469  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193470  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193471  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193472  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193473  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193474  |   3.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193475  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193476  |   6.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193477  |   9.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193478  |  98.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193479  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193480  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193481  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193482  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193483  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193484  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193485  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193486  |  97.2%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193487  |  96.6%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193488  |  99.7%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193489  |  99.7%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193490  |  25.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193491  |   1.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193492  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193493  |   2.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193494  |   2.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193495  |   2.8%     | Low Risk      | High Risk      | Routine screening\n",
            "Patient 193496  | 100.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193497  | 100.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193498  | 100.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193499  |  23.8%     | Low Risk      | High Risk      | Routine screening\n",
            "Patient 193500  |  11.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193501  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193502  |   0.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193503  |  32.8%     | Medium Risk   | High Risk      | Enhanced monitoring\n",
            "Patient 193504  |  87.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193505  |  83.6%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193506  |  86.6%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193507  |  95.4%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193508  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193509  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193510  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193511  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193512  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193513  | 100.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193514  | 100.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193515  | 100.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193516  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193517  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193518  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193519  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193520  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193521  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193522  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193523  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193524  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193525  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193526  |  97.1%     | High Risk     | Low Risk       | Comprehensive evaluation needed\n",
            "Patient 193527  |  66.7%     | High Risk     | Low Risk       | Comprehensive evaluation needed\n",
            "Patient 193528  |  40.4%     | Medium Risk   | Low Risk       | Enhanced monitoring\n",
            "Patient 193529  |  41.0%     | Medium Risk   | Low Risk       | Enhanced monitoring\n",
            "Patient 193530  |  14.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193531  |  16.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193532  |  16.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193533  |  68.1%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193534  |  98.7%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193535  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193536  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193537  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193538  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193539  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193540  |   8.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193541  |  17.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193542  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193543  |   6.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193544  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193545  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193546  |   8.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193547  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193548  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193549  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193550  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193551  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193552  | 100.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193553  |  99.9%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193554  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193555  |   7.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193556  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193557  |  21.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193558  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193559  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193560  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193561  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193562  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193563  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193564  |  59.4%     | Medium Risk   | High Risk      | Enhanced monitoring\n",
            "Patient 193565  |  68.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193566  |  49.7%     | Medium Risk   | High Risk      | Enhanced monitoring\n",
            "Patient 193567  |  95.5%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193568  |  98.1%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193569  |  98.8%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193570  |  99.6%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193571  |  99.9%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193572  |  99.9%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193573  |  99.9%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193574  |  99.9%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193575  |  99.9%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193576  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193577  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193578  |  16.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193579  |   4.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193580  |   8.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193581  |  37.0%     | Medium Risk   | Low Risk       | Enhanced monitoring\n",
            "Patient 193582  |  78.2%     | High Risk     | Low Risk       | Comprehensive evaluation needed\n",
            "Patient 193583  |  94.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193584  |  94.3%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193585  |  93.1%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193586  |  98.7%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193587  |  99.1%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193588  |  18.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193589  |  17.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193590  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193591  |  18.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193592  |  36.1%     | Medium Risk   | High Risk      | Enhanced monitoring\n",
            "Patient 193593  |  51.0%     | Medium Risk   | High Risk      | Enhanced monitoring\n",
            "Patient 193594  |  90.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193595  |   3.2%     | Low Risk      | High Risk      | Routine screening\n",
            "Patient 193596  |   5.3%     | Low Risk      | High Risk      | Routine screening\n",
            "Patient 193597  |  13.1%     | Low Risk      | High Risk      | Routine screening\n",
            "Patient 193598  |  99.4%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193599  |   9.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193600  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193601  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193602  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193603  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193604  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193605  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193606  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193607  |  99.5%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193608  |  99.9%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193609  |  99.9%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193610  |  97.6%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193611  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193612  |  96.4%     | High Risk     | Low Risk       | Comprehensive evaluation needed\n",
            "Patient 193613  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193614  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193615  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193616  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193617  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193618  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193619  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193620  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193621  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193622  |   1.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193623  |   1.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193624  |   1.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193625  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193626  |   7.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193627  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193628  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193629  |   0.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193630  |   0.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193631  |   1.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193632  |   0.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193633  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193634  |   0.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193635  |   0.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193636  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193637  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193638  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193639  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193640  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193641  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193642  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193643  |  24.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193644  |  98.8%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193645  |  97.5%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193646  |  97.3%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193647  |  99.7%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193648  | 100.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193649  |  35.5%     | Medium Risk   | Low Risk       | Enhanced monitoring\n",
            "Patient 193650  |  31.3%     | Medium Risk   | Low Risk       | Enhanced monitoring\n",
            "Patient 193651  |  40.1%     | Medium Risk   | Low Risk       | Enhanced monitoring\n",
            "Patient 193652  |  49.6%     | Medium Risk   | Low Risk       | Enhanced monitoring\n",
            "Patient 193653  |  97.4%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193654  |  92.8%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193655  |  99.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193656  |   1.4%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193657  |   1.4%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193658  |   1.4%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193659  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193660  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193661  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193662  |   0.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193663  |   0.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193664  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193665  |  65.5%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193666  |  98.4%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193667  |  95.3%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193668  |  17.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193669  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193670  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193671  |   0.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193672  |  99.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193673  |  13.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193674  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193675  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193676  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193677  |  21.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193678  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193679  |  43.7%     | Medium Risk   | Low Risk       | Enhanced monitoring\n",
            "Patient 193680  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193681  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193682  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193683  |   1.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193684  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193685  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193686  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193687  |  12.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193688  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193689  |   1.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193690  |   3.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193691  |   2.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193692  |   1.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193693  |  41.0%     | Medium Risk   | High Risk      | Enhanced monitoring\n",
            "Patient 193694  |  96.4%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193695  | 100.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193696  | 100.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193697  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193698  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193699  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193700  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193701  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193702  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193703  |   8.4%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193704  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193705  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193706  |   4.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193707  |  64.7%     | High Risk     | Low Risk       | Comprehensive evaluation needed\n",
            "Patient 193708  |  66.9%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193709  |  82.5%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193710  |  99.4%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193711  |  99.6%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193712  |   9.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193713  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193714  |  97.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193715  |  99.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193716  |   3.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193717  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193718  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193719  |   0.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193720  |  48.0%     | Medium Risk   | Low Risk       | Enhanced monitoring\n",
            "Patient 193721  |  73.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193722  |  96.3%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193723  |  99.2%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193724  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193725  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193726  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193727  |  21.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193728  |  95.2%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193729  |  92.8%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193730  |  99.4%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193731  |  99.7%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193732  |  99.7%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193733  |  99.7%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193734  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193735  |  20.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193736  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193737  |   4.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193738  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193739  |   8.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193740  | 100.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193741  |  50.1%     | Medium Risk   | High Risk      | Enhanced monitoring\n",
            "Patient 193742  |  96.9%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193743  |  99.1%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193744  |  99.5%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193745  |  44.3%     | Medium Risk   | High Risk      | Enhanced monitoring\n",
            "Patient 193746  |  51.0%     | Medium Risk   | High Risk      | Enhanced monitoring\n",
            "Patient 193747  |  57.9%     | Medium Risk   | High Risk      | Enhanced monitoring\n",
            "Patient 193748  |  92.1%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193749  |   1.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193750  |   1.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193751  |   1.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193752  |  18.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193753  |   5.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193754  |   5.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193755  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193756  |  51.8%     | Medium Risk   | High Risk      | Enhanced monitoring\n",
            "Patient 193757  |   4.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193758  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193759  |   3.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193760  |  39.3%     | Medium Risk   | Low Risk       | Enhanced monitoring\n",
            "Patient 193761  |  58.7%     | Medium Risk   | Low Risk       | Enhanced monitoring\n",
            "Patient 193762  |   1.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193763  |  99.7%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193764  |  99.8%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193765  |  99.8%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193766  | 100.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193767  |  91.6%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193768  | 100.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193769  |  20.4%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193770  |  72.8%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193771  |  95.2%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193772  |   1.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193773  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193774  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193775  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193776  |  25.0%     | Low Risk      | High Risk      | Routine screening\n",
            "Patient 193777  |   2.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193778  |   2.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193779  |   2.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193780  |   2.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193781  |   2.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193782  |   2.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193783  |   2.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193784  |   2.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193785  |   2.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193786  |   2.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193787  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193788  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193789  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193790  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193791  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193792  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193793  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193794  |   0.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193795  |   0.4%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193796  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193797  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193798  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193799  |   7.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193800  |  18.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193801  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193802  |   1.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193803  |   6.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193804  |   2.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193805  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193806  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193807  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193808  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193809  |   0.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193810  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193811  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193812  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193813  |  96.3%     | High Risk     | Low Risk       | Comprehensive evaluation needed\n",
            "Patient 193814  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193815  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193816  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193817  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193818  |   1.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193819  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193820  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193821  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193822  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193823  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193824  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193825  |   8.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193826  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193827  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193828  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193829  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193830  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193831  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193832  |   1.0%     | Low Risk      | High Risk      | Routine screening\n",
            "Patient 193833  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193834  |  28.3%     | Low Risk      | High Risk      | Routine screening\n",
            "Patient 193835  |  83.7%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193836  |  49.0%     | Medium Risk   | High Risk      | Enhanced monitoring\n",
            "Patient 193837  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193838  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193839  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193840  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193841  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193842  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193843  |   3.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193844  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193845  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193846  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193847  |   2.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193848  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193849  |  72.3%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193850  |  97.5%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193851  |  91.2%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193852  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193853  |   3.5%     | Low Risk      | High Risk      | Routine screening\n",
            "Patient 193854  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193855  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193856  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193857  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193858  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193859  |   1.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193860  |  10.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193861  |   1.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193862  |   1.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193863  |   1.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193864  |   1.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193865  |   1.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193866  |   1.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193867  |   1.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193868  |   2.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193869  |  87.8%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193870  |  90.5%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193871  |  95.2%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193872  |  99.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193873  |  98.2%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193874  |  99.9%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193875  |  99.9%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193876  |  99.9%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193877  |   2.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193878  |   2.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193879  |   2.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193880  |   2.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193881  |   2.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193882  |   2.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193883  |   2.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193884  |   2.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193885  |   2.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193886  |  95.7%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193887  |  98.4%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193888  |  99.3%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193889  |  14.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193890  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193891  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193892  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193893  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193894  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193895  |   5.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193896  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193897  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193898  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193899  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193900  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193901  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193902  |   5.4%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193903  |  90.3%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193904  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193905  |   0.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193906  |   0.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193907  |   0.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193908  |   0.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193909  |   0.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193910  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193911  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193912  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193913  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193914  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193915  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193916  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193917  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193918  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193919  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193920  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193921  |  14.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193922  |  99.5%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193923  |  99.6%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193924  |  66.2%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193925  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193926  |   1.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193927  | 100.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193928  |  21.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193929  |  20.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193930  |  93.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193931  |   1.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193932  |   1.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193933  |   1.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193934  |   1.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193935  |   1.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193936  |   1.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193937  |   1.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193938  |   1.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193939  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193940  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193941  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193942  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193943  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193944  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193945  |   2.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193946  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193947  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193948  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193949  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193950  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193951  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193952  |   2.4%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193953  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193954  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193955  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193956  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193957  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193958  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193959  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193960  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193961  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193962  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193963  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193964  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193965  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193966  |   0.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193967  |   0.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193968  |   0.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193969  |   0.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193970  |   9.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193971  |  18.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193972  |  10.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193973  |  52.0%     | Medium Risk   | Low Risk       | Enhanced monitoring\n",
            "Patient 193974  |   2.4%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193975  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193976  | 100.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193977  | 100.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193978  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193979  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193980  |   1.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193981  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193982  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193983  |  63.9%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193984  |   1.9%     | Low Risk      | High Risk      | Routine screening\n",
            "Patient 193985  |   4.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193986  |   0.9%     | Low Risk      | High Risk      | Routine screening\n",
            "Patient 193987  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193988  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193989  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193990  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193991  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193992  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193993  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193994  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193995  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193996  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 193997  |  93.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193998  |  98.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 193999  |  97.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194000  |  99.4%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194001  |  98.4%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194002  |  99.8%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194003  | 100.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194004  |   7.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194005  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194006  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194007  |  98.2%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194008  |  33.1%     | Medium Risk   | High Risk      | Enhanced monitoring\n",
            "Patient 194009  |  60.6%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194010  |  98.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194011  |  97.5%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194012  | 100.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194013  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194014  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194015  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194016  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194017  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194018  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194019  |  11.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194020  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194021  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194022  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194023  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194024  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194025  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194026  |   0.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194027  |   0.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194028  |   0.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194029  |   0.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194030  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194031  |   0.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194032  |   2.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194033  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194034  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194035  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194036  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194037  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194038  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194039  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194040  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194041  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194042  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194043  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194044  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194045  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194046  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194047  |  37.9%     | Medium Risk   | Low Risk       | Enhanced monitoring\n",
            "Patient 194048  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194049  |  19.6%     | Low Risk      | High Risk      | Routine screening\n",
            "Patient 194050  |  99.6%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194051  |  94.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194052  |  99.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194053  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194054  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194055  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194056  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194057  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194058  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194059  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194060  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194061  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194062  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194063  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194064  |  73.7%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194065  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194066  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194067  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194068  |   5.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194069  |  10.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194070  |   6.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194071  |  24.8%     | Low Risk      | High Risk      | Routine screening\n",
            "Patient 194072  |  40.1%     | Medium Risk   | High Risk      | Enhanced monitoring\n",
            "Patient 194073  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194074  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194075  |  10.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194076  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194077  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194078  |  14.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194079  |  98.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194080  |  99.3%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194081  |  99.8%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194082  |  99.6%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194083  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194084  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194085  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194086  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194087  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194088  |   8.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194089  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194090  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194091  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194092  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194093  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194094  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194095  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194096  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194097  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194098  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194099  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194100  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194101  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194102  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194103  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194104  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194105  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194106  |   1.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194107  |   1.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194108  |   1.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194109  |   1.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194110  |   1.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194111  |   1.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194112  |   1.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194113  |   1.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194114  |   1.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194115  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194116  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194117  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194118  |  10.1%     | Low Risk      | High Risk      | Routine screening\n",
            "Patient 194119  |  26.4%     | Low Risk      | High Risk      | Routine screening\n",
            "Patient 194120  |  18.0%     | Low Risk      | High Risk      | Routine screening\n",
            "Patient 194121  |  58.6%     | Medium Risk   | High Risk      | Enhanced monitoring\n",
            "Patient 194122  |  75.9%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194123  |  88.1%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194124  |  85.9%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194125  |  95.1%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194126  |  99.6%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194127  | 100.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194128  |  21.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194129  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194130  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194131  |  16.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194132  |  99.8%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194133  |  97.1%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194134  |  95.8%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194135  | 100.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194136  |  39.2%     | Medium Risk   | Low Risk       | Enhanced monitoring\n",
            "Patient 194137  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194138  |  17.7%     | Low Risk      | High Risk      | Routine screening\n",
            "Patient 194139  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194140  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194141  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194142  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194143  |   6.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194144  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194145  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194146  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194147  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194148  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194149  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194150  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194151  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194152  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194153  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194154  |   4.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194155  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194156  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194157  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194158  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194159  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194160  |  24.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194161  |  10.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194162  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194163  |  96.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194164  |  90.4%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194165  |  99.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194166  |  80.2%     | High Risk     | Low Risk       | Comprehensive evaluation needed\n",
            "Patient 194167  |  83.7%     | High Risk     | Low Risk       | Comprehensive evaluation needed\n",
            "Patient 194168  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194169  |  13.8%     | Low Risk      | High Risk      | Routine screening\n",
            "Patient 194170  |   3.5%     | Low Risk      | High Risk      | Routine screening\n",
            "Patient 194171  |   1.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194172  |   1.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194173  |   1.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194174  |   1.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194175  |  12.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194176  |  12.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194177  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194178  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194179  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194180  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194181  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194182  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194183  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194184  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194185  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194186  |  99.6%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194187  | 100.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194188  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194189  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194190  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194191  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194192  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194193  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194194  |   4.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194195  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194196  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194197  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194198  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194199  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194200  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194201  |  14.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194202  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194203  | 100.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194204  |  98.1%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194205  |  99.8%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194206  |  14.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194207  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194208  |  16.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194209  |  98.3%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194210  |  93.7%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194211  |  99.2%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194212  |  99.6%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194213  |  99.4%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194214  |  82.6%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194215  |  99.7%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194216  |  99.9%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194217  | 100.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194218  |   0.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194219  |  67.3%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194220  |  44.1%     | Medium Risk   | Low Risk       | Enhanced monitoring\n",
            "Patient 194221  |   2.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194222  |  10.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194223  |   1.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194224  |   1.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194225  |   1.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194226  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194227  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194228  |  91.8%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194229  |  99.4%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194230  |  99.3%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194231  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194232  |   7.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194233  |  11.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194234  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194235  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194236  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194237  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194238  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194239  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194240  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194241  |   7.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194242  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194243  |  61.5%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194244  |  96.6%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194245  |  99.3%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194246  |  97.3%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194247  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194248  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194249  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194250  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194251  |   0.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194252  |  72.5%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194253  |  96.3%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194254  |   8.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194255  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194256  |   8.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194257  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194258  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194259  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194260  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194261  |   8.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194262  |  15.4%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194263  |   2.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194264  |  99.7%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194265  |  99.8%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194266  |  99.9%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194267  |  67.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194268  |  97.6%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194269  |  99.4%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194270  |  99.6%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194271  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194272  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194273  |  26.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194274  |  56.1%     | Medium Risk   | High Risk      | Enhanced monitoring\n",
            "Patient 194275  |  59.5%     | Medium Risk   | High Risk      | Enhanced monitoring\n",
            "Patient 194276  |  94.3%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194277  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194278  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194279  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194280  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194281  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194282  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194283  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194284  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194285  |   0.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194286  |   0.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194287  |   0.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194288  |   0.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194289  |   0.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194290  |   0.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194291  |   0.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194292  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194293  |  24.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194294  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194295  |   9.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194296  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194297  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194298  |   9.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194299  |   8.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194300  |   9.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194301  |  84.6%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194302  |  90.1%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194303  |   1.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194304  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194305  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194306  |  99.8%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194307  |  99.9%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194308  |  99.7%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194309  |  99.7%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194310  |  99.7%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194311  |  99.8%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194312  |  92.5%     | High Risk     | Low Risk       | Comprehensive evaluation needed\n",
            "Patient 194313  |  85.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194314  |  74.1%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194315  |  69.6%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194316  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194317  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194318  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194319  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194320  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194321  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194322  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194323  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194324  |   1.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194325  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194326  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194327  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194328  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194329  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194330  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194331  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194332  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194333  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194334  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194335  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194336  |  10.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194337  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194338  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194339  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194340  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194341  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194342  |   4.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194343  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194344  |   4.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194345  |  95.1%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194346  |  96.6%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194347  | 100.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194348  | 100.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194349  |   2.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194350  |  99.9%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194351  |  99.4%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194352  |  99.6%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194353  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194354  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194355  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194356  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194357  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194358  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194359  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194360  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194361  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194362  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194363  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194364  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194365  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194366  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194367  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194368  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194369  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194370  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194371  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194372  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194373  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194374  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194375  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194376  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194377  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194378  |   7.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194379  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194380  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194381  |   2.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194382  |   0.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194383  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194384  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194385  |  13.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194386  |   8.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194387  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194388  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194389  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194390  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194391  |  58.7%     | Medium Risk   | High Risk      | Enhanced monitoring\n",
            "Patient 194392  |  13.8%     | Low Risk      | High Risk      | Routine screening\n",
            "Patient 194393  |  97.1%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194394  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194395  |   0.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194396  |   5.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194397  |   1.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194398  |   1.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194399  |  17.4%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194400  |   0.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194401  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194402  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194403  |   3.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194404  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194405  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194406  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194407  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194408  |   0.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194409  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194410  |   0.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194411  |  29.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194412  |  68.9%     | High Risk     | Low Risk       | Comprehensive evaluation needed\n",
            "Patient 194413  |  14.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194414  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194415  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194416  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194417  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194418  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194419  |  18.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194420  |  11.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194421  |  46.4%     | Medium Risk   | High Risk      | Enhanced monitoring\n",
            "Patient 194422  |  15.7%     | Low Risk      | High Risk      | Routine screening\n",
            "Patient 194423  |  99.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194424  |  99.9%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194425  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194426  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194427  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194428  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194429  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194430  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194431  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194432  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194433  |  94.5%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194434  |  98.7%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194435  |   1.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194436  |   1.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194437  |   1.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194438  |   1.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194439  |   1.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194440  |   1.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194441  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194442  |   0.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194443  |   0.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194444  |   0.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194445  |   0.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194446  |   0.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194447  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194448  |   0.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194449  |   0.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194450  |   0.5%     | Low Risk      | High Risk      | Routine screening\n",
            "Patient 194451  |  27.4%     | Low Risk      | High Risk      | Routine screening\n",
            "Patient 194452  |  56.4%     | Medium Risk   | High Risk      | Enhanced monitoring\n",
            "Patient 194453  |   9.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194454  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194455  |  78.8%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194456  |  55.2%     | Medium Risk   | High Risk      | Enhanced monitoring\n",
            "Patient 194457  |  76.1%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194458  |  99.5%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194459  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194460  |   5.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194461  |  91.3%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194462  |  65.6%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194463  |  57.3%     | Medium Risk   | High Risk      | Enhanced monitoring\n",
            "Patient 194464  |  96.2%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194465  |  98.6%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194466  |  98.4%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194467  |  99.2%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194468  |  33.9%     | Medium Risk   | High Risk      | Enhanced monitoring\n",
            "Patient 194469  |  47.4%     | Medium Risk   | High Risk      | Enhanced monitoring\n",
            "Patient 194470  |  99.2%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194471  |  99.5%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194472  |  99.9%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194473  |  99.9%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194474  |  99.9%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194475  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194476  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194477  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194478  |  53.7%     | Medium Risk   | High Risk      | Enhanced monitoring\n",
            "Patient 194479  |  99.2%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194480  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194481  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194482  |   7.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194483  |  13.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194484  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194485  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194486  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194487  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194488  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194489  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194490  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194491  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194492  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194493  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194494  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194495  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194496  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194497  | 100.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194498  |  99.9%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194499  | 100.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194500  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194501  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194502  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194503  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194504  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194505  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194506  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194507  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194508  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194509  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194510  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194511  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194512  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194513  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194514  |   9.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194515  |   7.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194516  |   3.4%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194517  |   1.5%     | Low Risk      | High Risk      | Routine screening\n",
            "Patient 194518  |   9.2%     | Low Risk      | High Risk      | Routine screening\n",
            "Patient 194519  |  11.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194520  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194521  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194522  |   6.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194523  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194524  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194525  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194526  |   7.4%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194527  |  36.1%     | Medium Risk   | Low Risk       | Enhanced monitoring\n",
            "Patient 194528  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194529  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194530  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194531  |   1.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194532  |  58.2%     | Medium Risk   | Low Risk       | Enhanced monitoring\n",
            "Patient 194533  |  75.7%     | High Risk     | Low Risk       | Comprehensive evaluation needed\n",
            "Patient 194534  |  96.2%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194535  | 100.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194536  | 100.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194537  | 100.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194538  |   2.4%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194539  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194540  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194541  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194542  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194543  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194544  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194545  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194546  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194547  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194548  |   3.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194549  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194550  |   5.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194551  |  61.2%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194552  |  75.1%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194553  |  55.0%     | Medium Risk   | High Risk      | Enhanced monitoring\n",
            "Patient 194554  |  95.7%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194555  |  98.3%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194556  |   2.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194557  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194558  |   1.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194559  |   2.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194560  |   1.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194561  |  20.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194562  |  67.7%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194563  |   2.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194564  |  99.9%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194565  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194566  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194567  |  98.6%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194568  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194569  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194570  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194571  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194572  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194573  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194574  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194575  |   4.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194576  |   8.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194577  |  83.6%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194578  |  90.6%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194579  |  98.1%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194580  |  96.9%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194581  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194582  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194583  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194584  |   7.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194585  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194586  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194587  |  18.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194588  |  13.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194589  |  12.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194590  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194591  |  10.4%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194592  |  99.2%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194593  | 100.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194594  |  11.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194595  |  50.7%     | Medium Risk   | Low Risk       | Enhanced monitoring\n",
            "Patient 194596  |  26.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194597  |  28.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194598  |  28.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194599  |  18.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194600  |  15.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194601  |   9.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194602  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194603  |  12.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194604  |  40.7%     | Medium Risk   | Low Risk       | Enhanced monitoring\n",
            "Patient 194605  |  14.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194606  |   4.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194607  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194608  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194609  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194610  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194611  |   2.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194612  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194613  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194614  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194615  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194616  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194617  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194618  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194619  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194620  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194621  |   4.4%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194622  |  21.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194623  |  40.9%     | Medium Risk   | Low Risk       | Enhanced monitoring\n",
            "Patient 194624  |  80.7%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194625  |  25.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194626  |  17.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194627  |   8.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194628  |   6.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194629  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194630  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194631  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194632  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194633  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194634  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194635  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194636  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194637  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194638  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194639  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194640  |   9.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194641  |   6.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194642  |   5.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194643  |   5.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194644  |  11.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194645  |   8.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194646  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194647  |   9.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194648  |   1.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194649  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194650  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194651  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194652  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194653  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194654  |  15.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194655  |   1.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194656  |   1.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194657  |   1.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194658  |   1.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194659  |   1.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194660  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194661  |   1.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194662  |   1.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194663  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194664  |   2.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194665  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194666  |   0.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194667  |   1.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194668  | 100.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194669  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194670  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194671  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194672  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194673  |  94.9%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194674  |  96.8%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194675  |  98.2%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194676  |  98.6%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194677  |   7.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194678  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194679  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194680  |   8.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194681  |  24.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194682  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194683  |   7.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194684  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194685  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194686  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194687  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194688  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194689  |  23.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194690  |   1.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194691  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194692  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194693  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194694  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194695  |  96.8%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194696  |  15.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194697  |   1.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194698  |   1.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194699  |   0.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194700  |   3.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194701  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194702  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194703  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194704  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194705  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194706  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194707  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194708  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194709  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194710  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194711  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194712  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194713  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194714  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194715  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194716  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194717  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194718  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194719  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194720  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194721  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194722  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194723  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194724  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194725  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194726  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194727  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194728  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194729  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194730  |  19.1%     | Low Risk      | High Risk      | Routine screening\n",
            "Patient 194731  |  83.6%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194732  |  94.3%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194733  |  93.3%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194734  |  93.3%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194735  |  80.7%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194736  |   1.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194737  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194738  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194739  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194740  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194741  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194742  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194743  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194744  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194745  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194746  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194747  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194748  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194749  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194750  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194751  |  67.2%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194752  |  94.5%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194753  |  98.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194754  |  50.4%     | Medium Risk   | High Risk      | Enhanced monitoring\n",
            "Patient 194755  |  73.2%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194756  |  79.9%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194757  |  97.7%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194758  |  96.1%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194759  |  97.8%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194760  |  99.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194761  |  97.5%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194762  |  99.9%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194763  |  99.9%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194764  |  99.8%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194765  |  99.8%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194766  |  99.8%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194767  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194768  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194769  |  38.8%     | Medium Risk   | High Risk      | Enhanced monitoring\n",
            "Patient 194770  |   1.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194771  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194772  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194773  |  17.4%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194774  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194775  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194776  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194777  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194778  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194779  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194780  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194781  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194782  |   5.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194783  |  91.5%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194784  |  99.4%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194785  |  99.6%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194786  |  99.6%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194787  |  99.6%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194788  | 100.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194789  |   1.4%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194790  |   9.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194791  |   1.4%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194792  |   1.4%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194793  |  20.4%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194794  |   1.4%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194795  |  16.3%     | Low Risk      | High Risk      | Routine screening\n",
            "Patient 194796  |  48.5%     | Medium Risk   | High Risk      | Enhanced monitoring\n",
            "Patient 194797  |  77.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194798  |  89.7%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194799  |  98.8%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194800  |  91.7%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194801  |   0.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194802  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194803  |   0.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194804  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194805  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194806  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194807  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194808  |   2.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194809  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194810  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194811  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194812  |   1.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194813  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194814  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194815  |   8.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194816  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194817  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194818  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194819  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194820  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194821  |   2.4%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194822  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194823  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194824  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194825  |  11.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194826  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194827  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194828  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194829  |   2.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194830  |   1.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194831  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194832  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194833  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194834  |   0.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194835  |   0.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194836  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194837  |   2.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194838  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194839  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194840  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194841  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194842  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194843  |   3.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194844  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194845  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194846  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194847  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194848  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194849  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194850  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194851  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194852  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194853  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194854  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194855  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194856  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194857  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194858  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194859  |  11.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194860  |   9.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194861  |   1.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194862  |   1.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194863  |   1.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194864  |   1.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194865  |   1.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194866  |   1.4%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194867  |   1.4%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194868  |   3.4%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194869  |   1.4%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194870  |   1.4%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194871  |  11.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194872  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194873  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194874  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194875  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194876  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194877  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194878  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194879  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194880  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194881  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194882  |  16.4%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194883  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194884  |  16.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194885  |   5.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194886  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194887  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194888  |  87.6%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194889  |  33.3%     | Medium Risk   | High Risk      | Enhanced monitoring\n",
            "Patient 194890  |  76.1%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194891  |  59.3%     | Medium Risk   | High Risk      | Enhanced monitoring\n",
            "Patient 194892  |  54.4%     | Medium Risk   | High Risk      | Enhanced monitoring\n",
            "Patient 194893  |  79.5%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194894  |  53.1%     | Medium Risk   | High Risk      | Enhanced monitoring\n",
            "Patient 194895  |  62.8%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194896  |  72.6%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194897  |  99.4%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194898  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194899  |   5.4%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194900  |  62.1%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194901  |  39.5%     | Medium Risk   | High Risk      | Enhanced monitoring\n",
            "Patient 194902  |  76.1%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194903  |  95.8%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194904  |  98.2%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194905  |  98.4%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194906  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194907  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194908  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194909  |   6.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194910  |   6.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194911  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194912  |  10.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194913  |   6.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194914  |   1.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194915  |   1.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194916  |   1.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194917  |   1.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194918  |   1.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194919  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194920  |   0.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194921  |   2.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194922  |   1.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194923  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194924  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194925  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194926  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194927  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194928  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194929  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194930  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194931  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194932  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194933  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194934  |   1.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194935  |   3.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194936  |   1.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194937  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194938  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194939  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194940  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194941  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194942  |   1.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194943  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194944  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194945  |   1.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194946  |   1.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194947  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194948  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194949  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194950  |   2.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194951  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194952  |   3.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194953  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194954  |   5.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194955  |   5.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194956  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194957  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194958  |  99.7%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194959  |  99.8%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194960  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194961  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194962  |  99.9%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194963  |  99.9%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194964  |  99.9%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194965  |  59.5%     | Medium Risk   | High Risk      | Enhanced monitoring\n",
            "Patient 194966  |  50.8%     | Medium Risk   | High Risk      | Enhanced monitoring\n",
            "Patient 194967  |  99.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194968  |   8.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194969  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194970  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194971  |   6.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194972  |   1.0%     | Low Risk      | High Risk      | Routine screening\n",
            "Patient 194973  |   0.9%     | Low Risk      | High Risk      | Routine screening\n",
            "Patient 194974  |   6.3%     | Low Risk      | High Risk      | Routine screening\n",
            "Patient 194975  |  22.3%     | Low Risk      | High Risk      | Routine screening\n",
            "Patient 194976  |  56.9%     | Medium Risk   | High Risk      | Enhanced monitoring\n",
            "Patient 194977  |  72.1%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194978  |  61.3%     | High Risk     | Low Risk       | Comprehensive evaluation needed\n",
            "Patient 194979  |   8.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194980  |   0.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194981  |   0.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194982  |   0.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194983  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194984  |   0.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194985  |   0.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194986  |   0.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194987  |   0.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194988  |   0.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194989  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194990  |   0.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194991  |   0.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194992  |   1.8%     | Low Risk      | High Risk      | Routine screening\n",
            "Patient 194993  |  23.5%     | Low Risk      | High Risk      | Routine screening\n",
            "Patient 194994  |  99.6%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194995  |  99.6%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 194996  |   1.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194997  |   1.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194998  |   1.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 194999  |   1.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195000  |   1.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195001  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195002  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195003  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195004  |   9.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195005  |   5.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195006  |   5.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195007  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195008  |   1.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195009  |   2.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195010  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195011  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195012  |   1.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195013  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195014  |  48.6%     | Medium Risk   | High Risk      | Enhanced monitoring\n",
            "Patient 195015  |  97.5%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 195016  |  99.3%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 195017  |   1.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195018  |  31.9%     | Medium Risk   | High Risk      | Enhanced monitoring\n",
            "Patient 195019  |  58.2%     | Medium Risk   | High Risk      | Enhanced monitoring\n",
            "Patient 195020  |  90.5%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 195021  |  99.9%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 195022  |  99.2%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 195023  | 100.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 195024  |  74.7%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 195025  |  99.7%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 195026  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195027  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195028  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195029  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195030  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195031  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195032  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195033  |   3.4%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195034  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195035  |  11.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195036  |   1.5%     | Low Risk      | High Risk      | Routine screening\n",
            "Patient 195037  |  97.7%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 195038  |  99.5%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 195039  |  99.5%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 195040  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195041  |  16.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195042  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195043  |   7.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195044  |  13.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195045  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195046  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195047  |   1.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195048  |   1.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195049  |   1.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195050  |   1.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195051  |   1.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195052  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195053  |   0.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195054  |   0.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195055  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195056  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195057  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195058  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195059  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195060  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195061  |  83.7%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 195062  |  98.1%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 195063  |  99.8%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 195064  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195065  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195066  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195067  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195068  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195069  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195070  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195071  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195072  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195073  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195074  |   3.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195075  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195076  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195077  |  18.9%     | Low Risk      | High Risk      | Routine screening\n",
            "Patient 195078  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195079  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195080  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195081  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195082  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195083  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195084  |   2.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195085  |  29.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195086  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195087  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195088  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195089  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195090  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195091  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195092  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195093  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195094  |  12.6%     | Low Risk      | High Risk      | Routine screening\n",
            "Patient 195095  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195096  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195097  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195098  |   5.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195099  |  43.1%     | Medium Risk   | High Risk      | Enhanced monitoring\n",
            "Patient 195100  |  13.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195101  |   3.2%     | Low Risk      | High Risk      | Routine screening\n",
            "Patient 195102  |  26.6%     | Low Risk      | High Risk      | Routine screening\n",
            "Patient 195103  |  36.9%     | Medium Risk   | High Risk      | Enhanced monitoring\n",
            "Patient 195104  |  70.6%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 195105  |   0.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195106  |   2.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195107  |   0.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195108  |  82.7%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 195109  |  92.4%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 195110  |  98.1%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 195111  |  98.6%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 195112  |  94.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 195113  |  99.6%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 195114  |  99.8%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 195115  |  99.8%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 195116  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195117  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195118  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195119  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195120  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195121  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195122  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195123  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195124  |  12.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195125  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195126  |   3.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195127  |   1.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195128  |   1.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195129  |   1.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195130  |   1.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195131  |   1.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195132  |   1.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195133  |   1.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195134  |   1.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195135  |   1.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195136  |  98.5%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 195137  |   1.4%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195138  |   1.4%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195139  |   7.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195140  |  98.8%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 195141  |  99.9%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 195142  |  99.9%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 195143  |  99.9%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 195144  |   1.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195145  |   1.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195146  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195147  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195148  |   4.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195149  |   7.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195150  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195151  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195152  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195153  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195154  |   1.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195155  |  92.8%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 195156  |  92.9%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 195157  |  88.3%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 195158  |  95.9%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 195159  |   1.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195160  |   0.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195161  |   0.7%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195162  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195163  |   1.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195164  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195165  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195166  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195167  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195168  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195169  |   3.2%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195170  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195171  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195172  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195173  |   1.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195174  |  99.6%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 195175  | 100.0%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 195176  |   0.8%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195177  |   0.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195178  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195179  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195180  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195181  |   3.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195182  |   2.3%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195183  |  57.8%     | Medium Risk   | High Risk      | Enhanced monitoring\n",
            "Patient 195184  |  53.9%     | Medium Risk   | High Risk      | Enhanced monitoring\n",
            "Patient 195185  |  93.6%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 195186  |  98.4%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 195187  |   2.1%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195188  |   0.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195189  |   0.5%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195190  |  25.0%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195191  |   9.9%     | Low Risk      | Low Risk       | Routine screening\n",
            "Patient 195192  |  84.7%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 195193  |  48.5%     | Medium Risk   | Low Risk       | Enhanced monitoring\n",
            "Patient 195194  |  28.1%     | Low Risk      | High Risk      | Routine screening\n",
            "Patient 195195  |  81.5%     | High Risk     | High Risk      | Comprehensive evaluation needed\n",
            "Patient 195196  |   1.6%     | Low Risk      | Low Risk       | Routine screening\n",
            "\n",
            "COMPLETE POPULATION RISK DISTRIBUTION:\n",
            "Low Risk (<30%): 128974 patients (66.1%)\n",
            "Medium Risk (30-60%): 11775 patients (6.0%)\n",
            "High Risk (60%): 54447 patients (27.9%)\n",
            "\n",
            "COMPREHENSIVE CLINICAL IMPACT:\n",
            "  - Correctly identified 49158 high-risk patients\n",
            "  - 5289 false positives (low-risk flagged as high-risk)\n",
            "  - Correctly identified 125281 low-risk patients\n",
            "  - 3693 false negatives (high-risk missed)\n",
            "\n",
            "MODEL PERFORMANCE ON FULL DATASET:\n",
            "  - Accuracy: 0.9301\n",
            "  - Precision: 0.8767\n",
            "  - Recall: 0.8881\n",
            "  - F1-Score: 0.8824\n",
            "\n",
            "RISK DISTRIBUTION BY ACTUAL STATUS:\n",
            " - Actual High-Risk patients correctly flagged: 49158/57590 (85.4%)\n",
            " - Low-Risk patients incorrectly flagged: 5289/137606 (3.8%)\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "# Final Dementia Risk Prediction Summary\n",
        "print(\"---DEMENTIA RISK PREDICTION FINAL SUMMARY---\")\n",
        "\n",
        "# Helper function for feature descriptions\n",
        "def get_feature_description(feature_name):\n",
        "    descriptions = {\n",
        "        'NACCAGE': 'Age',\n",
        "        'EDUC': 'Education Level',\n",
        "        'SEX': 'Gender',\n",
        "        'MARISTAT': 'Marital Status',\n",
        "        'TOBAC30': 'Tobacco Use',\n",
        "        'ALCFREQ': 'Alcohol Frequency',\n",
        "        'RESIDENC': 'Residence Type',\n",
        "        'NACCLIVS': 'Living Situation',\n",
        "        'INDEPEND': 'Independence Level',\n",
        "        'BILLS': 'Bill Management',\n",
        "        'SHOPPING': 'Shopping Ability',\n",
        "        'HEIGHT': 'Height',\n",
        "        'WEIGHT': 'Weight',\n",
        "        'RACE': 'Race',\n",
        "        'HISPANIC': 'Hispanic Ethnicity'\n",
        "    }\n",
        "    return descriptions.get(feature_name, feature_name)\n",
        "\n",
        "# Prepare top feature importance text\n",
        "feature_importance_text = \"\"\n",
        "if hasattr(best_model, 'feature_importances_'):\n",
        "    top_features_df = pd.DataFrame({\n",
        "        'feature': selected_features,\n",
        "        'importance': best_model.feature_importances_\n",
        "    }).sort_values('importance', ascending=False).head(5)\n",
        "\n",
        "    feature_importance_text = \"\\n\".join([\n",
        "        f\"  {i+1}. {row['feature']} (importance: {row['importance']:.4f}) - {get_feature_description(row['feature'])}\"\n",
        "        for i, (_, row) in enumerate(top_features_df.iterrows())\n",
        "    ])\n",
        "else:\n",
        "    feature_importance_text = \"\\n\".join([\n",
        "        f\"  {i+1}. {feature} - {get_feature_description(feature)}\"\n",
        "        for i, feature in enumerate(selected_features[:5])\n",
        "    ])\n",
        "\n",
        "# Print final summary\n",
        "print(f\"\"\"\n",
        "DEMENTIA RISK PREDICTION MODEL - FINAL SUMMARY\n",
        "==================================================\n",
        "\n",
        "MODEL PURPOSE\n",
        "----------------\n",
        "Predicts future dementia risk based on non-medical factors only.\n",
        "\n",
        "MODEL PERFORMANCE\n",
        "-------------------\n",
        "Model: {best_model_name}\n",
        "Number of Non-Medical Features: {len(selected_features)}\n",
        "\n",
        "Metrics:\n",
        "   Accuracy: {final_accuracy:.4f}\n",
        "   Precision: {final_precision:.4f} (correct high-risk predictions)\n",
        "   Recall: {final_recall:.4f} (proportion of actual high-risk identified)\n",
        "   F1-Score: {final_f1:.4f} (balance of precision & recall)\n",
        "   AUC-ROC: {final_auc:.4f} (discrimination between high/low risk)\n",
        "   CV Mean AUC: {cv_scores.mean():.4f}\n",
        "\n",
        "TOP 5 RISK FACTORS\n",
        "---------------------\n",
        "{feature_importance_text}\n",
        "\n",
        "RISK STRATIFICATION\n",
        "----------------------\n",
        "- Low Risk (<30%): Routine monitoring\n",
        "- Medium Risk (30-60%): Enhanced screening\n",
        "- High Risk (60%): Comprehensive evaluation recommended\n",
        "\n",
        "CLINICAL NOTES\n",
        "-----------------\n",
        "- Predicts FUTURE dementia risk, not current diagnosis\n",
        "- Uses non-medical factors only\n",
        "- Serves as preventive screening tool\n",
        "- High-risk individuals should receive medical evaluation\n",
        "\n",
        "MODEL READY FOR DEPLOYMENT!\n",
        "\"\"\")\n",
        "\n",
        "# --- Save Model Artifacts ---\n",
        "import joblib\n",
        "\n",
        "model_artifacts = {\n",
        "    'model': best_model,\n",
        "    'scaler': scaler,\n",
        "    'selected_features': selected_features,\n",
        "    'label_encoders': label_encoders,\n",
        "    'risk_categories': {'low': 30, 'medium': 60, 'high': 100},\n",
        "    'model_type': 'Dementia Risk Prediction',\n",
        "    'performance_metrics': {\n",
        "        'accuracy': final_accuracy,\n",
        "        'precision': final_precision,\n",
        "        'recall': final_recall,\n",
        "        'f1_score': final_f1,\n",
        "        'auc_score': final_auc,\n",
        "        'cv_mean_auc': cv_scores.mean()\n",
        "    },\n",
        "    'feature_descriptions': {f: get_feature_description(f) for f in selected_features}\n",
        "}\n",
        "\n",
        "joblib.dump(model_artifacts, 'dementia_risk_prediction_model.pkl')\n",
        "print(\"Model saved as 'dementia_risk_prediction_model.pkl'\")\n",
        "\n",
        "# --- Save performance summary ---\n",
        "performance_summary = pd.DataFrame({\n",
        "    'Metric': ['Accuracy', 'Precision', 'Recall', 'F1-Score', 'AUC-ROC', 'CV_Mean_AUC'],\n",
        "    'Value': [final_accuracy, final_precision, final_recall, final_f1, final_auc, cv_scores.mean()],\n",
        "    'Description': [\n",
        "        'Overall prediction accuracy',\n",
        "        'Proportion of correct high-risk predictions',\n",
        "        'Proportion of true high-risk cases identified',\n",
        "        'Balance between precision and recall',\n",
        "        'Ability to distinguish between high/low risk',\n",
        "        'Average performance across CV folds'\n",
        "    ]\n",
        "})\n",
        "performance_summary.to_csv('model_performance_summary.csv', index=False)\n",
        "print(\"Performance summary saved as 'model_performance_summary.csv'\")\n",
        "\n",
        "# --- Save feature importance ---\n",
        "if hasattr(best_model, 'feature_importances_'):\n",
        "    feature_importance_export = pd.DataFrame({\n",
        "        'Feature': selected_features,\n",
        "        'Importance': best_model.feature_importances_,\n",
        "        'Description': [get_feature_description(f) for f in selected_features]\n",
        "    }).sort_values('Importance', ascending=False)\n",
        "    feature_importance_export.to_csv('feature_importance_analysis.csv', index=False)\n",
        "    print(\"Feature importance saved as 'feature_importance_analysis.csv'\")\n",
        "\n",
        "print(\"\\nMODEL DEPLOYMENT READY!\")\n",
        "print(\"You can reload the model using: joblib.load('dementia_risk_prediction_model.pkl')\")\n"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "7nltt3fGS1Ik",
        "outputId": "9c7e1587-828c-4498-d86b-7c44b5ec895a"
      },
      "execution_count": 15,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "---DEMENTIA RISK PREDICTION FINAL SUMMARY---\n",
            "\n",
            "DEMENTIA RISK PREDICTION MODEL - FINAL SUMMARY\n",
            "==================================================\n",
            "\n",
            "MODEL PURPOSE\n",
            "----------------\n",
            "Predicts future dementia risk based on non-medical factors only.\n",
            "\n",
            "MODEL PERFORMANCE\n",
            "-------------------\n",
            "Model: XGBoost\n",
            "Number of Non-Medical Features: 15\n",
            "\n",
            "Metrics:\n",
            "   Accuracy: 0.9265\n",
            "   Precision: 0.8704 (correct high-risk predictions)\n",
            "   Recall: 0.8823 (proportion of actual high-risk identified)\n",
            "   F1-Score: 0.8763 (balance of precision & recall)\n",
            "   AUC-ROC: 0.9724 (discrimination between high/low risk)\n",
            "   CV Mean AUC: 0.9833\n",
            "\n",
            "TOP 5 RISK FACTORS\n",
            "---------------------\n",
            "  1. INDEPEND (importance: 0.4641) - Independence Level\n",
            "  2. SHOPPING (importance: 0.1742) - Shopping Ability\n",
            "  3. BILLS (importance: 0.1063) - Bill Management\n",
            "  4. TRAVEL (importance: 0.0858) - TRAVEL\n",
            "  5. TAXES (importance: 0.0562) - TAXES\n",
            "\n",
            "RISK STRATIFICATION\n",
            "----------------------\n",
            "- Low Risk (<30%): Routine monitoring\n",
            "- Medium Risk (30-60%): Enhanced screening\n",
            "- High Risk (60%): Comprehensive evaluation recommended\n",
            "\n",
            "CLINICAL NOTES\n",
            "-----------------\n",
            "- Predicts FUTURE dementia risk, not current diagnosis\n",
            "- Uses non-medical factors only\n",
            "- Serves as preventive screening tool\n",
            "- High-risk individuals should receive medical evaluation\n",
            "\n",
            "MODEL READY FOR DEPLOYMENT!\n",
            "\n",
            "Model saved as 'dementia_risk_prediction_model.pkl'\n",
            "Performance summary saved as 'model_performance_summary.csv'\n",
            "Feature importance saved as 'feature_importance_analysis.csv'\n",
            "\n",
            "MODEL DEPLOYMENT READY!\n",
            "You can reload the model using: joblib.load('dementia_risk_prediction_model.pkl')\n"
          ]
        }
      ]
    }
  ],
  "metadata": {
    "colab": {
      "name": "Welcome To Colab",
      "toc_visible": true,
      "provenance": []
    },
    "kernelspec": {
      "display_name": "Python 3",
      "name": "python3"
    }
  },
  "nbformat": 4,
  "nbformat_minor": 0
}